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 ABSTRACT	In	 the	 last	 decades	 a	 great	 deal	 of	 work	 in	 model	 organisms	 has	 revealed	 that	lifespan	of	an	organism	is	regulated	by	conserved	signaling	pathways	including	the	insulin/IGF-1	 and	 the	 target	 of	 rapamycin	 (TOR)	 signaling	pathways	 that	mediate	longevity	 across	 species.	 A	 number	 of	 conserved	 transcription	 factors	 have	 been	identified	that	work	downstream	of	these	pathways	to	modulate	lifespan	extension.	However,	 it	 still	 remains	 elusive	 if	 there	 are	 common	 downstream	 targets	 and	shared	mechanisms	that	are	affected	by	all	these	pathways	to	bring	about	a	change	in	 organismal	 lifespan.	 It	 is	 therefore	 of	 great	 interest	 to	 understand	 these	convergent	 mechanisms	 because	 fine-tuning	 of	 the	 factors	 involved	 in	 these	mechanisms	 may	 be	 sufficient	 to	 induce	 longevity	 and	 lead	 to	 resistance	 against	age-associated	diseases.	 Therapeutic	 interventions	 could	 be	 designed	 to	modulate	the	 function	of	 these	convergent	mechanisms,	which	may	prove	 to	be	sufficient	 to	avail	of	the	benefits	of	improved	health	and	longevity.																In	this	study	we	found	ncl-1	as	a	convergent	regulator	of	C.	elegans	lifespan	working	downstream	of	 different	 longevity	 pathways.	We	 identified	ncl-1	 in	RNAi	based	 genetic	 screens	 as	 a	 suppressor	 of	 dietary	 restriction	 (DR)	 mediated	longevity,	using	the	eat-2	mutant,	which	is	the	genetic	model	of	DR	in	C.	elegans.	ncl-
1	 encodes	 a	 cytoplasmic	B-box	 zinc	 finger	protein	 that	 inhibits	 rRNA	and	5S	RNA	transcription	and	protein	synthesis.	Consistent	with	a	role	 in	ribosome	biogenesis,	NCL-1	regulates	nucleolar	size	and	ncl-1	mutants	have	larger	nucleoli	especially	 in	neuronal,	 muscle	 and	 hypodermal	 cells.	 Lifespan	 analyses	 revealed	 that	 ncl-1	 is	required	 for	 longevity	 conferred	 by	 DR,	 reduced	 insulin/IGF-1	 and	 reduced	 TOR	signaling	pathways.	ncl-1	was	also	required	for	mitochondrial	and	gonadal	longevity	models	 in	 C.	 elegans	 indicating	 that	 NCL-1	 works	 as	 a	 common	 downstream	regulator	 of	 longevity	 in	 C.	 elegans.	 Consistent	 with	 these	 findings,	 ncl-1	 over-expression	was	sufficient	to	promote	longevity.																	Since	 loss	 of	 ncl-1	 enlarges	 nucleoli	 of	 worms	 in	 different	 tissues,	 we	investigated	 nucleolar	 size	 in	 different	 long-lived	 worms	 representing	 different	longevity	 pathways	 in	 C.	 elegans.	 Strikingly	 we	 observed	 that	 all	 the	 long-lived	
 animals	tested,	exhibited	smaller	nucleoli	in	different	tissues	compared	to	wildtype.	Among	 wildtype	 animals	 there	 is	 a	 high	 variation	 in	 nucleolar	 size,	 however	 we	found	 that	 it	 is	highly	predictive	 for	 lifespan	 in	an	 isogenic	population.	Consistent	with	 smaller	 nucleoli,	 all	 these	 different	 long-lived	 animals	 possessed	 reduced	ribosome	 biogenesis	 and	 reduced	 levels	 of	 the	 nucleolar	marker	 FIB-1/Fibrillarin	and	these	effects	were	reversed	with	the	loss	of	ncl-1.		In	accord	with	reduced	levels	of	FIB-1/Fibrillarin	in	long-lived	animals,	a	modest	reduction	of	FIB-1/Fibrillarin	in	wildtype	animals	increased	their	lifespan.																	Consistent	 with	 our	 findings	 in	 C.	 elegans,	we	 observed	 smaller	 nucleoli,	reduced	ribosome	biogenesis	and	reduced	FIB-1	levels	in	long-lived	Drosophila.	We	also	 detected	 smaller	 nucleoli	 in	 different	 tissues	 of	 long-lived	 DR	 and	 IRS-1	knockout	mice	and	also	in	humans	who	undergo	modest	dietary	restriction	coupled	with	 exercise.	 Thus	 it	 is	 highly	 suggestive	 that	 smaller	 nucleoli	 and	 reduced	ribosome	biogenesis	are	hallmarks	of	longevity	across	species.		
	
	
	
	
	
	
	
	
	
	
	
 ZUSAMMENFASSUNG	Die	 wissenschaftliche	 Arbeit	 der	 letzten	 Jahrzehnte	 hat	 gezeigt,	 dass	 die	Lebensdauer	 eines	 Organismus	 durch	 konservierte	 Signalwege	 reguliert	 wird.	 Zu	diesen	 gehören	 beispielsweise	 der	 Insulin/IGF-1-	 und	 der	 TOR-(engl.	 target	 of	rapamycin)-Signalweg,	welche	wichtige	Rollen	für	die	Langlebigkeit	verschiedenster	Spezies	 spielen.	Es	wurden	viele	konservierte	Transkriptionsfaktoren	 identifiziert,	welche	 diesen	 Signalwegen	 nachgeschaltet	 sind	 und	 die	 Langlebigkeit	 vermitteln.	Jedoch	 ist	 es	 bislang	 ungeklärt	 ob	 all	 diese	 Signalwege	 gemeinsame	 Targets	 oder	Mechanismen	beeinflussen,	um	eine	Änderung	der	Lebensdauer	hervorzurufen.	Es	besteht	 großes	 Interesse	 daran,	 diese	 zusammenlaufenden	 Mechanismen	 zu	verstehen,	 da	 auch	 nur	 kleinste	 Manipulationen	 an	 diesen	 Mechanismen	ausreichend	 sein	 könnten	 um	 Langlebigkeit	 und	 Resistenz	 gegenüber	altersbedingten	 Erkrankungen	 zu	 vermitteln.	 Therapeutische	 Eingriffe	 könnten	darauf	 basieren,	 diese	 konvergenten	 Mechanismen	 zu	 modulieren	 und	 deren	Vorteile	für	Gesundheit	und	Langlebigkeit	nutzbar	zu	machen.																In	 der	 vorliegenden	 Arbeit	 haben	 wir	 mit	 ncl-1	 einen	 konvergenten	Regulator	der	Lebensdauer	des	Modellorganismus	C.	elegans	 gefunden.	Wir	haben	
ncl-1	in	einem	RNAi-basierten	genetischen	Screen	als	Suppressor	der	Langlebigkeit	von	 eat-2	 Mutanten	 identifiziert.	 Die	 Langlebigkeit	 dieser	 Mutanten	 wird	 durch	Beschränkung	der	Nahrungsaufnahme	(engl.	dietary	restriction,	DR)	hervorgerufen.	
ncl-1	kodiert	ein	zytoplasmatisches	B-Box	Zinkfingerprotein,	welches	die	Synthese	ribosomaler	RNA	und	Proteinbiosynthese	 inhibiert.	 In	Übereinstimmung	mit	einer	Rolle	 in	der	Ribosom-Biogenese	reguliert	NCL-1	die	Größe	der	Nukleoli	und	ncl-1-Mutanten	 weisen	 größere	 Nukleoli	 auf,	 vor	 allem	 im	 neuronalen,	 Muskel-	 und	hypodermalen	 Gewebe.	 Unsere	 Analyse	 der	 Lebensdauer	 von	 verschiedenen	langlebigen	Wurmstämmen	 hat	 ergeben,	 dass	ncl-1	 für	 die	 Langlebigkeit	 benötigt	wird,	 welche	 durch	 DR,	 reduzierte	 Insulin/IGF-1-	 und	 TOR-Signalübertragung	induziert	wird.	Des	Weiteren	war	ncl-1	 	auch	 für	die	mitochondriale	und	gonadale	Langlebigkeit	 erforderlich,	 welches	 darauf	 hinweist,	 dass	 NCL-1	 als	 allgemeiner	
 Regulator	 der	 Langlebigkeit	 in	 C.	 elegans	 agiert.	 Dementsprechend	 genügte	 die	Überexpression	von	NCL-1,	um	Langlebigkeit	in	Würmern	zu	induzieren.																	Da	 der	 Verlust	 von	ncl-1	 zur	 Vergrößerung	 der	Nukleoli	 in	 verschiedenen	Geweben	 des	 Wurmes	 führt,	 untersuchten	 wir	 die	 Größe	 der	 Nukleoli	 in	verschiedenen	 langlebigen	 C.	 elegans	 Mutanten,	 welche	 verschiedene		Langlebigkeits-Signalwege	 repräsentieren.	 Dabei	 machten	 wir	 die	 erstaunliche	Beobachtung,	 dass	 alle	 untersuchten	 langlebigen	 Mutanten	 kleinere	 Nukleoli	 in	verschiedenen	 Geweben	 aufwiesen	 als	 Wildtyp-Würmer.	 Innerhalb	 der	 Wildtyp-Population	herrschte	eine	recht	große	Variabilität	in	der	Größe	der	Nukleoli.	Jedoch	erlaubte	die	Größe	des	Nukleolus	eine	Vorhersage	der	Lebenserwartung	innerhalb	einer	 isogenen	 Population.	 Konsistent	 mit	 der	 reduzierten	 nukleolären	 Größe	wiesen	 alle	 langlebigen	 Tiere	 eine	 verringerte	 Biogenese	 von	 Ribosomen	 und	niedrigere	 Level	 des	 nukleolären	 Markers	 Fibrillarin	 (FIB-1)	 auf,	 welches	 durch	Verlust	 von	 ncl-1	 aufgehoben	 werden	 konnte.	 In	 Übereinstimmung	 mit	 dem	verringerten	FIB-1	Level	in	langlebigen	Tieren	konnte	eine	leichte	Erniedrigung	der	FIB-1	Level	die	Lebensdauer	von	Wildtyp-Tieren	erhöhen.																Im	 Einklang	 mit	 unseren	 Ergebnissen	 in	 C.	 elegans	 konnten	 wir	 kleinere	Nukleoli,	 reduzierte	 Ribosomen-Biogenese	 und	 niedrigere	 FIB-1	 Level	 in	langlebigen	 Fruchtfliegen	 beobachten.	 Zusätzlich	 stellten	 wir	 eine	 signifikant	reduzierte	 nukleoläre	 Größe	 in	 verschiedenen	 Geweben	 von	 langlebigen	 DR-	 und	IRS-1-KO	 Mäusen	 sowie	 in	 Menschen,	 welche	 einer	 milden	 DR	 kombiniert	 mit	physischer	Anstrengung	ausgesetzt	waren,	fest.	Unsere	Resultate	weisen	also	stark	darauf	 hin,	 dass	 kleinere	 Nukleoli	 und	 reduzierte	 Ribosomen-Biogenese	Kennzeichen	der	Langlebigkeit	in	verschiedenen	Spezies	sind.			
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1.1 	Genetics	of	Aging	
Aging	was	formerly	believed	to	be	a	completely	random	process	occurring	due	to	a	decline	 in	 bodily	 functions	with	 time.	However	 our	 present	 understanding	 is	 that	regulated	longevity	processes	that	promote	and	maintain	cellular	functionality	and	counteract	aging,	gradually	become	dysregulated	and	thereby	lead	to	a	progressive	decline	 in	organismal	health.	Recent	 research	has	provided	 considerable	 evidence	that	 organismal	 lifespan	 is	 not	 random	 but	 a	 multifactorial	 process	 regulated	 by	genetic	and	environmental	factors.	A	large	number	of	genes	have	been	discovered	to	play	vital	roles	in	regulating	organismal	longevity.	Among	the	first	organisms	used	to	 study	 lifespan	 regulation	 using	 genetic	 approaches	 was	 the	 soil	 nematode	 C.	
elegans	(Klass,	1977).		The	prime	example	of	a	genetic	basis	of	lifespan	regulation	is	single	gene	mutations	that	modestly	reduce	the	insulin/IGF	signaling	pathway	and	cause	a	dramatic	extension	in	C.	elegans	lifespan	(Kenyon	et	al.,	1993;	Kimura	et	al.,	1997).	These	seminal	studies	led	to	the	prominence	of	genetics	in	the	field	of	aging	research	 to	 establish	 cause	 and	 effect	 relationships	 between	 gene	 function	 and	length	 of	 life.	 Subsequently	many	 other	 genes	 governing	 different	 pathways	 have	been	discovered	in	diverse	model	organisms	that	contribute	to	aging,	many	of	which	have	also	been	found	to	be	conserved	in	mammals	(Lopez-Otin	et	al.,	2013).	Genetic	factors	 have	 also	 been	 implicated	 in	 regulation	 of	 longevity	 in	 humans.	Polymorphisms	 in	 the	 insulin/IGF	pathway	have	been	associated	with	exceptional	longevity	in	centenarians	(van	Heemst	et	al.,	2005).	Single	gene	alterations	can	lead	to	drastic	differences	in	rates	of	aging,	as	in	the	case	of	human	progeroid	syndrome	(Navarro	 et	 al.,	 2006).	 Additionally,	mutations	 in	 nuclear	 and	mitochondrial	 DNA	have	been	associated	with	deterioration	of	somatic	stem	cell	 function	contributing	to	 aging	 (Sharpless	 and	 DePinho,	 2007).	 This	 growing	 body	 of	 evidence	 has	established	beyond	doubt	that	lifespan	of	an	organism	has	a	genetic	component.	The	field	of	molecular	genetics	of	aging	 is	moving	ahead	 in	 the	direction	of	unraveling	the	mechanisms	of	 action	and	 interaction	of	different	genetic	pathways	 impinging	on	 aging	 with	 the	 long	 term	 goal	 of	 increasing	 health	 span	 and	 reducing	 the	occurrence	of	age-associated	diseases.	
  2 
1.2	C.	elegans	as	a	Model	Organism	for	Aging	Research	
C.	elegans	is	a	soil	nematode	which	has	been	extensively	studied	in	the	field	of	aging	research.	It	was	established	as	a	model	organism	for	biological	research	by	Sydney	Brenner	 (Brenner,	 1974).	 C.	 elegans	 is	 an	 exemplary	 model	 system	 for	 studying	aging	because	 of	 its	 short	 lifespan	 and	powerful	 genetics.	Average	 lifespan	of	 this	nematode	worm	 is	 around	 three	 weeks,	 which	 makes	 it	 very	 convenient	 to	 do	lifespan	analyses	in	a	relatively	shorter	period	of	time.		Its	small	size	(1	mm),	growth	in	 large	 numbers,	 and	 easy	 handling	 also	 make	 it	 a	 convenient	 model	 system	 to	work	with.	Furthermore	C.	elegans	is	a	self-fertilizing	hermaphrodite	with	extensive	genetic	 tools	 available,	 making	 genetic	 manipulation	 and	 crosses	 relatively	 easy.	This	 is	 particularly	 important	 for	 performing	 genetic	 epistasis	 and	 synergy	experiments	 to	 establish	 genetic	 pathways.	 Another	 useful	 advantage	 is	 that	 gene	function	 can	 be	 specifically	 and	 potently	 knocked	 down	 using	 RNA	 inhibition	(RNAi),	whereby	double	stranded	RNA	against	a	given	gene	reduces	its	expression,	an	approach	first	discovered	in	C.	elegans	resulting	in	the	Nobel	prize	(Andrew	Fire	and	 Craig	 C.	 Mello)	 (Fire	 et	 al.,	 1998).	 RNAi	 is	 fairly	 easy	 and	 straightforward;	feeding	 specific	 short	 double-stranded	RNA	expressing	bacteria	 effectively	 knocks	down	the	target	gene	(Timmons	et	al.,	2001).	This	advantage	can	be	ideally	used	in	designing	 high-throughput	 RNAi	 based	 genetic	 screens	 (Boutros	 and	 Ahringer,	2008).	Another	benefit	that	C.	elegans	offers	is	that	it	consists	of	only	around	1000	somatic	cells	at	maturity,	which	has	allowed	its	cellular	development	to	be	traced	in	entirety	 (Sulston	 and	 Horvitz,	 1977;	 Sulston	 et	 al.,	 1983).	 	 Its	 transparency	 also	allows	live	imaging	of	worms	without	tedious	procedures	of	sample	preparation	for	imaging.	Moreover,	C.	elegans	was	the	first	multicellular	organism	to	have	its	whole	genome	sequenced	(Consortium,	1998).	This	allowed	for	the	identification	of	a	large	number	of	protein	coding	genes	 that	have	homologs	 in	mammals	and	 thus	can	be	studied	in	the	context	of	aging	and	disease.					
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1.3	Pathways	that	Regulate	Longevity			
1.3a	Insulin/IGF-1	Signaling	(IIS)	Pathway	and	Longevity	
By	far	the	most	extensively	investigated	signaling	pathway	in	the	context	of	aging	is	insulin/IGF-1	signaling	(IIS)	pathway.	The	first	evidence	that	IIS	pathway	regulates	longevity	 came	 with	 the	 isolation	 of	 single	 gene	 mutations	 that	 extend	 lifespan	(Klass,	 1983).	 Some	of	 these	 loci	were	 subsequently	 followed	up,	 including	age-1,	encoding	worm	ortholog	of	PI3K	(Morris	et	al.,	1996),	whose	mutation	induced	an	80%	 increase	 in	 longevity	 (Friedman	 and	 Johnson,	 1988).	 Later,	 the	 daf-2	 locus,	encoding	the	worm	ortholog	of	 the	 insulin/IGF	receptor	(Kimura	et	al.,	1997)	was	also	shown	to	extend	lifespan	by	2-3	fold	(Kenyon	et	al.,	1993).																Several	 lines	 of	molecular	 genetic	 evidence	 supported	 the	 view	 that	age-1	and	daf-2	worked	in	the	same	pathway.	For	example	there	was	no	additive	influence	on	lifespan	when	both	age-1	and	daf-2	were	mutated	together	(Dorman	et	al.,	1995;	Larsen	et	 al.,	 1995).	Additionally,	 the	 longevity	 conferred	by	both	age-1	 and	daf-2	mutants	required	 the	same	 factors	namely	daf-16	 and	daf-18,	which	encode	worm	orthologs	of	FOXO	and	Phosphatase	and	Tensin	Homolog	(PTEN)	(Lin	et	al.,	1997;	Ogg	et	al.,	1997;	Ogg	and	Ruvkun,	1998).		Both	daf-16/FOXO	and	daf-18/PTEN	work	downstream	 of	 daf-2	 in	 the	 IIS	 pathway.	 The	 IIS	 pathway	 relays	 its	 effects	 by	regulating	 the	 phosphorylation	 status	 of	 DAF-16/FOXO.	 When	 active,	 signaling	through	the	 IIS	pathway	 leads	 to	 the	activation	of	phosphoinositide	3-kinase	AGE-1/PI3K,	 which	 phosphorylates	 phosphatidylinositol	 4,5,-bisphosphate	 (PIP2)	 to	form	 phosphatidylinositol	 3,4,5-triphosphate	 (PIP3)	 (Morris	 et	 al.,	 1996).	 In	 the	presence	 of	 PIP3,	 3–phosphoinositide-dependent	 kinase	 PDK-1	 (Paradis	 et	 al.,	1999)	 phosphorylate	 AKT/PKB	 (Paradis	 and	 Ruvkun,	 1998)	 which	 together	 with	the	serine/threonine	kinase	SGK-1	phosphorylates	DAF-16/FOXO	(Hertweck	et	al.,	2004).	 Phosphorylated	 DAF-16/FOXO	 is	 thus	 exported	 out	 of	 the	 nucleus	 and	retained	in	the	cytoplasm	(Henderson	and	Johnson,	2001;	Lee	et	al.,	2001;	Lin	et	al.,	2001).	 In	contrast,	down-regulation	of	 this	kinase	cascade	 in	 turn	 leads	 to	nuclear	localization	of	DAF-16/FOXO	which	then	induces	the	expression	of	its	target	genes	thereby	leading	to	longevity	and	stress	resistance	(Murphy	et	al.,	2003).	Other	more	
  4 
recently	 identified	 transcriptional	mediators	 of	 IIS	 signaling	 include	 SKN-1/NRF2,	HSF-1,	and	PQM-1	(Hsu	et	al.,	2003;	Tepper	et	al.,	2013;	Tullet	et	al.,	2008).	Insulin	like	 peptides	 (ILPs),	which	 are	 the	 ligands	 of	 DAF-2,	 form	 the	 components	 of	 the	endocrine	 system.	 	 40	 of	 these	 ILPs	 have	 been	 described	 in	C.	 elegans,	 which	 are	variously	expressed	in	neurons,	gut,	and	gonad,	and	several	of	which	affect	lifespan	e.g.	daf-28	(Li	et	al.,	2003)	and	ins-7	(Murphy	et	al.,	2007).			Some	ILPs	such	as	INS-1	and	INS-18	act	antagonistically	to	DAF-2	and	thereby	over-expression	of	these	INS-1	and	 INS-18	 phenocopies	 the	 effects	 of	 daf-2	 reduction	 of	 function	 (Pierce	 et	 al.,	2001).	 Remarkably,	 the	 lifespan	 regulation	 by	 the	 IIS	 signaling	 pathway	 is	evolutionarily	conserved.	In	Drosophila	and	also	in	mice,	a	reduction	in	IIS	signaling	leads	to	an	extension	in	 lifespan	(Bartke,	2008;	Clancy	et	al.,	2001;	Kappeler	et	al.,	2008;	Selman	et	al.,	2008;	Tatar	et	al.,	2001).	Moreover,	in	humans,	polymorphisms	in	 the	 insulin/IGF	 pathway	 have	 been	 linked	with	 longevity	 in	 centenarians	 (van	Heemst	et	al.,	2005).																	In	 addition	 to	 regulating	 longevity,	 the	 IIS	 pathway	 also	 regulates	 larval	arrest	 called	 dauer	 in	 worms.	 Components	 of	C.	 elegans	IIS	 first	 emerged	 from	forward	genetic	 screens	designed	 to	 identify	mutants	with	abnormal	 regulation	of	dauer	arrest	 (Riddle	et	 al.,	 1981).	daf-2,	age-1	and	akt-1;	akt-2	double	null	mutants	all	 arrest	 non-conditionally	 as	 dauers	 at	 25°C	 and	 27°C,	 unlike	 wildtype	 worms	which	grow	normally	at	25°C	and	show	low	levels	of	dauer	arrest	at	27	°C	(Alam	et	al.,	2010;	Gems	et	al.,	1998;	Kimura	et	al.,	1997;	Morris	et	al.,	1996;	Oh	et	al.,	2005)	and	 these	 dauer-constitutive	 phenotypes	 of	 these	mutants	 are	 suppressed	 by	daf-
16/FOXO	 null	mutations	 (Gottlieb	 and	 Ruvkun,	 1994;	 Larsen	 et	 al.,	 1995;	 Vowels	and	Thomas,	1992).	IIS	signaling	also	regulates	stress	resistance	in	C.	elegans;	daf-2	mutants	are	more	resistant	to	different	stress	conditions	including	heat	(Lithgow	et	al.,	1994;	Lithgow	et	al.,	1995),	oxidative	stress	(Honda	and	Honda,	1999,	2002)	and	hypoxia	(Scott	et	al.,	2002).	Finally,	another	physiological	aspect	regulated	by	the	IIS	pathway	is	fat	metabolism.	daf-2	mutants	possess	elevated	fat	content	compared	to	wildtype	worms	(Ashrafi	et	al.,	2003;	Kimura	et	al.,	1997;	O'Rourke	et	al.,	2009;	Ogg	et	al.,	1997;	Perez	and	Van	Gilst,	2008)	attributed	to	 increased	de	novo	lipogenesis	(Perez	 and	 Van	 Gilst,	 2008)	 and	 dependent	 on	daf-16/FOXO	 (Ashrafi	 et	 al.,	 2003;	
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Ogg	et	al.,	1997;	Perez	and	Van	Gilst,	2008).	Therefore	the	IIS	pathway	regulates	a	myriad	of	processes	some	of	which	contribute	to	its	longevity	phenotype.			
1.3b	Mitochondrial	Function	and	Longevity	
Another	 intriguing	 longevity	pathway	 is	 that	of	mitochondrial	 longevity	wherein	a	partial	 reduction	 of	 mitochondrial	 activity	 leads	 to	 lifespan	 extension.	 These	findings	 suggest	 that	 reduced	 metabolic	 rate	 can	 result	 in	 organismal	 lifespan	extension.	A	number	of	genes	have	been	 identified	which	when	mutated	 lead	 to	a	partial	 reduction	 in	mitochondrial	 function	 and	 respiration	 and	 thereby	 cause	 an	extension	 in	 lifespan	 in	 yeast,	 worms,	 flies	 and	 mice	 (Copeland	 et	 al.,	 2009;	Dell'agnello	 et	 al.,	 2007;	 Pospisilik	 et	 al.,	 2007).	 One	 of	 the	 first	 examples	establishing	a	causal	relation	between	metabolic	rate	and	aging	in	C.	elegans	was	the	long-lived	 clk-1	mutant.	 clk-1	 encodes	 a	 homolog	 of	 COQ7	 enzyme	 involved	 co-enzyme	 Q	 biosynthesis	 (Ewbank	 et	 al.,	 1997;	 Lakowski	 and	 Hekimi,	 1996).	 clk-1	mutants	have	slower	rates	of	respiration	and	growth,	and	live	longer	than	wild	type.		Similarly	C.	elegans	isp-1	encodes	an	iron	sulfur	protein	in	mitochondrial	complex	III	whose	mutation	 leads	to	 impaired	electron	transport	 function	and	an	extension	of	lifespan	(Feng	et	al.,	2001)	(Yang	and	Hekimi,	2010).	Large-scale	RNAi	screens	also	identified	 knockdown	 of	 mitochondrial	 functions	 to	 extend	 lifespan	 (Dillin	 et	 al.,	2002;	Lee	et	al.,	2003).	However,	 there	are	also	mutations	 in	ETC	known	 that	 can	cause	 lifespan	 shortening	 e.g.	 mev-1	 mutants,	 which	 have	 a	 mutation	 in	 the	succinate	 dehydrogenase	 cytochrome	b560	 subunit	 of	 mitochondrial	 respiratory	chain	 complex	 II	 (Ishii	 et	 al.,	 1998),	 live	 shorter	 than	wildtype.	Therefore	 it	 is	not	well	understood	how	a	reduction	in	mitochondrial	function	can	regulate	aging	in	a	positive	or	a	negative	way.																	Initially	it	was	thought	that	the	longevity	effect	upon	reduced	mitochondrial	function	 results	 from	 a	 reduction	 in	 the	 production	 of	 Reactive	 Oxygen	 Species	(ROS).	ROS	are	produced	primarily	through	mitochondrial	respiration	and	can	cause	damage	to	cellular	macromolecules	including	DNA	and	proteins.	This	explanation	is	consistent	with	the	free	radical	theory	of	aging	by	Denham	Harman,	which	proposes	
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that	 an	 accumulation	 of	 cellular	 damage	 induced	 by	 oxidative	 damage	 and	 ROS	causes	aging	(Harman,	1956).	However,	 just	the	opposite	was	observed;	long-lived	mitochondrial	mutants	had	 increased	 levels	of	 superoxide,	 and	mild	 levels	of	pro-oxidant	 paraquat	 extended	 lifespan	 (Yang	 and	 Hekimi,	 2010).	 Moreover,	 other	interventions	that	provoke	mild	ROS	increase	lifespan,	leading	to	the	mitohormesis	hypothesis	 (Schulz	et	 al.,	 2007)	 -	 that	 low	 levels	of	ROS	stimulate	general	defense	response.	 Therefore,	 it	 still	 remains	 unresolved	 if	 mitochondrial	 longevity	 works	through	 elevated	or	 reduced	 levels	 of	ROS	 and	 if	 increased	or	decreased	 levels	 of	ROS	are	beneficial	for	longevity	and	aging	(Gems	and	Partridge,	2013).																	Another	 aspect	 that	 connects	 mitochondria	 and	 lifespan	 regulation	 is	 the	mitochondrial	 unfolded	 protein	 response	 or	 UPRMT.	 UPRMT	 is	 a	mitochondrial–to-nuclear	 signal	 transduction	 pathway,	 initiated	 by	 the	 accumulation	 of	 unfolded	proteins	 in	 the	 mitochondria	 and	 resulting	 in	 the	 induction	 of	 specific	 stress	response	proteins	that	work	to	restore	mitochondrial	nuclear	balance	(Benedetti	et	al.,	2006;	Martinus	et	al.,	1996;	Merkwirth	et	al.,	2016).	UPRMT	was	first	associated	with	aging	when	it	was	reported	that	UPRMT	is	essential	for	the	lifespan	extension	of	long-lived	mitochondrial	mutants,	isp-1	and	clk-1	(Durieux	et	al.,	2011).	A	number	of	studies	have	provided	more	evidence	about	the	involvement	of	UPRMT	in	aging.	For	example	 a	 recent	 study	 reported	 that	 UPRMT	 components	 and	 mitochondrial	biogenesis	 are	 up-regulated	 in	 long-lived	 Complex	 IV	 deficiency	 Surf1-/-	 mice	(Pulliam	et	 al.,	 2014).	Another	 study	 reported	 that	 a	knockdown	of	mitochondrial	ribosomal	 protein	 5	 (mrps-5)	 strongly	 induced	 UPRMT	 and	 extended	 lifespan	 in	worms	 in	 a	 UPRMT	dependent	 manner	 (Houtkooper	 et	 al.,	 2013).	 Despite	 all	 this	evidence,	 it	 is	 not	 clearly	 understood	 how	 this	 stress	 response	 mechanism	 can	promote	longevity.																	
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1.3c	Reproduction	and	Longevity	
In	addition	to	IIS	and	mitochondrial	longevity	models,	it	is	also	well	established	that	germline	 stem	 cell	 removal	 leads	 to	 extended	 lifespan.	 In	 C.	 elegans	 it	 was	discovered	 that	 laser	 microsurgical	 ablation	 of	 the	 germ	 cells	 could	 extend	 the	lifespan	of	the	animal	by	60%.	However,	somatic	gonad	cells	were	required	for	this	effect;	removal	of	the	entire	gonad	including	the	somatic	gonad	cells	abolished	this	longevity	benefit	(Hsin	and	Kenyon,	1999).	Genetic	manipulation	rendering	worms	germlineless	 using	 glp-1/Notch	 receptor	 knock-out	 also	 extends	 lifespan	 while	mutations	that	lead	to	over-proliferation	of	germline	such	as	gld-1	shorten	lifespan	(Arantes-Oliveira	 et	 al.,	 2002).	 Gonadal	 longevity,	 as	 it	 is	 called,	 is	 dependent	 on	many	 factors	 namely	 DAF-16/	 FOXO	 (Hsin	 and	 Kenyon,	 1999),	 steroid	 receptor	DAF-12/FXR	 and	 its	 ligands	 (Gerisch	 et	 al.,	 2007;	 Gerisch	 et	 al.,	 2001;	 Hsin	 and	Kenyon,	 1999),	 DAF-18/PTEN	 (Berman	 and	 Kenyon,	 2006),	 HSF-1	 (Hansen	 et	 al.,	2005),	SMK-1/SMEK-1	(Wolff	et	al.,	2006),	PHA-4/FOXA	(Lapierre	et	al.,	2011)	and	SKN-1/Nrf	 (Steinbaugh	 et	 al.,	 2015).	 DAF-16/FOXO,	 the	 major	 transcriptional	regulator	of	the	IIS	pathway,	is	nuclear	localized	in	the	intestine	and	neurons	upon	reduction	 in	 the	 activity	 of	 the	 IIS	 pathway.	 However,	 upon	 germline	 loss	 DAF-16/FOXO	 is	 shuttled	 into	 the	nucleus	only	 in	 the	gut	 indicating	 that	 the	gut	 is	 the	major	 tissue	 in	 mediating	 the	 systemic	 effect	 of	 lifespan	 increase	 in	 the	 gonadal	longevity	 model	 (Yamawaki	 et	 al.,	 2010).	 In	 addition	 to	 the	 above-mentioned	factors,	 which	work	mostly	 through	 the	 IIS	 pathway,	 there	 are	 other	 factors	 that	have	been	discovered	to	be	playing	key	roles	in	the	gonadal	longevity	model	e.g	KRI-1,	which	is	an	ankyrin	repeat	and	FERM	domain-containing	protein	orthologous	to	human	 KRIT1	 (Berman	 and	 Kenyon,	 2006)	 and	 TCER-1,	 which	 is	 a	 transcription	elongation/splicing	 regulator	 orthologous	 to	 human	 TCERG1	 (Ghazi	 et	 al.,	 2009).	Additionally,	 the	TOR	pathway	which	 is	 a	nutrient	 sensing	pathway	and	 regulates	lifespan	 across	 multiple	 species,	 has	 been	 associated	 with	 the	 maintenance	 of	germline	 stem	 cell	 proliferation	 through	 ribosomal	 protein	 S6	 Kinase	 (S6K)	 in	worms	 (Korta	 et	 al.,	 2012).	 Germline	 loss	 triggers	 down-regulation	 of	 TOR	 and	consistent	with	its	role	in	gonadal	longevity,	TOR	RNAi	extends	lifespan	of	wildtype	
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worms	 but	 does	 not	 further	 extend	 the	 lifespan	 of	 glp-1	 worms	 (Lapierre	 et	 al.,	2011).	 	 Moreover,	 gonadal	 longevity	 is	 implicated	 in	 regulating	 fat	 metabolism,	requiring	the	activity	of	lipl-4,	which	encodes	a	triglyceride	lipase	and	is	required	for	extended	lifespan	of	glp-1	animals	(Wang	et	al.,	2008).	Additional	evidence	pointing	towards	 the	 involvement	 of	 fat	 metabolism	 in	 regulating	 gonadal	 longevity	 came	when	 FAT-6,	 which	 is	 an	 acyl-CoA	 desaturase,	 was	 found	 to	 be	 required	 for	longevity.	 Germline	 loss	 induces	 FAT-6	 to	 higher	 levels,	 which	 works	 by	desaturating	stearic	acid	to	oleic	acid.	The	loss	of	longevity	in	germlineless	animals	upon	fat-6	knockdown	can	be	restored	by	nutritional	supplementation	of	oleic	acid	(Goudeau	 et	 al.,	 2011)	 giving	 a	 direct	 evidence	 of	 fat	metabolism	 being	 regulated	upon	germline	removal	and	 its	 involvement	 in	mediating	 longevity	upon	germline	loss.	Fatty	acids	likely	signal	through	nuclear	receptors	NHR-80	and	NHR-49,	which	work	in	a	complex	to	regulate	fat	metabolism,	β-oxidation	and	longevity	(Goudeau	et	al	2011,	Folick	et	al	2015).	Regulation	of	lifespan	by	the	gonad	is	present	in	other	species	as	well	e.g.	 in	Drosophila	 loss	of	germ	cells	 in	adults	 is	known	to	modulate	the	IIS	pathway	and	increase	lifespan	(Flatt	et	al.,	2008).	In	mice	it	was	shown	that	a	transplantation	of	ovaries	from	young	to	old	mice	increased	the	lifespan	of	the	old	mice	by	31-44%	providing	more	evidence	of	a	link	between	the	reproductive	system	and	 lifespan	 even	 in	 mammals	 (Cargill	 et	 al.,	 2003;	 Kagawa	 et	 al.,	 2010).	 These	studies	indicate	an	evolutionarily	conserved	link	between	reproduction	and	aging.											
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1.3d	Endocrine	Signaling	and	Longevity	
Endocrine	mechanisms	 coordinate	 development	 and	 physiology	 in	 response	 to	environmental	cues	and	internal	signals	and	this	regulation	is	crucial	for	sustaining	organismal	 physiology,	 reproduction	 and	 lifespan.	 The	 most	 majorly	 studied	endocrine	 pathway	 regulating	 physiology	 and	 lifespan	 has	 been	 the	 IIS	 pathway	(discussed	above).	However,	 recent	work	 in	model	organisms	has	brought	 to	 light	some	other	endocrine	mechanisms	that	affect	aging	and	other	life	history	traits.	An	important	 example	 is	 nuclear	 hormone	 receptors	 (NHRs)	 and	 their	 lipophilic	ligands	 that	 have	 been	 shown	 to	 affect	 aging	 in	 different	 model	 organisms	(Fielenbach	and	Antebi,	2008;	Flatt	et	al.,	2005;	Rottiers	and	Antebi,	2006;	Tatar	et	al.,	 2003).	 NHRs	 normally	 comprise	 a	 ligand	 binding	 domain	 and	 a	 DNA	 binding	domain.	There	are	various	NHRs	present	across	species;	humans	possess	48	NHRs	while	lower	organisms	like	Drosophila	and	C.	elegans	have	18	and	284	respectively,	a	bulk	of	which	remain	poorly	characterized.	In	C.	elegans	the	most	widely	studied	NHR	 is	DAF-12	which	 is	a	homolog	of	human	vitamin	D	receptor,	 farnesoid-X	and	liver	 X	 receptor	 (VDR,	 FXR,	 LXR).	 It	 has	 been	 described	 to	 regulate	 diapause	formation,	developmental	timing	and	longevity	and	has	ben	identified	as	the	major	target	of	the	dafachronic	acid	(DA)	pathway	in	C.	elegans	(Antebi,	2013;	Antebi	et	al.,	2000).																	Worms	respond	to	nutritional	conditions	through	the	sensory	head	neurons	via	 cGMP	 and	 serotonergic	 signaling	 (Birnby	 et	 al.,	 2000;	 Thomas	 et	 al.,	 1993).	Under	 extreme	 conditions	 like	 over-crowding,	 elevated	 temperature	 or	 food	shortage	worms	enter	a	diapause	state	called	dauer.	 	 Several	pathways	have	been	described	 to	 regulate	 dauer	 formation	 and	multiple	 genes	 have	 been	 identified	 in	dauer	 screens	 (Albert	 and	 Riddle,	 1988;	 Morris	 et	 al.,	 1996;	 Pierce	 et	 al.,	 2001;	Riddle	 et	 al.,	 1981;	 Wolkow	 et	 al.,	 2002).	 In	 these	 studies	 major	 pathways	 that	regulate	 lifespan	 like	 transforming	growth	 factor	β	 (TGFβ),	 IIS	 and	TOR	have	also	been	 identified	 eventually	 impinging	 on	 the	 DA	 pathway	 for	 dauer	 decision	 (Hu,	2007).	 Sensory	 perception	 regulates	 synthesis	 and	 secretion	 of	 TGF-β	 (Ren	 et	 al.,	1996)	 and	 ILPs	 (Li	 et	 al.,	 2003)	 activating	 downstream	 signaling	 cascades	 and	
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thereby	regulating	steroidal	hormone	signaling	(Gerisch	and	Antebi,	2004;	Mak	and	Ruvkun,	2004).	IIS	and	TGFβ	are	active	under	favorable	conditions	(Murakami	et	al.,	2001),	which	eventually	 lead	to	DA	production	via	the	DA	pathway	(Wollam	et	al.,	2011).	 	 The	 final	 decision	 of	 DA	 synthesis	 is	 under	 tight	 regulation	 via	 multiple	upstream	 inputs	 including	 serotonin	 (Sze	 et	 al.,	 2000),	 acetylcholine	 (Lee	 et	 al.,	2014)	 and	TOR	 (Jia	 et	 al.,	 2004).	DA	 thus	produced	binds	 to	 the	 receptor	DAF-12	and	promotes	normal	reproductive	growth	(Antebi	et	al.,	2000;	Motola	et	al.,	2006).	In	 the	 absence	 of	 DA,	 DAF-12	 binds	 to	 DIN-1	 and	 leads	 to	 dauer	 formation	 and	extended	 lifespan	 (Ludewig	 et	 al.,	 2004).	 In	 accord	 with	 this,	 DAF-12	 mutants	cannot	enter	the	dauer	diapause	and	are	short	lived	(Antebi	et	al.,	2000).	Therefore,	DA	and	DAF-12	act	in	conjunction	to	govern	dauer	diapause	decisions	and	regulate	lifespan	in	worms.	This	endocrine	signaling	network	is	not	only	limited	to	regulating	
C.	elegans’	physiology	but	also	plays	a	similar	role	 in	higher	organisms	like	 insects	and	mammals.	Both	IIS	and	TGFβ	pathways	regulate	ecdysteroidogenesis	 in	 insect	metamorphosis	 and	 steroidogenesis	 in	 mammalian	 puberty	 (Tennessen	 and	Thummel,	2011).																
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1.4	Dietary	Restriction	and	Aging	
Environmental	 interventions	 like	DR	have	 long	been	known	to	regulate	 lifespan	in	different	 organisms.	DR	 is	 a	 reduction	 of	 food	 intake	without	malnutrition,	which	often	 confers	 health	 benefits	 and	 extends	 lifespan.	 The	 first	 seminal	 study	 that	demonstrated	 that	 DR	 could	 bring	 about	 an	 extension	 in	 health	 and	 lifespan	was	done	in	rodents	(McCay	et	al.,	1935).	In	this	study	rats	were	fed	ad	libitum	or	a	low	calorie	 diet	 and	 the	 major	 objective	 of	 the	 study	 was	 to	 determine	 the	 effect	 of	retarding	 growth	 on	 lifespan	 and	 body	 size.	 It	 came	 as	 a	 surprise	 to	 see	 DR	 rats	showed	average	 lifespan	 extension	of	more	 than	60%	compared	 to	ad	 libitum	 fed	rats.	This	groundbreaking	discovery	paved	the	way	for	the	field	of	DR	to	emerge	and	people	 tried	different	methods	of	employing	DR	on	different	organisms	and	 found	out	 that	 the	effects	were	conserved.	These	DR	experiments	have	been	successfully	reproduced	in	higher	organisms	like	primates	as	well.	Limiting	the	caloric	intake	by	10-30%	 compared	 to	 the	 baseline-unrestricted	 intake	 reduces	 the	 incidence	 of	diabetes,	cancer,	cardiovascular	disease,	and	brain	atrophy	and	also	slows	ageing	in	rhesus	 monkeys	 (Colman	 et	 al.,	 2009).	 Although	 another	 study	 saw	 no	 effect	 on	mortality,	they	observed	less	incidence	of	age-related	disease	(Mattison	et	al.,	2012).	The	fundamental	assumption,	that	DR	can	extend	the	mean	and	maximum	lifespan	and	 delay	 the	 onset	 of	 age-associated	 disorders,	 has	 been	 demonstrated	 in	many	organisms	 including	 yeast,	worms,	 flies	 and	mammals	 (Anderson	 and	Weindruch,	2010;	 Kennedy	 et	 al.,	 2007;	 Piper	 and	 Bartke,	 2008)	 (Figure	 1).	 Even	 in	 humans	undergoing	 voluntary	 DR,	 the	 risks	 for	 developing	 cardiovascular	 diseases	 and	cancer	are	reduced	(Fontana	et	al.,	2010).	DR	in	humans	results	in	similar	molecular	changes	as	those	seen	in	laboratory	animals	including	reduced	myocardial	stiffness,	reduced	 body	 temperature,	 down-regulation	 of	 pi3k/akt/foxo	 etc	 (Cava	 and	Fontana,	 2013;	 Mercken	 et	 al.,	 2013).	 The	 fact	 that	 different	 organisms	 show	improvement	in	most	aspects	of	health	during	aging	has	instigated	great	interest	in	this	 field.	 Indeed,	 now	 research	 is	 also	 proceeding	 ahead	 in	 the	 direction	 of	understanding	 the	 basic	 mechanisms	 underlying	 DR	 so	 that	 DR	 mimetics	 can	 be	designed,	which	might	mimic	the	same	benefits	as	DR	without	actually	undergoing	
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drastic	alteration	in	the	diet.																	There	 are	 various	 ways	 of	 carrying	 out	 DR	 in	 different	 organisms.	 For	example	 in	 yeast,	 the	 most	 predominant	 way	 of	 performing	 DR	 is	 glucose	deprivation.	A	drop	in	glucose	concentration	from	2%	to	0.01%	increases	the	mean	and	 maximum	 lifespan	 in	 yeast	 (Lin	 et	 al.,	 2000).	 In	 C.	 elegans	 there	 are	 eight	different	procedures	of	manipulating	the	diet	that	all	lead	to	an	extension	in	lifespan	to	 varying	 degrees,	 allowing	 comparison	 among	 the	 different	 DR	 regimens.	 The	major	DR	 regimens	 include	dilution	of	 the	bacterial	 food,	 deprivation	of	 peptones	from	 the	 diet	 etc	 (Greer	 and	 Brunet,	 2009;	 Hosono	 et	 al.,	 1989).	 Additionally,	 a	genetic	 model	 for	 DR	 in	 C.	 elegans	 is	 the	 eat-2	 mutant,	 in	 which	 the	 pharyngeal	pumping	 rate	 and	 hence	 food	 intake	 are	 reduced,	 leading	 to	 approximately	 20%	increase	in	lifespan	(Lakowski	and	Hekimi,	1998).	Strikingly,	different	DR	regimens	act	through	different	downstream	factors,	which	eventually	 leads	to	an	increase	in	lifespan.	 Thus,	 diverse	 DR	 regimens	 evoke	 somewhat	 independent	 genetic	pathways,	 depending	 on	 how	 DR	 is	 induced.	 The	 notion	 that	 reduced	 intake	 of	calories	can	 lead	to	 lifespan	extension	upon	DR	gained	ground	by	whole	organism	transcriptomic	studies	in	Drosophila.	It	was	reported	that	reduction	in	caloric	intake	reverted	the	transcriptional	changes	that	occur	during	aging	(Pletcher	et	al.,	2002).	However	 this	 theory	 was	 challenged	 when	 reduced	 intake	 of	 different	 nutrients	rather	than	overall	caloric	intake,	was	shown	to	exhibit	the	effects	of	DR	(Mair	et	al.,	2005).	Based	on	the	current	evidence,	ratio	of	protein	to	carbohydrate	in	the	diet	of	the	fruit	fly	regulates	lifespan.	Lower	ratios	like	1/16	increase	lifespan	while	higher	ratios	 like	1/2	shorten	 it	 (Fanson	and	Taylor,	2012;	Grandison	et	al.,	2009).	Other	reports	also	show	that	methionine	deprivation	extends	the	lifespan	of	flies	(Troen	et	al.,	2007)	and	mice	(Miller	et	al.,	2005;	Sun	et	al.,	2009).	In	rodents,	a	reduction	in	food	 by	 30%	 to	 40%	 leads	 to	 lifespan	 extension	 (Wanagat	 et	 al.,	 1999).	 Reduced	food	 intake	 has	 been	 associated	 with	 lower	 incidence	 of	 age-related	 diseases	including	 cardiovascular	 disease,	 sarcopenia,	 neoplasia	 and	 type-2	 diabetes	 and	prolonged	youthful	metabolic	state	(Anderson	and	Weindruch,	2012;	Colman	et	al.,	2009;	Kemnitz,	2011;	Masoro,	2005).			
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1.5	Regulators	of	Dietary	Restriction	Mediated	Longevity	
Though	the	molecular	mechanisms	by	which	DR	confers	health	benefits	and	extends	lifespan	are	largely	unknown,	some	regulators	that	mediate	DR	response	have	been	identified.	 One	 of	 the	 major	 factors	 that	 is	 known	 to	 mediate	 DR	 longevity	 in	 C.	
elegans	 is	 pha-4	 which	 encodes	 a	 fork	 head	 box	 A	 (FOXA)	 transcription	 factor	(Panowski	 et	 al.,	 2007).	 Knockdown	 of	 pha-4	 abrogates	 longevity	 conferred	 by	bacterial	 dilution	 regimen	 and	 of	 eat-2	 mutants	 without	 affecting	 the	 increased	lifespan	by	reduced	IIS.	This	suggests	that	pha-4	specifically	plays	a	regulatory	role	in	mediating	DR	longevity.	Another	important	factor	that	is	required	for	sDR	(solid	DR),	one	of	the	DR	regimens	in	C.	elegans,	is	aak-2	(Greer	et	al.,	2007).	aak-2	codes	for	 the	 α-catalytic	 subunit	 of	 the	 important	 energy	 homeostasis	 regulator	 AMP	kinase	 or	 AMPK.	When	 energy	 levels	 drop	 leading	 to	 an	 increase	 in	 AMP	 to	 ATP	ratio,	 AMP	 binds	 to	 the	 γ	 regulatory	 subunit	 of	 AMPK.	 Binding	 of	 AMP	 results	 in	phosphorylation	of	a	threonine	residue	on	the	α	subunit	thereby	activating	AMPK,	which	 increases	 the	 ATP	 production	 and	 reduces	 the	 consumption	 of	 ATP	 by	suppressing	 energy-consuming	 processes	 and	 thereby	 maintains	 energy	homeostasis	 (Hardie,	 2011).	 In	 addition	 to	 DR,	 aak-2	 is	 also	 required	 for	 the	longevity	of	rsks-1	mutants	providing	evidence	that	DR	and	the	TOR	pathway	confer	longevity	through	the	same	mechanism	(Selman	et	al.,	2009).	Another	transcription	factor	 shown	 to	be	 important	 for	DR	 in	C.	elegans	 is	hypoxia	 inducible	 factor	1	or	HIF-1	(Chen	et	al.,	2009).	During	normoxic	conditions	HIF-1	undergoes	proteasomal	degradation.	 egl-9	 encodes	 for	 the	 proline	 hydroxylase	 that	 mediates	 this	degradation	of	HIF-1.	Therefore,	a	 loss	of	 function	of	egl-9	stabilizes	and	 increases	the	 levels	 of	 HIF-1	 (Epstein	 et	 al.,	 2001).	 Interestingly,	 loss	 of	 egl-9	abolishes	DR	mediated	longevity	and	the	longevity	of	rsks-1	mutants.	Consistent	with	this	finding,	
hif-1	mutants	were	 shown	 to	 be	 long-lived	 and	 there	was	 no	 further	 extension	 of	lifespan	when	hif-1	worms	were	subjected	to	DR	(Chen	et	al.,	2009).	Besides	these	factors,	the	nuclear	factor-erythroid-related-factor	or	Nrf	ortholog	SKN-1	in	worms	is	 induced	 in	 ASI	 neurons	 which	 signals	 cell	 non-autonomously	 to	 other	 tissues	thereby	 mediating	 longevity	 under	 DR	 (Bishop	 and	 Guarente,	 2007).	 Lifespan	
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extension	 by	 inhibiting	 the	 TOR	 pathway	 through	 Rapamycin	 treatment	 also	requires	the	activity	of	SKN-1	(Robida-Stubbs	et	al.,	2012).																	Genetic	screens	in	C.	elegans	using	the	DR	model	eat-2	have	been	extensively	carried	out	by	a	number	of	 laboratories	to	 identify	new	genes	that	are	 involved	 in	the	DR	pathway.	Such	a	screen	performed	by	the	Kenyon	 lab	 identified	 four	genes	namely	sams-1/S-adenosyl	methionine	synthetase,	rab-10/RAB-like	GTPase,	drr-1,-
2/dietary	restriction	response.	These	genes	extend	the	lifespan	of	insulin	signaling	FOXO	 transcription	 factor	 (daf-16)	 mutant	 but	 are	 incapable	 of	 extending	 the	lifespan	of	eat-2	mutants	 suggesting	overlapping	mechanisms	with	DR	 (Hansen	et	al.,	2005).	In	another	set	of	genetic	screens	performed	in	our	lab,	we	identified	for	the	first	time	a	nuclear	hormone	receptor,	NHR-62	to	be	required	for	DR	longevity	in	 eat-2	worms	 and	 in	bacterial	 dilution	 regimen	 (Heestand	 et	 al.,	 2013).	 	 Loss	 of	NHR-62	 altered	 the	 metabolic	 phenotypes	 of	 eat-2	 including	 fat	 levels	 and	autophagy.																	
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1.6	 Dietary	 Restriction,	 TOR	 Pathway	 and	 Protein	 Synthesis	 in	
Aging		
Of	all	the	nutrient-sensing	pathways,	the	Target	of	Rapamycin	or	the	TOR	pathway	has	been	prominently	 associated	with	DR.	The	TOR	pathway	 is	 a	 central	pathway	that	 senses	 nutrients	 (amino	 acids,	 sugars	 etc.),	 promotes	 cell	 growth	 and	suppresses	 degradation	 and	 recycling	 processes	 like	 autophagy	 when	 the	 food	 is	plentiful	 (Kapahi	 et	 al.,	 2010).	 TOR	 inhibition	 extends	 lifespan	 across	 different	species	all	the	way	from	yeast	to	mice	(Harrison	et	al.,	2009;	Kaeberlein	et	al.,	2005;	Kapahi	et	al.,	2004;	Sheaffer	et	al.,	2008;	Vellai	et	al.,	2003)	(Figure	1).	There	have	been	many	studies	done	that	link	the	TOR	pathway	with	DR.	For	example	inhibition	of	TOR	and	DR	show	similar	physiological	effects	and	there	is	no	additive	longevity	observed	when	 the	 TOR	 pathway	 is	 suppressed	 under	 DR	 conditions	 in	 different	organisms	 (Bjedov	 et	 al.,	 2010;	Hansen	 et	 al.,	 2007;	Kapahi	 et	 al.,	 2004).	 There	 is	also	some	evidence	in	mammals	that	supports	the	notion	of	TOR	being	involved	in	DR.	A	mutation	in	murine	S6	kinase,	which	is	the	downstream	target	of	TOR,	extends	lifespan	and	shows	a	similar	transcriptional	profile	as	that	of	DR,	which	implies	that	TOR	 regulates	 the	 effects	 of	 DR	 (Selman	 et	 al.,	 2009).	 TOR	 regulates	 numerous	processes	that	might	be	involved	in	DR	mediated	longevity,	a	prime	example	being	protein	synthesis.	TOR	stimulates	protein	synthesis	by	modulating	key	components	of	 the	 translation	 machinery.	 In	 response	 to	 nutrients,	 TOR	 phosphorylates	 and	activates	 ribosomal	 subunit	 S6	kinase	which	 in	 turn	phosphorylates	 and	activates	translation	elongation	factor	2	(eEF2)	kinase	thereby	promoting	global	translational	levels	 (Wang	 et	 al.,	 2001).	 Consistent	 with	 this,	 reduced	 food	 intake	 causes	suppression	of	 the	TOR	pathway	and	thus	reduction	 in	translation	and	 increase	 in	lifespan	(Kapahi	et	al.,	2010).	In	line	with	the	reduction	of	the	TOR	pathway	leading	to	longevity,	reduced	levels	of	S6	kinase	extends	lifespan	in	yeast,	worms,	flies	and	mice	(Hansen	et	al.,	2007;	Kaeberlein	et	al.,	2005;	Kapahi	et	al.,	2004;	Selman	et	al.,	2009).	 In	C.	elegans	 the	 longevity	 conferred	 by	 the	 loss	 of	 rsks-1/S6K	depends	 on	several	factors	including	pha-4/FOXA	(Sheaffer	et	al.,	2008),	hif-1	(Chen	et	al.,	2009)	and	 hsf-1	 (Seo	 et	 al.,	 2013).	 A	 plausible	 explanation	 for	 the	 longevity	 benefits	
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observed	 with	 the	 down-regulation	 of	 TOR	 is	 that	 TOR	 knockdown	 leads	 to	reduction	 in	protein	 synthesis	 rates,	which	makes	animals	 live	 longer.	 	An	overall	reduction	 in	 protein	 synthesis	 is	 known	 to	 extend	 lifespan	 (discussed	 below).	Concordantly,	rates	of	protein	synthesis	are	reduced	in	rsks-1/S6K	worms	(Ching	et	al.,	2010;	Hansen	et	al.,	2007;	Pan	et	al.,	2007),	which	might	be	 the	reason	behind	their	longevity.															In	 addition,	 TOR	 also	 phosphorylates	 and	 inhibits	 4E-binding	 protein	 (4E-BP),	which	represses	translation	by	binding	to	translation	initiation	factor	eIF4E.	C.	
elegans	does	not	possess	a	structural	4E-BP	homologue	(Syntichaki	et	al	2007).	 In	
Drosophila,	4E-BP	 is	not	 required	 for	 increased	 lifespan	 in	 response	 to	 rapamycin	and	one	form	of	DR	(Partridge	et	al.,	2011)	although	its	effects	on	translation	have	been	 implicated	 in	 a	 second	 type	 of	 DR	 through	 modulation	 of	 mitochondrial	activity	(Zid	et	al.,	2009).	TOR	may	relay	its	effects	on	aging	indirectly	through	other	processes	 such	 as	 stress	 resistance,	 endoplasmic	 reticulum	 stress	 signaling	 and	metabolic	alterations	(Kapahi	et	al.,	2010)	but	it	is	not	completely	understood	how	these	processes	may	slow	aging.	
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Figure 1. DR extends lifespan across species. The TOR pathway modulates the effects of DR 
in multiple species in part by regulating autophagy and also S6 kinase activity and thereby 
translation. (Adapted from (Kenyon, 2010)  																	Another	cellular	process	that	regulates	lifespan	is	protein	synthesis.	Protein	synthesis	links	nutritional	state	with	overall	organismal	growth	and	is	regulated	by	the	TOR	pathway	as	discussed	above.	In	addition,	protein	synthesis	is	also	regulated	by	 the	 IIS	 pathway	 (Proud,	 2006;	 Shamji	 et	 al.,	 2003;	 Sonenberg	 et	 al.,	 2000).	Reduced	nutrients	lower	the	level	of	insulin	which	in	turn	decreases	the	activity	of	Ser/Thr	kinase	Akt	preventing	Akt	 from	phosphorylating	and	activating	S6	kinase.	Therefore	IIS	and	TOR	pathways	cross	talk	in	regulating	protein	synthesis	levels	via	the	 common	 mediator	 S6	 kinase.	 Furthermore	 inputs	 from	 the	 MAPK	 signaling	pathway	 also	 regulate	 protein	 synthesis.	 Signaling	 through	 the	 MAPK	 pathway	promotes	 the	 assembly	 of	 the	 initiation	 factor	 complexes	 and	 also	 activates	 the	elongation	machinery	for	translation	of	mRNA	(Hsieh	and	Papaconstantinou,	2004;	
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Proud,	 2007).	 Besides	 IIS	 and	 TOR	 pathways	 which	 when	 suppressed	 extend	lifespan,	knockdown	of	a	few	other	factors	leads	to	reduced	translational	levels	and	thereby	promotes	longevity.	For	example	knockdown	of	several	ribosomal	proteins	including	 RPS15,	 RPL6	 and	 RPL19	 reduces	 translation	 and	 increases	 lifespan	(Hansen	et	al.,	2007).	Reduction	in	the	levels	of	translation	initiation	factors	eIF2β,	eIF4G	 and	 eIF4E	 also	 leads	 to	 an	 extension	 in	 lifespan	 (Hansen	 et	 al.,	 2007;	Syntichaki	et	al.,	2007).	However	the	reasons	why	organismal	lifespan	is	increased	with	 a	 modest	 reduction	 in	 protein	 synthesis	 are	 still	 unclear.	 Conceivably,	 a	reduction	in	protein	synthesis	conserves	cellular	energy	reserves.	 It	 is	well	known	that	translation	is	a	high-energy	consuming	process	(Proud,	2002).	A	single	amino	acid	 addition	 into	 a	 growing	 polypeptide	 requires	 the	 energy	 derived	 from	 the	hydrolysis	of	four	ATP	molecules.	Therefore	a	reduction	in	translation	can	conserve	cellular	 energy	 reserves	 that	 can	be	 channeled	 towards	 the	mechanisms	of	 repair	and	maintenance,	 leading	 to	 prolonged	 cell	 survival	 and	 resistance	 against	 stress	conditions.	Nevertheless,	the	exact	molecular	mechanism	of	how	different	pathways	coordinate	 under	 nutritional	 stress	 to	 down-regulate	 translation	 and	 extend	lifespan	is	not	clearly	understood.															
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1.7	Cellular	Processes	that	Mediate	Longevity	
Besides	the	signaling	pathways	that	were	discussed	afore,	certain	cellular	processes	can	 also	 play	 a	 role	 in	 regulating	 lifespan	 of	 an	 organism.	 Prime	 example	 of	 this	regulation	is	the	mechanism	of	improving	protein	homeostasis	or	proteostasis.	Cells	have	 inherent	 mechanisms	 of	 keeping	 their	 proteome	 in	 balance.	 The	 two	 main	processes	by	which	 this	 is	carried	out	biologically	are	autophagy	and	proteasomal	degradation.	Macroautophagy	(hereafter	referred	to	as	autophagy)	is	the	process	of	regulated	 degradation	 and	 recycling	 of	 unnecessary	 or	 dysfunctional	 cellular	components	occurring	by	isolation	of	targeted	cellular	components	within	a	double-membrane	 vesicle	 called	 an	 autophagosome.	 The	 autophagosome	 fuses	 with	 a	lysosome	and	the	contents	are	degraded	and	recycled.	Proteasomal	degradation	of	the	 unneeded	 or	 damaged	 proteins	 happens	 through	 the	 Ubiquitin	 Proteasome	System	 (UPS)	 which	 involves	 the	 tagging	 of	 proteins	 with	 ubiquitin	 and	 further	degradation	 of	 these	 tagged	 proteins	 via	 the	 26S	 proteasome.	 It	 is	 known	 that	proteostasis	mechanisms	decline	with	age	and	in	accord	with	this	improving	protein	quality	control	leads	to	longevity	benefits.	It	is	also	known	that	protein	homeostasis	is	enhanced	in	long-lived	animals	(Morimoto	and	Cuervo,	2014).	Therefore	it	is	easy	to	 imagine	 that	 a	 lot	 of	 diseases	 involving	 protein	 aggregation	 are	 age-associated	and	generally	appear	in	old	age	e.g.	neurodegenerative	diseases	like	Alzheimer’s	and	Parkinson’s.	 Thus	 a	 lot	 of	 contemporary	 research	 focuses	 on	 improving	 protein	quality	control	 in	order	 to	 find	 therapeutic	 interventions	 to	combat	such	diseases.	The	 following	 paragraphs	 discuss	 the	 current	 understanding	 of	 proteostasis	particularly	focusing	on	autophagy	and	proteasomal	degradation.																	Autophagy	is	an	important	cellular	mechanism	acting	as	a	bulk	degradation	process	 in	metabolic	 stress	 conditions	 like	 starvation,	DNA	damage,	 oxidative	 and	endoplasmic	 reticulum	 (ER)	 stress	 (Egan	 et	 al.,	 2011;	 Rubinsztein	 et	 al.,	 2011).	Autophagy	 induction	 using	 pharmacological	 agents	 or	 genetic	 methods	 increases	lifespan	in	worms,	flies	and	mice	(Harrison	et	al.,	2009;	Kenyon,	2010).	Autophagy	is	not	 only	 required	 in	 almost	 all	 the	 longevity	models	 studied	 (Gelino	 and	Hansen,	2012)	but	is	also	sufficient	for	lifespan	extension.	For	example,	the	longevity	of	daf-2	
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worms	is	reversed	with	the	loss	of	BEC-1,	which	plays	a	role	in	localizing	autophagy	proteins	 to	pre-autophagosomal	membranes	(Melendez	et	al.,	2003).	Autophagy	 is	also	required	for	longevity	conferred	by	calcineurin	deficiency	(Dwivedi	et	al.,	2009)	and	 depletion	 of	 p53	 homolog	 CEP-1	 (Tavernarakis	 et	 al.,	 2008)	 in	 C.	 elegans.	Similarly,	 lifespan	 extension	 in	 worms	 achieved	 by	 genetic	 or	 pharmacologic	activation	of	the	SIRT1	ortholog	SIR-2.1	(Morselli	et	al.,	2010),	or	treatment	with	the	acetyltransferase	 inhibitor	 spermidine	 (Eisenberg	 et	 al.,	 2009)	 is	 abrogated	 if	autophagy	 is	 inactivated.	 Important	 regulatory	 genes	 of	 autophagy	 including	Atg1	and	Atg8	when	overexpressed	 in	Drosophila	promote	 longevity	 (Rubinsztein	et	al.,	2011).	Atg5	over-expression	in	mice	induces	autophagy	and	increases	lifespan	(Pyo	et	al.,	2013).	Autophagy	is	also	required	for	DR	mediated	longevity	in	C.	elegans	(Jia	and	 Levine,	 2007).	 In	 conjunction	 with	 its	 requirement	 for	 longevity	 in	 worms,	another	study	reported	that	autophagy	 is	 induced	upon	dietary	restriction	 in	mice	(Morselli	 et	 al.,	 2010).	 In	 addition	 to	 extending	 lifespan,	 multiple	 studies	 have	reported	that	autophagy	modulation	leads	to	beneficial	effects	in	diseases	occurring	due	to	protein	aggregation.	For	example,	in	flies	and	mice	autophagy	induction	using	rapamycin	enhances	the	clearance	of	aggregates	of	tau	and	Aβ	(Berger	et	al.,	2006;	Caccamo	 et	 al.,	 2010).	 Similarly,	 rapamycin	 induced	 autophagy	 also	 clears	 α-synuclein	 aggregates	 in	 cultured	 cells	 (Webb	 et	 al.,	 2003).	 Another	 study	 showed	that	overexpression	of	beclin-1,	which	plays	a	crucial	role	in	autophagy,	ameliorates	aggregation	of	α-synuclein	(Spencer	et	al.,	2009).	And	lastly	it	has	also	been	shown	that	 pharmacological	 interventions	 that	 induce	 autophagy	 lead	 to	 a	 drastic	improvement	 of	 Huntington’s	 disease	 phenotype	 (Sarkar	 et	 al.,	 2007).	 All	 this	evidence	points	towards	the	fact	that	an	inherent	 improvement	in	proteostasis	via	autophagy	 can	 lead	 to	 an	 improvement	 in	 healthspan	 and	 also	 an	 increase	 in	lifespan	of	organisms.																Another	 key	 component	 for	 maintaining	 proper	 proteostasis	 is	 the	 UPS.	Protein	quality	control	mechanisms	carried	out	by	the	UPS	decline	with	age.	There	are	 various	 levels	 reported	 at	 which	 the	 UPS	 activity	 declines	with	 age	 including	decreased	expression	of	the	components	of	the	UPS	(Lee	et	al.,	1999),	alteration	of	the	proteasomal	subunits	(Ferrington	et	al.,	2005),	disassembly	of	the	proteasomal	
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machinery	 (Vernace	 et	 al.,	 2007)	 or	 inactivation	 of	 the	 UPS	 through	 protein	aggregates	 (Andersson	 et	 al.,	 2013).	 There	 have	 been	 several	 studies	 conducted	which	provide	a	 clear	 link	between	protein	 clearance	mechanisms	and	aging.	And	this	holds	true	for	different	species.	For	example	proteasome	inhibitor	treatment	of	fibroblasts	 reduces	 their	 replicative	 lifespan	 and	 induces	 senescence	 like	 features	(Torres	 et	 al.,	 2006).	 Likewise	 RNAi	 knockdown	 of	 19S	 and	 20S	 subunits	 of	 the	proteasome	in	C.	elegans	shortens	lifespan	(Ghazi	et	al.,	2007;	Vilchez	et	al.,	2012).	And	conversely	if	the	activity	of	the	UPS	is	increased,	this	leads	to	increased	lifespan	in	 various	 organisms.	 In	 S.	 cerevisae,	over-expression	 of	 UMP1/POMP,	 which	 is	 a	proteasomal	 chaperone,	 stabilizes	 the	 activity	 of	 the	 UPS	 and	 leads	 to	 increased	viability	 during	 stationary	 phase	 (Chen	 et	 al.,	 2006).	 rpn11	 is	 a	 multi-protein	complex	involved	in	the	ATP-dependent	degradation	of	ubiquitinated	proteins	and	its	 overexpression	 in	 Drosophila	 inhibits	 the	 age-dependent	 decline	 of	 26S/30S	proteasome	 activity	 and	 thereby	 increases	 lifespan.	 Similarly	 overexpression	 of	
rpn6,	a	subunit	of	 the	19S	proteasome,	 increases	 lifespan	of	worms	 (Tonoki	et	 al.,	2009;	 Vilchez	 et	 al.,	 2012).	 Well-established	 C.	 elegans	 models	 of	 longevity	 have	been	 associated	 with	 elevated	 UPS	 activity.	 For	 example	 a	 recent	 study	 reported	that	 decreased	 IIS	 in	 worms	 leads	 to	 an	 induction	 of	 proteasomal	 activity	(Matilainen	et	al.,	2013).	Another	study	reported	that	the	CUL-1	E3	ubiquitin	ligase	complex	(Skp-1-Cul-1-F-Box)	is	required	for	longevity	conferred	by	reduction	in	the	IIS	 pathway	 (Ghazi	 et	 al.,	 2007).	 	 Similarly	HECT	 E3	 ubiquitin	 ligase	 in	C.	 elegans	called	WWP-1	acts	as	a	positive	regulator	of	lifespan	in	response	to	DR	(Carrano	et	al.,	 2009).	 DR	 also	 induces	 the	 expression	 of	 the	 19S	 proteasomal	 subunit	Psmc3/Rpt5	 and	 the	 proteasome	 activator	 PA28	 (Lee	 et	 al.,	 1999).	 Intriguingly	results	 from	the	studies	on	higher	animals	are	consistent	with	the	observations	 in	the	lower	organisms.	Interesting	studies	reported	elevated	UPS	activity	in	naturally	occurring	 exceptionally	 long-lived	 animals	 like	 the	 naked	 mole	 rat	 (Perez	 et	 al.,	2009)	and	the	giant	clam	(Ungvari	et	al.,	2013).																	In	addition	to	regulating	lifespan,	several	reports	have	evidenced	clear	links	between	age-related	neurodegenerative	diseases	and	proteasomal	activity	(Zabel	et	al.,	 2010).	For	example,	 the	 inclusion	bodies	observed	 in	Alzheimer’s,	Parkinson’s,	
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Huntington’s	Disease	and	Amyotrophic	Lateral	Sclerosis	contain	very	high	amounts	of	 ubiquitin	 suggesting	 an	 association	 between	 proteasomal	 dysfunction	 and	neurodegeneration	 (Huang	 and	 Figueiredo-Pereira,	 2010;	 Matsuda	 and	 Tanaka,	2010).	 Proteasome	 activity	 is	 decreased	 in	 the	 brains	 of	 patients	 suffering	 from	Alzheimer’s	 disease	 (Keck	 et	 al.,	 2003).	 Moreover	 elevating	 the	 UPS	 activity	 has	been	 proven	 beneficial	 for	 Huntington’s	 disease	 model.	 Higher	 levels	 of	 rpn6	 in	worms	and	rpn11	in	flies	decrease	the	toxic	protein	aggregates	in	the	Huntington’s	disease	model	(Tonoki	et	al.,	2009;	Vilchez	et	al.,	2012).	Hence	there	is	substantial	evidence	that	 increased	protein	quality	control	 leads	to	an	 increase	 in	health-span	by	ameliorating	a	number	of	age-associated	diseases	and	in	addition	also	increases	lifespan	across	different	species.																	Besides	cellular	processes	leading	to	protein	quality	control,	our	lab	recently	demonstrated	 that	 metabolic	 pathways	 can	 also	 play	 a	 role	 in	 regulating	proteostasis.	 Activation	 of	 the	 hexosamine	 pathway	 either	 genetically	 or	 by	 the	supplementation	 of	 N-glycan	 precursor,	 N-acetylglucosamine	 in	 the	 medium	increases	 lifespan	 of	 C.	 elegans.	 Moreover	 activation	 of	 this	 pathway	 leads	 to	 an	improvement	in	the	pathology	of	distinct	neurotoxic	disease	models.	This	improved	health	 state	 and	 increased	 lifespan	 depend	 on	 elevated	 ER-associated	 protein	degradation,	 proteasomal	 activity	 and	 autophagy	 (Denzel	 et	 al.,	 2014).	 Hence	activation	of	the	hexosamine	pathway	leads	to	improved	protein	quality	control	and	in	 the	 future	 may	 be	 a	 promising	 pathway	 to	 target	 for	 developing	 therapeutic	interventions	against	age-associated	proteotoxic	diseases.										
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1.8	Convergent	Mechanisms	Regulating	Longevity	
As	 described	 earlier	 there	 are	 a	 number	 of	 genes	 and	 pathways	 that	 regulate	longevity	across	different	species	and	some	of	them	act	independently	of	each	other.	However	 there	 is	 recent	 evidence	 that	 highlights	 the	 crosstalk	 across	 different	models	 of	 longevity.	 The	 remarkable	 molecular	 conservation	 of	 the	 components	linked	with	different	 longevity	pathways	allows	us	to	understand	longevity	 from	a	multi-species	 perspective.	 The	 degree	 to	 which	 distinct	 longevity	 pathways	converge	on	common	downstream	factors	is	not	entirely	understood	yet	and	there	have	 been	 a	 handful	 of	 these	 convergent	 factors	 recently	 identified	 that	 get	functional	 inputs	 from	 different	 pathways	 governing	 lifespan.	 HLH-30	 was	described	recently	as	one	such	factor	which	acts	downstream	of	multiple	longevity	pathways	and	is	required	for	lifespan	extension	in	these	distinct	models	of	longevity	in	C.	elegans	(Lapierre	et	al.,	2013).	HLH-30	is	the	worm	homolog	of	the	mammalian	transcription	factor	EB	(TFEB).	TFEB	was	recently	reported	to	act	as	a	pivotal	factor	regulating	 lysosomal	 biogenesis,	 autophagy	 and	 fat	 metabolism	 in	 mammals	(Sardiello	 et	 al.,	 2009;	 Settembre	 et	 al.,	 2013;	 Settembre	 et	 al.,	 2011).	 	 C.	 elegans	HLH-30	 also	 regulates	 the	 expression	 of	multiple	 autophagy	 and	 lysosomal	 genes	and	 thereby	 modulates	 the	 autophagy	 process	 (Lapierre	 et	 al.,	 2013).	 In	 various	longevity	models,	HLH-30	is	shuttled	to	the	nucleus	where	it	drives	the	expression	of	 multiple	 autophagy	 genes.	 Over-expression	 of	 hlh-30	 is	 sufficient	 to	 induce	longevity	 in	wildtype	worms	(Lapierre	et	al.,	2013).	 	 In	the	same	study	it	was	also	reported	that	the	levels	of	TFEB	were	higher	in	the	liver	extracts	of	mice	subjected	to	DR	(Lapierre	et	al.,	2013),	suggesting	that	TFEB	could	impart	some	of	the	benefits	of	DR.																		Recently	 our	 lab	 identified	 another	 protein	 complex	 belonging	 to	 the	Myc	superfamily	that	works	downstream	of	the	major	longevity	pathways	and	acts	as	a	convergent	node	in	 longevity	regulation	in	C.	elegans.	Myc	family	members	MML-1	(Myc/mondo-like)	 and	 its	 partner	MXL-2	 (Max,	Max-like)	were	 identified	 in	RNAi	based	suppressor	screens	for	suppression	of	germline-mediated	longevity	in	worms	(Johnson	 et	 al.,	 2014;	Nakamura	 et	 al.,	 2016).	MML-1	 and	MXL-2	 are	 required	 for	
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longevity	conferred	by	multiple	 longevity	pathways	 including	 the	 IIS	pathway	and	DR	 (Nakamura	 et	 al.,	 2016).	 The	 study	 further	 reported	 that	 MML-1	 and	 MXL-2	work	 in	 transcriptional	 cascades	 down-regulating	 TOR	 activity,	 which	 in	 turn	activates	 autophagy	 and	 HLH-30	 activity	 in	 the	 nucleus.	 This	 study	 reveals	 a	fundamental	regulatory	network	largely	affecting	worm	lifespan.																	Another	convergent	mechanism,	which	is	required	for	lifespan	extension	in	almost	all	 longevity	pathways	 in	C.	elegans	is	autophagy.	 	Autophagy,	as	discussed	above	in	detail,	is	a	major	cellular	process	for	degradation	and	subsequent	recycling	of	 proteins	 and	 organelles	 in	 eukaryotic	 cells.	 Autophagy	 is	 induced	 in	 major	longevity	models	including	IIS,	TOR	and	DR	and	is	required	for	extended	lifespan	in	these	 pathways	 (Hansen	 et	 al.,	 2008;	 Melendez	 et	 al.,	 2003).	 Autophagy	 is	 also	required	for	rapamycin	to	extend	lifespan	in	Drosophila	(Bjedov	et	al.,	2010)	making	it	an	important	convergent	mechanism	for	lifespan	extension	in	different	species.																			ROS	 levels	 have	 also	 been	 associated	 with	 lifespan	 in	 different	 longevity	models.	The	free	radical	 theory	of	aging	has	been	challenged	by	numerous	studies	that	have	reported	elevated	levels	of	ROS	to	be	required	for	lifespan	extension.		For	example	 ROS	 promote	 lifespan	 extension	 in	 germline-deficient	 worms	 (Wei	 and	Kenyon,	 2016).	 In	 yeast	 and	 worms	 it	 has	 been	 shown	 that	 DR	 induces	mitochondrial	respiration	and	oxidative	stress	(Mesquita	et	al.,	2010;	Schulz	et	al.,	2007;	 Sharma	 et	 al.,	 2011).	 In	 worms	 it	 was	 also	 reported	 that	 treatment	 with	juglone,	 which	 generates	 ROS	 extends	 lifespan	 in	 a	 manner	 dependent	 on	 DAF-16/FOXO	 (Heidler	 et	 al.,	 2010).	 There	 are	 contradicting	 studies	 about	 the	 role	 of	superoxide	 dismutase	 (SOD),	 which	 is	 a	 ROS	 scavenger,	 on	 lifespan	 (Back	 et	 al.,	2012;	 Liochev,	 2013).	 However	 there	 is	 evidence	 that	 longevity	 due	 to	overexpression	of	SOD	is	not	caused	by	decreased	oxidative	damage	(Cabreiro	et	al.,	2011),	 favoring	 the	 notion	 that	 ROS	 accumulation	 does	 not	 affect	 lifespan	negatively.	Since	there	is	ample	evidence	in	favor	of	an	association	between	elevated	ROS	 levels	 and	 lifespan,	 it	 can	 be	 proposed	 as	 a	 convergent	 mechanism	 that	regulates	aging	across	multiple	species	and	in	different	pathways.				
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	1.9	Nucleolar	and	Ribosomal	Proteins	in	Aging	
The	 nucleolus	 is	 the	 most	 obvious	 sub-nuclear	 structure	 where	 ribosomal	 RNA	(rRNA)	 and	 ribosomal	 subunits	 are	 synthesized.	 Within	 the	 nucleolus,	 ribosomal	DNA	 (rDNA)	 is	 transcribed	 by	 RNA	 polymerase	 I	 (RNA	 Pol	 I).	 Transcription	 over	rDNA	 region	 generates	 precursor	 rRNA	 or	 pre-rRNA	 molecules	 that	 are	 further	processed	to	generate	mature	28S,	18S,	and	5.8S	rRNAs.	These	rRNAs	together	with	ribosomal	proteins	are	exported	out	of	the	nucleus	to	the	cytoplasm	for	the	purpose	of	translation	(Figure	2)	(Boulon	et	al.,	2010).	The	size	of	the	nucleolus	is	a	measure	of	 the	 rate	 of	 ribosome	 biogenesis.	 Thus	 actively	 proliferating	 cells	 that	 require	higher	 levels	 of	 ribosomes	 and	 elevated	 global	 translational	 levels	 possess	 large	nucleoli	whereas	nucleolar	size	decreases	in	metabolically	inactive	cells	(Derenzini	et	al.,	1998).	Since	nucleolus	is	the	site	of	ribosome	biogenesis,	it	plays	an	active	role	in	 determining	 the	 metabolic	 state	 of	 a	 cell.	 There	 is	 growing	 evidence	 that	 the	processes	regulated	by	the	nucleolus	play	important	roles	in	regulating	aging.		
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Figure 2. Ribosome biogenesis at a glance. Pre-rRNAs generated by RNA polymerase I 
transcription in the nucleolus are processed into 28S, 5.8S and 18S rRNAs and assembled 
together with ribosomal proteins (RPs) and 5S rRNAs to form pre-60S and 40S ribosomal 
subunits. These subunits are translocated to the cytoplasm where they mature and carry out 
translation. 	For	 example	 the	 TOR	 pathway	 in	 addition	 to	 regulating	 lifespan	 also	 regulates	ribosome	 biogenesis,	 which	 implies	 that	 changes	 in	 nucleolar	 function	 can	 affect	lifespan	of	an	organism	(Martin	et	al.,	2006).	Rapamycin	treatment,	which	 inhibits	the	TOR	pathway,	has	been	shown	to	inhibit	synthesis	and	processing	of	rRNA	and	also	 promotes	 its	 decay.	 Furthermore,	 it	 was	 reported	 that	 mTORC1	 and	 its	components	raptor	and	mTOR	are	present	in	nucleoli	and	that	rapamycin	treatment	induces	loss	of	these	components	from	nucleoli	(Iadevaia	et	al.,	2012).	There	is	also	evidence	 in	 C.	 elegans	 that	 reduction	 in	 TOR	 signaling	 reduces	 nucleolar	 size	(Sheaffer	 et	 al.,	 2008).	 Further	 interesting	data	 that	 supports	 the	 evidence	 for	 the	
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link	between	nucleolus	and	aging	comes	from	the	yeast	gene	sgs1,	which	encodes	a	helicase	 like	 protein	 that	 localizes	 to	 the	 nucleolus.	 sgs1	 is	 closely	 related	 to	 the	human	 Werner	 gene	 (WRN)	 (Watt	 et	 al.,	 1996).	 Mutations	 in	 the	WRN	 gene	 in	humans	 lead	 to	 a	 pre-mature	 aging	 disease	 called	 the	 Werner	 Syndrome.	 And	intriguingly,	WRN	protein	is	also	localized	in	the	nucleolus	of	human	cells	(Gray	et	al.,	 1998).	 sgs1	mutations	 cause	pre-mature	 aging	 in	 yeast	 and	 together	with	pre-mature	aging	 there	 is	also	a	significant	enlargement	and	 fragmentation	of	nucleoli	(Sinclair	et	al.,	1997).	In	 line	with	this,	 there	have	been	studies	that	have	reported	that	an	alteration	in	ribosome	biogenesis	can	also	affect	aging.	Replicative	 lifespan	of	yeast	increases	by	altering	ribosome	biogenesis	through	the	knock	down	of	genes	encoding	 60S	 ribosomal	 subunit	 proteins.	 Furthermore,	 inhibiting	 60S	 subunit	biogenesis	using	small	molecule	inhibitors	also	increases	the	replicative	lifespan	of	yeast	(Steffen	et	al.,	2008).		And	it	is	known	that	knock	down	of	different	ribosomal	proteins	 and	 a	 modest	 down-regulation	 of	 protein	 synthesis	 leads	 to	 lifespan	extension	in	C.	elegans	(Hansen	et	al.,	2007;	Pan	et	al.,	2007;	Syntichaki	et	al.,	2007).	In	addition,	it	was	shown	that	RNAi	mediated	knock	down	of	nucleolar	GTPase	NOG-1,	 which	 is	 required	 for	 60S	 subunit	 biogenesis,	 leads	 to	 longevity	 in	 worms.	Consistent	with	this,	overexpression	of	NOG-1	reduced	wildtype	lifespan	(Kim	et	al.,	2014).	All	this	evidence	points	towards	a	role	of	nucleolus	and	ribosome	biogenesis	in	regulating	 lifespan	of	an	organism.	Another	recent	study	also	reported	a	role	of	nucleolus	in	aging	in	Drosophila.	In	this	study,	a	basic	helix-loop-helix	transcription	factor	called	Mnt	was	reported	to	regulate	the	expression	of	various	genes	that	are	involved	 in	 ribosome	 biogenesis.	 Over-expression	 of	 Mnt	 in	 skeletal	 muscle	improved	 the	 climbing	 ability	 of	 flies	 in	 old	 age	 indicative	 of	 improved	 health.	Moreover	 Mnt	 over-expression	 in	 skeletal	 muscle	 also	 increased	 lifespan.	Expression	 profiles	 revealed	 a	 down-regulation	 of	 the	 genes	 encoding	 nucleolar	proteins	and	reduced	levels	of	rRNA	upon	Mnt	over-expression.	RNAi	against	genes	involved	in	rRNA	processing	and	ribosome	biogenesis	increased	lifespan	indicating	nucleolar	function	in	determining	lifespan	(Demontis	et	al.,	2014).																	Although	 there	 is	 enough	 evidence	 to	 back	 the	 connection	 of	 nucleolar	processes	in	regulating	aging,	the	exact	mechanism	of	how	these	effects	are	brought	
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about	 is	not	clearly	understood.	There	are	various	hypotheses	that	still	need	to	be	validated.	 For	 example	 it	 is	 known	 that	 an	 increase	 in	 Arf	 and	 p53	 proteins	promotes	cancer	resistance	and	also	increases	lifespan	in	mice	(Matheu	et	al.,	2007).	Arf	 is	 alternative	 reading	 frame	 protein,	which	 is	 induced	 upon	mitogenic	 stimuli	such	 as	 aberrant	 growth.	 p53	 is	 an	 extensively	 studied	 tumor	 suppressor	 gene	which	maintains	the	stability	of	the	genome	by	preventing	mutations	that	can	lead	to	tumor.	p53	is	induced	by	the	inhibition	of	ribosome	biogenesis	(Le	Bouteiller	et	al.,	 2013)	 and	 it	 can	 be	 argued	 that	 the	 cancer	 resistance	 and	 longevity	 with	decreased	 ribosome	 biogenesis	 may	 be	 caused	 by	 the	 elevated	 levels	 of	 p53.	Likewise,	reduced	metabolic	rates	and	a	drop	in	free	radical	production	have	been	linked	to	aging	and	lifespan	implying	a	link	between	ribosome	biogenesis	and	aging	(Hulbert	et	al.,	2007).																				
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1.10	Aims	of	the	Study	
As	 discussed	 above,	 a	 number	 of	 pathways	 and	 cellular	 processes	 contribute	 to	longevity	 across	 multiple	 species.	 Single	 gene	 mutations	 can	 lead	 to	 significant	longevity	 benefits	 and	 improved	 health	 quality.	 But	 how	 these	 pathways	 interact	with	 each	 other	 and	whether	 the	 inputs	 from	 these	 pathways	 converge	 is	 largely	unknown,	 despite	 the	 discovery	 of	 some	 important	 players	 such	 as	 HLH-30	 and	MML-1/MXL-2.	The	overarching	aim	of	my	thesis	work	is	to	 identify	novel	players	that	act	 in	mediating	 longevity	across	different	 longevity	pathways.	Furthermore	 I	seek	 to	 understand	what	 are	 the	 processes	 that	 the	 different	 longevity	 pathways	converge	on	 to	bring	 about	 lifespan	extension.	This	 study	 can	 reveal	 the	 common	nodes	that	work	downstream	of	various	pathways.	If	one	is	able	to	understand	these	convergent	 mechanisms	 in	 detail,	 it	 could	 prove	 useful	 to	 develop	 diagnostic	 or	therapeutic	strategies	to	target	 factors	 involved	 in	these	pathways,	 to	combat	age-related	diseases	and	improve	health-span	into	old	age.																		For	 this	 study,	 genetic	 screens	 carried	 out	 by	 a	 former	 colleague	 (Bree	Heestand)	identified	a	number	of	mediators	DR	longevity	 in	C	.elegans.	I	started	to	characterize	 one	 of	 these	 genes	 called	 ncl-1,	 which	 encodes	 a	 homolog	 of	mammalian	 TRIM2	 and	 Drosophila	 BRAT/tumor	 suppressor.	 NCL-1	 affects	nucleolar	size	and	rRNA	production	in	C.	elegans	(Hedgecock	and	Herman,	1995).		
	The	following	were	the	major	aims	of	my	thesis:	
Aim	1.	Determine	the	role	of	ncl-1	in	various	longevity	pathways,	and	thereby	see	if	it	regulates	a	convergent	axis	of	lifespan	regulation.		
Aim	2.	Explore	the	physiologic	effects	and	genetic	interactions	of	ncl-1	and	longevity	pathways	on	nucleolar	physiology	and	ribosome	biogenesis.		
Aim	3.	Investigate	if	the	effects	observed	in	C.	elegans	are	also	conserved	in	higher	organisms.			
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2.1	Growth,	Maintenance	and	Culturing	of	C.	elegans	Strains		All	 the	worm	strains	were	grown	using	standard	procedures	on	nematode	growth	medium	(NGM)	in	petri	dishes	seeded	with	E.	coli	strain	OP50	(Brenner,	1974).	NGM	is	 composed	 of	 NaCl,	 peptone,	 agar,	 KPO4,	 cholesterol,	 CaCl,	 MgSO4,	 and	 water.		OP50	 bacteria	 used	 as	 the	 food	 source	 for	C.	elegans	are	 uracil-auxotrophs	which	allows	for	the	slow	growth	of	the	bacterial	 lawn.	 	All	C	elegans	strains	were	grown	and	 maintained	 at	 20°C	 unless	 otherwise	 noted.	 Strains	 carrying	 glp-1(e2141)	mutation	 were	maintained	 at	 15°C	 and	 shifted	 to	 25°C	 for	 inducing	 germlineless	phenotype.	The	strains	used	for	the	experiments	were:	N2	(wildtype),	eat-2(ad465),	
ncl-1(e1865),	 ncl-1(e1942),	 eat-2(ad465);ncl-1(e1865),	 eat-2(ad465);ncl-1(e1942),	
isp-1(qm150),	 isp-1(qm150);ncl-1(e1942),	 glp-1(e2141),	 glp-1(e2141);ncl-1(e1942),	
daf-2(e1370),	 daf-2(e1370);daf-16(mgDf50),	 hlh-30(tm1978),	 cguIs001	(FIB-1::GFP)	(Lee	 et	 al.,	 2010),	 eat-2(ad465)+cguIs001,	 ncl-1(e1942)+	 cguIs001	 and	 eat-
2(ad465);ncl-1(e1942)+	 cguIs001.	 dhEx1007	 ncl-1	 extra-chromosomal	 transgenic	strain	 was	 generated	 by	 injecting	 fosmid	 DNA	WRM0611AC10	 (ncl-1::TY1	 EGFP)	(30	ng/μl)	and	a	co-injectable	marker	(myo-2::mcherry	at	10	ng/μl)	in	N2	strain	and	further	 crossed	 into	eat-2(ad465),	eat-2(ad465);ncl-1(e1865)	and	eat-2(ad465);ncl-
1(e1942)	 backgrounds.	 The	 transgenic	 worms	 were	 maintained	 by	 selecting	 the	worms	showing	the	expression	of	the	co-injected	marker.	Worm	maintenance	also	entailed	decontaminating	strains	from	time	to	time	to	get	rid	of	contaminants,	which	was	done	by	bleaching.	 In	this	method,	contaminated	plates	were	washed	off	with	M9	physiological	buffer	and	the	worms	were	collected	 in	a	 falcon	tube.	The	 falcon	tubes	were	briefly	centrifuged	so	that	the	worms	were	collected	at	the	bottom.	M9	buffer	 was	 replaced	 by	 the	 bleach	 solution	 containing	 sodium	 hypochlorite,	potassium	hydroxide	and	water.	Worms	were	incubated	with	the	bleach	solution	for	around	10	minutes	at	room	temperature	and	afterwards	the	samples	were	washed	twice	 with	 M9	 buffer.	 At	 the	 end	 of	 the	 treatment	 only	 the	 eggs	 of	 the	 animals	survive	which	were	then	seeded	on	plates	containing	E.	coli	OP50	bacteria.		
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2.2	Lifespan	Analyses	Lifespan	 analyses	 were	 performed	 at	 20°C	 as	 previously	 reported	 (Gerisch	 et	 al.,	2001).	 Worms	 were	 age-synchronized	 by	 6-8	 hours	 of	 egg-lays.	 Lifespan	experiments	were	started	by	using	a	total	of	120	worms.	The	experimental	worms	were	moved	to	6	cm	petri	dishes	at	the	density	of	15	worms	per	plate.		Worms	were	scored	 for	 movement	 every	 other	 day.	 Until	 the	 end	 of	 the	 reproductive	 span,	worms	were	moved	 to	 fresh	 plates	 every	 other	 day.	 Animals	 that	 crawled	 off	 the	plates,	 burst	 due	 to	 a	 ruptured	 vulva	 or	 had	 internal	 hatching	 of	 the	 eggs	 were	censored	from	the	experiment.	RNAi	lifespan	analysis	experiments	were	carried	out	following	previously	described	protocol	(Kamath	et	al.,	2001).	All	RNAi	treatments	were	 performed	 throughout	 development	 and	 adulthood	 except	 let-363/TOR	 and	
fib-1,	which	were	initiated	on	the	first	day	of	adulthood.	Finally	the	data	was	plotted	to	calculate	mean,	median,	and	maximum	lifespans	and	log-rank	(Mantel-Cox)	analysis	was	used	to	determine	significance	between	the	lifespan	curves	(Supplementary	Table	2).	
	
2.3	Bacterial	Dilution	Regimen	(BDR)	for	Lifespan	Analyses	For	 BDR	 lifespan	 analyses,	 the	 method	 followed	 was	 the	 same	 as	 described	previously	 (Panowski	 et	 al.,	 2007).	 90	 worms	 were	 used	 for	 each	 bacterial	concentration	to	be	tested	and	the	worms	were	scored	every	3-4	days.	The	worms	were	 transferred	 to	 freshly	 prepared	 bacterial	 conditions	 on	 each	 day	 of	 scoring.	The	 liquid	media	also	called	 the	BDR	media	was	made	up	of	NaCl,	K2HPO4,	KH2PO4,	cholesterol	 and	 water.	 Additionally,	 antibiotics	 carbenicillin	 (50ug/ml),	 kanamycin	(10ug/ml),	 and	 tetracycline	 (1ug/ml)	were	 added	 to	 inhibit	 bacterial	 replication	 and	thus	maintain	 the	 concentration	 of	 bacteria.	 	 The	 experiment	was	 carried	 out	 in	 12	well	 cell	 culture	 dishes.	 For	 the	 first	 two	 weeks	 of	 the	 experiment	 FUdR	 (100	mg/mL)	was	added	 to	 the	BDR	media	 to	prevent	progeny	production.	Mantel-Cox	Log	Rank	method	was	used	for	statistical	analysis	(Supplementary	Table	2).	Bacterial	concentration	was	 estimated	 by	 serial	 dilutions,	 subsequent	 plating	 and	 counting	colony	forming	units	(CFUs).	
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2.4	Western	Blotting	Day	1	adult	worms	(50)	were	collected	in	M9	and	Laemmli	 lysis	buffer	was	added	and	the	samples	were	snap-frozen	in	liquid	nitrogen.	The	samples	were	then	boiled	at	 95°C	 for	 5	 minutes,	 ultrasonicated	 for	 10	 cycles	 and	 loaded	 on	 4-15%	 Mini-PROTEAN®	TGXTM	Precast	Protein	Gels.	After	separation,	proteins	were	blotted	on	a	nitrocellulose	membrane	using	Trans-Blot®	TurboTM	Transfer	System	(BioRad).	The	membranes	were	then	blocked	for	an	hour	at	room	temperature	in	5%	milk	in	Tris-buffered	 Saline	 and	 Tween20	 (TBST)	 and	 probed	 with	 the	 following	 antibodies	against:	 RPS-6	 (abcam®	 ab70227,	 1:1000),	 RPS-15	 (antibodies-online.com	ABIN503870,	 1:1000),	 Fibrillarin	 (Novus	 Biologicals	 NB300-269,	 1:1000)	 and	 β-Actin	 (abcam®	 ab8224,	 1:5000).	 The	 antibodies	 were	 diluted	 in	 TBST	 with	 1%	Bovine	 Serum	 Albumin	 (BSA).	 The	 membranes	 were	 incubated	 in	 the	 primary	antibody	 overnight	 at	 4°C.	 Specific	 secondary	 antibodies	 (mouse	 or	 rabbit)	 were	used	at	 a	 concentration	of	1:4000	 in	TBST	with	1%	BSA	at	 room	 temperature	 for	one	 hour.	 The	 membranes	 were	 developed	 with	 Western	 Lightening®	 Plus-Enchanced	 Chemiluminescence	 Substrate	 (PerkinElmer).	 The	 membranes	 were	imaged	then	with	ChemiDoc	Imager	(BioRad)	[For	all	Western	Blots:	n=50	worms/replicate,	3	independent	replicates]																	For Drosophila western blots, 5 females were homogenised in 100 µl of RIPA 
lysis buffer carrying 1X Complete mini protease inhibitor (EDTA free) (Roche). The 
homogenized lysates were cleared by centrifugation. Protein content was determined by 
following the Pierce™ BCA Protein Assay Kit (ThermoFisher Scientific). 30 µg of total 
protein was loaded on precast gels (Bio-Rad Any KD, Mini-PROTEAN® TGXTM). The 
proteins were transferred to nitrocellulose membranes using	 Trans-Blot®	 TurboTM	Transfer	System	(BioRad).	The	membranes	were	then	blocked	for	an	hour	at	room	temperature	 in	 5%	milk	 in	 Tris-buffered	 Saline	 and	Tween20	 (TBST)	 and	 probed	with	the	same	antibodies	as	above	following	the	same	dilutions. 
[For all Western Blots: n=5 flies/replicate, 3 independent replicates] 
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2.5	qRT-PCR	One	hundred	age-matched	day	1	adult	worms	were	collected	in	TRIzol	(Invitrogen)	and	snap-frozen	in	liquid	nitrogen.	RNA	extraction	was	performed	by	using	RNeasy	Mini	 Kit	 (QIAGEN).	 Extracted	 RNA	 samples	 were	 analyzed	 by	 NanoDrop	 2000c	(peqLab)	to	validate	purity	and	determine	quantity	of	RNA.	cDNA	was	subsequently	synthesized	from	the	extracted	RNA	using	iScript	cDNA	Synthesis	Kit	(Bio-Rad).	The	samples	 were	 loaded	 along	 with	 the	 primers	 onto	 a	 384	 well	 plate	 using	 JANUS	automated	 workstation	 (PerkinElmer).	 Power	 SYBR	 Green	 master	 mix	 (Applied	Biosystems)	was	used	for	qRT-PCR	on	a	ViiA7	384	Real-Time	PCR	System	machine	(Applied	 Biosystems).	 ama-1	 served	 as	 the	 endogenous	 control.	 qPCR	 primer	sequnces	are	given	in	Supplementary	Table	1		
2.6	rRNA	Analyses	Levels	of	rRNA	were	monitored	by	running	total	RNA,	extracted	from	100	worms	as	described	above	(2.5	qRT-PCR	section),	on	agarose	gels.	NorthernMax®	Kit	protocol	was	 followed	 for	 running	 RNA	 gels.	 The	 extracted	 RNA	 was	 mixed	 with	 three	volumes	of	formaldehyde	load	dye	from	the	kit.	The	samples	were	incubated	at	65°C	for	15	min	and	were	loaded	into	the	wells	of	an	agarose	gel	prepared	for	RNA	grade	work.	1	µl	of	commercial	Ethidium	Bromide	was	added	to	the	samples	right	before	loading	them	on	the	gel.	The	gel	was	run	at	~5	V/cm	for	two	hours.	Alpha	Innotech	MultiImage	II	was	used	for	imaging	the	gel.	[For	RNA	extraction:	n=100	worms/replicate,	3	independent	replicates]		
	
2.7	Immunofluorescence		Immunofluorescence	was	performed	on	10	μm	thick	cryo-sections	of	mouse	tissues	derived	 from	 kidney,	 liver	 and	 brain	 by	 fixing	 the	 samples	 with	 4%	Paraformaldehyde	 for	 15	 minutes	 at	 room	 temperature	 (RT)	 followed	 by	 three	washes	with	PBS	at	RT.	The	 samples	were	 then	blocked	with	5%	Normal	Donkey	Serum	 in	PBS	with	0.1%	Triton-X	 for	30	minutes	at	RT	 followed	by	an	over-night	incubation	at	4°C	with	the	primary	antibody	against	Fibrillarin	(abcam®	ab166630,	
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1:200).	 After	 three	 subsequent	 washes	 with	 PBS,	 the	 samples	 were	 then	 probed	with	the	secondary	anti-rabbit	antibody	at	RT	for	one	hour	followed	by	three	more	washes	 with	 PBS.	 The	 samples	 were	 mounted	 with	 ProLong®	 Gold	 Mounting	Medium	containing	DAPI	(ThermoFisher	Scientific)	and	imaged	with	Axio	Imager	Z1	(Zeiss)	 and	 a	 laser-scanning	 confocal	 microscope	 (TCS	 SP5-X;	 Leica).		Immunofluorescence	 quantification	 represents	 three	 independent	 biological	replicates	 with	 each	 replicate	 representing	 3	 mice	 (DR)	 and	 2	 mice	 (IRS1	 KO).	Imaging	and	quantification	of	the	experiments	were	performed	in	a	blinded	manner.															For	Drosophila,	 guts	 and	 fat	 bodies	were	 dissected	 out	 in	 PBS	 followed	 by	immediate	fixation	with	4%	PFA	in	PBS	and	permeabilization	for	10	minutes	at	RT	with	0.3%	Triton	X-100	 in	PBS	(PBST).	Blocking,	primary	and	secondary	antibody	incubation	 were	 done	 in	 5%	 BSA	 in	 PBST	 using	 Fibrillarin	 (Novus	 Biologicals	NB300-269,	 1:250)	 as	 the	 primary	 antibody	 and	 goat	 anti-mouse	 conjugated	 to	Alexa	Fluor	488	(Invitrogen	Inc.,	1:1000)	as	the	secondary	antibody.	Hoechst	33342	was	 applied	 at	 1:1000	 for	 staining	 nuclei.	 Tissues	 were	 extensively	 washed	 with	PBST	 after	 antibody	 treatments	 and	 finally	 mounted	 on	 glass	 slides	 with	 80%	glycerol	 in	 PBS.	 The	 quantification	 represents	 three	 independent	 biological	replicates	 with	 each	 replicate	 representing	 5	 dissected	 flies.	 Imaging	 and	quantification	of	the	experiments	were	performed	in	a	blinded	manner.																	For	staining	human	muscle	biopsies,	samples	were	thawed	at	RT.	Then	the	samples	 were	 blocked	 with	 5%	 milk	 in	 PBS	 with	 0.05%	 Tween	 (PBST)	 for	 30	minutes	at	RT,	followed	by	three	washes	with	PBST.	The	primary	antibody,	Rabbit-anti-Fibrillarin	(abcam®	ab166630,	1:600	in	PBST),	was	incubated	overnight	at	4°C.	After	 three	washes	with	 PBST,	 samples	were	 incubated	with	 the	 secondary	 goat-anti-rabbit-conjugated-Alexa647	antibody	(Molecular	Probes,	1:1000	in	PBST)	for	1	hour	at	RT,	followed	by	three	washes	in	PBST	and	one	wash	in	PBS	containing	DAPI	(0.5μg/mL,	 Sigma-Aldrich,	 Saint	 Louis,	 Missouri,	 USA).	 Slides	 were	mounted	with	Aqua	Poly-Mount®	(Polysciences	Inc,	Niles,	Illinois,	USA).	All	samples	were	stained	on	the	same	day	with	the	same	antibody	mixes.																	For	cells,	after	appropriate	starvation	 the	medium	was	washed	off	and	 the	cells	were	washed	twice	briefly	with	PBS.	Then	the	cells	were	fixed	with	4%	PFA	at	
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4°C	 for	 10	minutes	 followed	by	 a	wash	with	PBS.	Then	1	ml	 of	 ice-cold	methanol	(100%)	was	added	and	the	cells	were	incubated	for	10	minutes	at	-20	°C.	The	cells	were	washed	 in	PBS	 twice	and	 further	blocked	 in	5%	BSA	 in	PBS	 for	one	hour	at	room	 temperature.	 Anti-Fibrillarin	 (abcam®	 ab166630,	 1:200)	 antibody	 served	 as	the	primary	antibody	and	was	added	for	one	hour	at	room	temperature	followed	by	three	washes	each	lasting	five	minutes	with	PBS.	Then	the	secondary	antibody	anti-rabbit	 conjugated	 to	 Alexa	 Fluor	 488	 (Invitrogen	 Inc.,	 1:500)	 was	 applied	 to	 the	samples	 and	 the	 samples	 were	 incubated	 in	 the	 dark	 for	 one	 hour	 at	 room	temperature.	The	samples	were	then	washed	three	times	with	PBS	and	mounted	on	the	slides	using	ProLong®	Gold	Mounting	Medium	containing	DAPI	 (ThermoFisher	Scientific).	 	 Imaging	 of	 the	 cells	 was	 performed	 at	 63X	 magnification	 with	 Axio	Imager	Z1	(Zeiss).				
2.8	Imaging	and	Quantification	DIC	microscopy	was	used	to	perform	all	 the	nucleolar	 imaging.	Hypodermal,	germ	cell	and	pharyngeal	muscle	nucleoli	of	age-matched	day	1	adults	were	imaged	using	100X	magnification	with	Axio	 Imager	Z1	 (Zeiss)	 (Supplementary	Table	3).	Worms	carrying	 FIB-1::GFP	 and	 NCL-1::GFP	 transgenes	 were	 imaged	 using	 63X	magnification	 with	 Axio	 Imager	 Z1	 (Zeiss).	 Immunofluorescent	 images	 were	acquired	using	a	 laser-scanning	confocal	microscope	 (TCS	SP5-X;	Leica),	 equipped	with	a	white	light	laser,	a	405-	diode	UV	laser,	and	a	100X	objective	lens	(HCX	Plan-Apochromat	 CS	 100X	oil,	 1.46	 NA).	 For	 human	 muscle	 biopsies,	 a	 total	 15	representative	fields	with	a	63X	objective	from	each	muscle	sample	were	obtained,	using	the	DM5500	fluorescent	microscope	(Leica)	and	the	LAS	AF	software	(version	2.3.6,	 Leica).	 Anti-Fibrillarin	 was	 detected	 with	 the	 Y5	 cube,	 and	 nuclei	 were	detected	 with	 the	 A4	 cube.	 The	 area	 of	 the	 nucleolar	 and	 nuclear	 regions	 was	quantified	 manually	 with	 the	 freehand	 tool,	 and	 subsequently	 the	 ratio	 of	nucleolar/nuclear	area	was	calculated.	For	the	human	samples,	the	average	ratio	of	nucleolar/nuclear	area	(from	an	average	of	100.4	(±	28.9)	nuclei)	per	sample	was	used	for	the	analyses.	
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2.9	Drosophila	melanogaster	Experiments:	DR,	Rapamycin	
Treatment	and	dilp2-3,5	DR	in	Drosophila	melanogaster	was	performed	by	feeding	a	total	of	50	hatched	flies	with	0.5x	SYA	food	compared	to	ad	libitum	food	supply	of	2x	SYA	for	10	days	(Bass	
et.	 al.,	 2007).	 Rapamycin	 treatment	 was	 performed	 by	 dissolving	 Rapamycin	 in	absolute	ethanol	and	mixing	it	with	SYA	food	at	a	final	concentration	of	200	μM	and	fed	 to	 a	 total	 of	 50	 age-matched	 flies.	 For	 control	 food,	 ethanol	 alone	was	 added.	Both	DR	and	Rapamycin	 treatment	were	performed	 for	10	days	before	harvesting	the	flies	for	experiments.	The	treatments	were	performed	separately	in	3	different	vials	serving	as	3	independent	biological	replicates.	Long-lived	dilp2-3,5	(Grönke	et.	
al.,	 2010)	 and	 control	wDah	 flies	were	harvested	on	day	1	of	 adulthood.	The	 flies	were	dissected	and	immunofluorescence	was	performed	on	the	dissected	tissues	as	described	above.		
2.10	DR	and	IRS1	KO	Mice	The	 mice	 used	 for	 the	 experiments	 were	 handled	 according	 to	 the	 guidelines	 of	LANUV	 (Landesamt	 für	 Natur,	 Umwelt	 und	 Verbraucherschutz	 Nordrhein-Westfalen,	Germany).	C57BL/6	male	mice	were	maintained	under	12	hour	light:12	hour	 dark	 schedule	 and	 were	 fed	 standard	 chow	 diet	 (SC)	 -	 4.5g	 SC/animal/24	hours	(ssniff®	Spezialdiäten	GmbH)	until	10	weeks	of	age	and	then	subjected	to	DR	at	75%	food	intake	(3g	SC	per	animal/24	hours)	compared	to	ad	libitum	fed	control	mice.	The	DR	regimen	was	continued	 for	1	month	and	the	mice	were	sacrificed	at	the	age	of	14	weeks	along	with	the	ad	libitum	fed	controls	to	perform	cryosectioning	for	 the	 analysis	 of	 nucleoli.	 The	 tissues	 sampled	with	 sectioning	were	 kidney	 and	liver.	C57BL/6	IRS1	KO	male	(Selman	et.	al.,	2008)	and	WT	control	male	mice	were	maintained	similarly	on	SC	diet.	The	animals	were	sacrificed	at	the	age	of	12	months	to	 perform	 cryo-sectioning	 for	 the	 analysis	 of	 nucleoli.	 The	 tissues	 sampled	 with	sectioning	 were	 kidney	 and	 brain.	 For	 both	 the	 experiments	 cryo-sectioning	 was	performed	horizontally	across	the	entire	tissue.	This	nature	of	processing	aided	 in	observing	the	effect	of	the	treatments	across	different	cell	types	in	each	tissue.	
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2.11	 Dietary	 Restriction	 and	 Exercise	 Intervention	 in	 Human	
Volunteers	Samples	for	nucleolar	staining	were	obtained	from	the	biomaterial	collected	in	the	Growing	 Old	 Together	 Study,	 a	 13-weeks	 lifestyle	 intervention	 in	 older	 adults,	consisting	 of	 12.5%	 caloric	 restriction	 and	 12.5%	 increase	 in	 physical	 activity,	resulting	 in	 an	 average	 weight	 loss	 of	 3.3kg.	 The	 study	 design,	 inclusion	 and	exclusion	 criteria,	 and	 changes	 in	 metabolic	 parameters	 have	 been	 described	previously	(van	de	Rest	et	al.,	2016).	For	the	current	study	we	used	samples	from	5	men	 and	 5	 women	 selected	 based	 on	 the	 greatest	 weight	 loss	 due	 to	 the	intervention	and	the	availability	of	muscle	tissue	from	before	and	after	the	lifestyle	intervention.	 This	 subgroup	 had	 an	 average	 age	 of	 62.4	 years	 (±	 4.1)	 and	 lost	 an	average	of	6.8kg	(±	1.3)	due	to	the	intervention.	Characteristics	of	this	subgroup	are	detailed	in	Supplementary	Table	4.																All	participants	 signed	a	written	 informed	consent	 for	participating	 in	 this	study.	All	experiments	were	performed	in	accordance	with	the	relevant	regulations	and	 guidelines.	 The	 medical	 ethical	 committee	 of	 the	 Leiden	 University	 Medical	Center	approved	this	study.	This	trial	(NTR3499)	was	registered	at	the	Dutch	Trial	Register	(www.trialregister.nl).			
2.12	Muscle	Biopsies	and	Sectioning	Muscle	biopsies	were	collected	from	the	vastus	lateralis	muscle	before	and	after	the	lifestyle	 intervention.	 Biopsies	 were	 collected	 40-45	 minutes	 following	 a	standardized	 liquid	 meal	 (Nutridrink™,	 Nutricia	 Advanced	 Medical	 Nutricion,	Zoetermeer,	 The	 Netherlands)	 in	 the	 morning	 after	 at	 least	 10	 hours	 of	 fasting.	Under	 local	 anesthesia,	 an	 incision	 was	 made	 10cm	 cranial	 of	 the	 patella	 on	 the	lateral	side	of	the	upper	leg.	A	biopsy	needle	(3mm	thick)	was	inserted	to	obtain	the	muscle	 biopsy.	 The	muscle	 biopsy	was	 immediately	 frozen	 in	 liquid	 nitrogen	 and	stored	at	-80°C	prior	to	cryo-sectioning.		
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															Cryosections	 of	 16μm	 were	 made	 with	 the	 CM3050-S	 cryostat	 (Leica,	Wetzlar,	Germany),	pasted	on	SuperFrost	Plus	slides	(Menzel-Gläser,	Braunschweig,	Germany)	and	stored	at	-20°C	prior	to	staining.		
2.13	Cell	Culture		Primary	 mouse	 embryonic	 fibroblasts	 (MEFs)	 and	 primary	 human	 keratinocytes	were	 used	 for	 the	 cell	 culture	 experiments.	 The	 cells	 were	 thawed	 and	 grown	 in	Dulbecco's	 Modified	 Eagle	 Medium	 (DMEM)-GlutaMAXTM	 (Life	 Technologies)	containing	 20%	 fetal	 calf	 serum	 (FCS).	 The	 cells	 were	 used	 at	 passage	 3	 for	starvation	 experiments	 followed	 by	 immunofluorescence.	 Starvation	 protocol	was	followed	 which	 included	 washing	 off	 the	 old	 medium	 from	 the	 cells	 and	 further	washing	 the	 cells	 with	 PBS.	 Then	 Earle's	 Balanced	 Salt	 Solution	 (EBSS)	(ThermoFisher	Scientifc)	starvation	medium	was	added	on	experimental	cells	while	the	normal	DMEM	growth	medium	was	added	on	the	control	cells.	After	3	hours	of	starvation,	 MEFs	 were	 harvested	 for	 fixation	 and	 immunofluorescence	 further.	Primary	human	keratinocytes	were	starved	for	8	hours	and	the	medium	used	was	DMEM	and	Ham’s	F12	(Sigma-Aldrich	D6421).	The	cells	were	similarly	processed	as	pMEFs.			
2.14	Worm	Size	Measurements	Day	 one	 adult	 worms	 were	 used	 for	 body	 size	 measurements.	 Worms	 were	anesthetized	 using	 0.01%	 sodium	 azide,	mounted	 on	 slides	 and	 imaged	with	 10X	magnification.	This	magnification	ensured	that	an	entire	worm	would	fit	in	the	focal	plane.	 The	 length	 of	 the	 worms	 was	 quantified	 using	 the	 measure	 tool	 of	 Axio	Imager	Z1	(Zeiss)	microscope	software.				
2.15	Blinding	of	Experiments	All	 the	 lifespan	 analysis	 experiments	 were	 performed	 in	 a	 blinded	 manner.	 For	blinding,	the	strain	names	were	concealed	during	scoring,	analyzing	and	plotting	the	
  40 
data.	 Nucleolar	 imaging	 and	 quantification	 were	 also	 performed	 with	 concealed	strain	names.																Drosophila	nucleolar	size	analysis	was	performed	in	a	blinded	manner.	Two	different	people	were	involved	in	performing	the	experiment.	One	individual	carried	out	 fly	 feeding	 and	 mutant	 strain	 maintenance	 and	 the	 samples	 were	 passed	 on	blinded	for	imaging	and	quantification	to	the	second	experimenter.																Mouse	nucleolar	size	analysis	was	also	carried	out	blinded.	Three	different	people	were	involved	in	performing	the	experiments.	One	experimenter	maintained	the	 mice	 while	 carrying	 out	 the	 feeding/treatments	 and	 sacrificed	 the	 mice	 for	sectioning.	The	experiment	was	blinded	henceforth.	The	sectioning	was	carried	out	blinded	by	the	second	experimenter.	The	blinded	sections	were	stained,	imaged	and	quantified	by	the	third	experimenter.																Two	different	experimenters	performed	human	muscle	biopsy	staining.	The	whole	 experiment	 including	 staining,	 imaging	 and	 image	 quantification	 were	performed	completely	blinded.											
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3.1	ncl-1	is	Required	for	DR-Induced	Longevity	
In	order	 to	 identify	 regulators	of	DR	mediated	 longevity	 in	C.	elegans,	RNAi	based	suppressor	 screens	 were	 performed	 by	 our	 lab	 on	 the	 DR	 genetic	 model	 eat-
2(ad465).	NHR-62	was	identified	in	these	screens	as	being	the	first	nuclear	hormone	receptor	 involved	 in	DR	 longevity	 (Heestand	et.	 al.,	 2013).	 In	 addition	 to	NHR-62,	RING	finger	protein,	NCL-1	was	identified	in	these	genetic	screens	to	be	required	for	DR	longevity	revealing	another	potential	regulator.	ncl-1	encodes	a	cytoplasmic	zinc	finger	 protein	 that	 inhibits	 rRNA	 and	 5S	RNA	 transcription	 and	 protein	 synthesis	(Frank	 and	 Roth,	 1998).	 NCL-1	 is	 an	 ortholog	 of	 the	 TRIM2/BRAT	 tumor	suppressor,	 containing	 B-box,	 ring	 finger,	 and	 NHL	 repeats.	 Even	 though	 the	expression	of	ncl-1	is	largely	cytoplasmic,	it	regulates	nucleolar	size	in	worms	by	as	yet	an	unknown	mechanism.	Loss	of	ncl-1	leads	to	enlarged	nucleolar	size	especially	in	 neuronal,	 muscle	 and	 hypodermal	 cells	 (Hedgecock	 and	 Herman,	 1995).	Consistent	 with	 its	 role	 in	 nucleolar	 size	 regulation,	 ncl-1	 loss	 leads	 to	 increased	rRNA	and	protein	synthesis	indicating	that	ncl-1	plays	a	role	in	ribosome	biogenesis	and	 thereby	 regulates	 translation.	 In	 addition,	 NCL-1	 also	 regulates	 body	 size	 of	worms;	 ncl-1	 animals	 are	 9%	 larger	 than	 wild-type	 worms,	 possess	 22%	 more	protein	and	twice	as	much	rRNA	as	wild-type	animals	(Frank	and	Roth,	1998).																	Since	ncl-1	was	identified	in	an	RNAi	based	screen	for	DR	longevity,	we	went	on	 further	 to	 validate	 its	 role	with	ncl-1	null	mutants.	 Two	different	ncl-1	mutant	alleles	were	used	namely	ncl-1(e1865)	and	ncl-1(e1942).	Both	the	alleles	carry	point	mutations	 in	the	coding	region	of	the	gene,	resulting	 in	a	non-functional	truncated	protein.	We	generated	eat-2;ncl-1	double	mutants	and	performed	lifespan	analyses	to	confirm	if	the	longevity	conferred	by	DR	is	abrogated	with	the	loss	of	ncl-1.	With	the	loss	of	ncl-1,	the	longevity	of	eat-2	was	completely	abolished	suggesting	that	ncl-
1	 is	 required	 for	eat-2	 longevity	(Figure	3A,B).	Since	 there	are	various	methods	of	carrying	 out	 DR	 in	 worms,	 we	 resorted	 to	 Bacterial	 Dilution	 Regimen	 (BDR)	 to	induce	 a	DR	 response	 in	 order	 to	 investigate	 if	 the	 longevity	 conferred	by	BDR	 is	also	 abrogated	 with	 the	 loss	 of	 ncl-1.	 We	 performed	 BDR	 experiment	 by	 feeding	seven	different	 concentrations	 of	OP50	bacteria	 to	wildtype	 and	ncl-1	worms	 and	
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monitored	 their	 lifespan.	 The	 highest	 concentration	 corresponding	 to	 ad-libitum	feeding	 was	 5.85×109	 CFU/ml.	 The	 results	 show	 that	 the	 loss	 of	 ncl-1	 also	suppresses	 the	 longevity	 induced	 by	 BDR	 (Figure	 3C).	 The	 optimal	 concentration	where	the	graph	shows	a	peak	and	maximum	lifespan	extension	in	wildtype	worms	was	 found	out	 to	be	6.5×108	CFU/ml.	At	 this	 concentration,	wildtype	worms	 lived	significantly	longer	than	ncl-1	mutants	implying	that	ncl-1	 is	also	required	for	BDR	longevity.	Taken	together,	these	results	clearly	show	that	ncl-1	plays	a	pivotal	role	in	mediating	DR	longevity	in	C.	elegans.			
	
Figure 3. ncl-1 is required for DR longevity. (A,B) eat-2(ad465) is significantly longer lived than 
wildtype (N2) (p<0.0001). Loss of ncl-1 suppresses the longevity of eat-2 (ad465) worms 
(p<0.0001). (C) Wildtype (N2) worms are significantly longer lived compared to ncl-1 upon 
bacterial dilution cross 7 different concentrations (p<0.0001). p-values calculated by log-rank test. 
 To	 further	 study	 the	 role	 of	 ncl-1	 in	 the	 context	 of	 regulating	 lifespan	 under	 DR	conditions,	we	obtained	a	gfp	 fused	ncl-1	 translational	reporter	construct	from	the	TransgeneOme	project	(Sarov	et	al.,	2012).	The	construct	was	injected	into	wildtype	worms	and	thus	two	independent	transgenic	strains	were	generated	which	carried	
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the	construct	as	an	extra-chromosomal	array.	The	expression	of	ncl-1	was	seen	to	be	largely	 cytoplasmic	 across	different	 tissues	 including	neurons,	 pharynx,	 body	wall	muscle,	 seam	 cells	 and	 vulva	 (Figure	 4A).	 These	 transgenic	 lines	 served	 as	 over-expression	 strains	 for	 ncl-1	 in	 N2	 background.	 We	 next	 wanted	 to	 validate	 the	function	of	ncl-1	transgene.	Therefore,	ncl-1	transgenic	worms	were	crossed	in	ncl-1	mutant	 background	 and	 nucleolar	 size	 was	 examined.	 As	 discussed	 above,	 ncl-1	mutants	possess	significantly	 larger	nucleoli	compared	to	wildtype	worms	(Figure	4B,C).	 	As	expected,	ncl-1	 transgene	rescued	the	large	nucleolar	phenotype	in	ncl-1	mutants	back	to	wildtype	levels	(Figure	4B,C).			
	
Figure 4. Transgenic expression of ncl-1 rescues large nucleolar size of ncl-1 mutants. (A) 
The arrows indicate the expression of ncl-1 across multiple tissues. Scale bar represents 20 µm. 
(B,C) Over-expression of ncl-1 decreases nucleolar size in N2. Restoring ncl-1 transgenically 
rescues the big nucleolar phenotype of ncl-1 mutants. Scale bar represents 5 µm. **** p<0.0001, 
unpaired t-test. 	
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We	next	crossed	the	ncl-1	transgenic	line	in	eat-2;ncl-1	background	and	monitored	the	 lifespan.	Upon	restoring	 functional	ncl-1	transgenically,	 longevity	of	eat-2;ncl-1	was	 restored	 back	 to	 eat-2	 levels	 (Figure	 5A,B).	 Furthermore,	 over-expression	 of	
ncl-1	in	wildtype	worms	increased	lifespan	however	there	was	no	additive	longevity	observed	 in	 eat-2	 suggesting	 an	 overlapping	 mechanism	 (Figure	 5C,D).	 Lifespan	analysis	with	over-expression	of	ncl-1	in	N2	was	performed	using	two	independent	transgenic	 strains	 both	 of	 which	 showed	 similar	 lifespan	 extension	 (Figure	 5C).	These	 results	 clearly	 suggest	 that	 ncl-1	 plays	 an	 important	 role	 in	 DR	 mediated	lifespan	 extension	 and	 that	 an	 over-expression	 of	 this	 gene	 is	 sufficient	 to	 drive	longevity.	These	results	also	validate	the	functionality	of	transgenic	ncl-1.			
	
Figure 5. Over-expression of ncl-1 extends lifespan. (A,B) Survivorship curves of Wildtype 
(N2), eat-2, ncl-1, eat-2;ncl-1 and eat-2;ncl-1 carrying wildtype ncl-1 transgene. ncl-1 transgene in 
eat-2;ncl-1 rescues the longevity of eat-2;ncl-1 mutants (p<0.0001). (C,D) ncl-1 overexpression in 
wildtype (N2) background extends lifespan (p<0.0001) but there is no significant lifespan 
extension in eat-2 with ncl-1 overexpression. p-values calculated by log-rank test. 
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3.2	ncl-1	Regulates	Body	Size	of	C.	elegans	
In	addition	to	extending	lifespan,	DR	reduces	body	size	of	different	organisms.	Body	size	of	eat-2(ad465)	mutants	 is	significantly	smaller	compared	to	wildtype	worms.	However,	ncl-1	 loss	 rescues	 the	 smaller	 body	 size	 of	 eat-2	worms	 back	 to	 almost	wildtype	levels.	eat-2;ncl-1	double	mutants	are	significantly	larger	in	size	compared	to	eat-2(ad465)	single	mutants	(Figure	6).	These	results	suggest	ncl-1	plays	a	role	in	regulating	body	growth	and	that	the	loss	of	ncl-1	restores	the	small	body	size	of	eat-
2	back	 to	wildtype	 levels.	eat-2(ad465)	worms	have	a	slower	pharyngeal	pumping	rate	which	leads	to	reduced	food	intake	and	ncl-1	mutation	in	eat-2(ad465)	worms	does	not	affect	 this	 trait.	These	data	uncouple	 the	body	size	and	 food	 intake;	both	
eat-2(ad465)	and	eat-2;ncl-1	worms	eat	less,	yet	eat-2;ncl-1	mutants	grow	bigger	in	size	than	eat-2(ad465)	single	mutant.										
Figure 6. ncl-1 regulates body size. Loss of ncl-1 restores the body size of eat-2 worms back to 
wildtype levels. N2 vs eat-2, p<0.0001; eat-2 vs eat-2,ncl-1 (both alleles), p<0.0001. p-values 
were calculated by unpaired t-test. 	
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3.3	ncl-1	Plays	a	Role	in	Other	Longevity	Models	
Since	there	are	already	some	well	characterized	longevity	pathways	known,	we	next	asked	if	ncl-1	also	modulates	longevity	in	these	known	longevity	models.	We	started	by	studying	the	role	of	ncl-1	in	the	TOR	pathway.	The	TOR	pathway	has	been	closely	linked	 with	 DR	 and	 is	 already	 known	 to	 mediate	 lifespan	 extension	 under	 DR	conditions	(Hansen	et	al.,	2007).	Therefore	we	tested	if	the	loss	of	ncl-1	would	also	abrogate	 lifespan	 extension	under	TOR	 inhibition	 conditions.	We	performed	RNAi	against	 let-363/TOR	 kinase	 on	 wildtype	 and	 ncl-1	 mutants	 and	 monitored	 the	lifespan.	TOR	RNAi	was	started	on	the	first	day	of	adulthood	since	TOR	knockdown	causes	developmental	arrest	when	initiated	egg-on.	Interestingly,	ncl-1	mutants	had	a	 significantly	 shorter	 lifespan	 than	 the	 wildtype	 counterparts	 upon	 let-363/TOR	RNAi	knockdown	(Figure	7A,B).	These	results	imply	that	ncl-1	works	downstream	of	the	TOR	pathway	and	is	required	for	mediating	lifespan	extension	upon	knockdown	of	TOR.																Reduced	insulin	signaling	(IIS	pathway)	and	reduced	mitochondrial	activity	are	known	to	extend	lifespan	(Dillin	et	al.,	2002;	Kenyon	et	al.,	1993).	Next,	we	asked	if	ncl-1	would	be	required	 for	 lifespan	extension	 in	 these	already	known	longevity	pathways.	 To	 address	 this	 question	we	 performed	RNAi	mediated	 knock	 down	of	the	C.	elegans	 insulin/IGF	receptor	daf-2,	 to	 investigate	the	 involvement	of	ncl-1	in	the	IIS	pathway.	To	examine	the	role	of	ncl-1	in	the	mitochondrial	longevity	pathway	we	crossed	ncl-1	in	isp-1	mutant	background.	isp-1	encodes	an	iron	sulfur	protein	in	mitochondrial	 complex	 III	 and	 a	mutation	 of	 this	 gene	 leads	 to	 impaired	 electron	transport	 function	 and	 an	 extension	 in	 lifespan	 (Yang	 and	 Hekimi,	 2010).	 As	reported	 earlier,	 RNAi	 against	 daf-2	 increased	 the	 lifespan	 of	 wildtype	 worms	significantly.	However	ncl-1	mutants	were	not	as	long	lived	as	the	wildtype	worms	upon	daf-2	knock	down	 indicating	 that	ncl-1	 is	partially	 involved	 in	regulating	 the	lifespan	upon	reduced	insulin	signaling	(Figure	7C,D).	A	similar	trend	was	observed	in	the	lifespan	of	isp-1	compared	to	isp-1;ncl-1	also.	isp-1	worms	were	long-lived	and	
isp-1;ncl-1	 mutants	 had	 an	 intermediate	 lifespan,	 still	 longer	 lived	 than	 wildtype	however	significantly	shorter	lived	than	isp-1	single	mutants	(Figure	7F).	These	data	
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indicate	 that	ncl-1	 plays	 a	 partial	 but	 significant	 role	 in	modulating	 lifespan	 upon	reduced	insulin	signaling	and	reduced	mitochondrial	activity.		
	
Figure 7. ncl-1 is required for multiple longevity pathways. (A,B) let-363/TOR RNAi extends 
lifespan of wildtype (N2) worms but not of ncl-1 mutants (p<0.0001). (C,D) ncl-1 mutants are not 
as long lived as wildtype (N2) upon daf-2 RNAi (p<0.0001). (E,F) glp-1(e2141) and isp-1(qm150) 
are significantly longer lived than glp-1;ncl-1 (p<0.0001) and isp-1;ncl-1 (p=0.0016). p-values 
calculated by log-rank test. 
 Another	well-characterized	model	 of	 longevity	 is	 the	 gonadal	 longevity	model.	 As	discussed	above	germline	ablation	extends	lifespan	in	diverse	organisms	suggesting	its	evolutionary	conservation.	There	are	two	ways	of	removing	germline	in	worms	discussed	in	detail	above.	There	is	a	laser	microsurgical	method	by	which	germline	precursor	cells	can	be	ablated	 in	 larval	stage	1	or	L1	worms	and	this	removes	the	germline	in	the	animals	entirely.	A	genetic	way	of	inducing	germline	removal	is	by	
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growing	 the	 worms	 harboring	 glp-1	mutation	 at	 25°C.	 glp-1	 codes	 for	 a	 notch	transmembrane	receptor	in	C.	elegans	and	its	disruption	and	subsequent	growth	at	25°C	renders	the	worms	germlineless.	 	Both	these	treatments	of	germline	removal	induce	 significant	 longevity.	 We	 asked	 if	 ncl-1	 is	 responsible	 for	 mediating	 this	longevity.	We	generated	glp-1;ncl-1	double	mutants	to	address	this	question.	Since	both	 these	 genes	 lie	 close	 together	 on	 Chromosome	 III,	 the	 genetic	 cross	 was	tedious.	Nevertheless	we	were	able	to	generate	a	double	mutant	with	one	of	the	ncl-
1	 alleles.	 We	 next	 monitored	 the	 lifespan	 and	 interestingly	 ncl-1	 loss	 totally	abolished	 the	 longevity	 of	 germlineless	 glp-1	 animals	 (Figure	 7E).	 These	 results	show	that	ncl-1	is	required	for	mediating	longevity	conferred	by	germline	removal.																	Taken	 together,	 our	 data	 indicate	 that	 ncl-1	 plays	 a	 role	 in	 modulating	lifespan	 upon	 DR,	 reduced	 TOR	 pathway,	 reduced	 IIS	 pathway,	 reduced	mitochondrial	activity	and	also	upon	germline	removal.	Longevity	conferred	by	DR,	reduced	 TOR	 signaling	 and	 germline	 removal	 are	 completely	 abolished	 in	 the	absence	of	ncl-1	indicating	a	crucial	role	played	by	ncl-1,	whereas	it	plays	a	partial	role	 in	mediating	 longevity	upon	 reduced	 IIS	pathway	and	 reduced	mitochondrial	activity	 suggesting	 that	 there	 are	 other	 mechanisms	 independent	 of	 ncl-1	 which	orchestrate	this	lifespan	extension.	Nevertheless,	ncl-1	plays	into	all	the	well-known	mechanisms	 that	 increase	 lifespan	 in	 C.	 elegans.	Therefore	 it	 acts	 as	 a	 universal	regulator	 of	 longevity	 across	 different	 longevity	 models	 pointing	 towards	 a	convergent	mechanism	 that	 leads	 to	 lifespan	extension	and	 is	 regulated	by	 inputs	from	ncl-1.			
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3.4	Smaller	Nucleoli	Associate	with	Longevity	in	C.	elegans	
The	 nucleolus	 is	 the	 site	 of	 rRNA	 transcription	 and	 ribosome	 biogenesis.	 It	 was	previously	 described	 that	 NCL-1	 regulates	 nucleolar	 size	 in	 C.	 elegans	 and	 ncl-1	mutants	 have	 larger	 nucleoli	 especially	 in	 neuronal,	muscle	 and	 hypodermal	 cells	(Hedgecock	 &	Herman,	 1995).	 In	 both	ncl-1(e1865)	 and	ncl-1(e1942)	 nucleoli	 are	larger	 compared	 to	 wildtype	 worms	 (Figure	 8A).	 Since	 we	 found	 that	 ncl-1	 is	required	 for	mediating	 lifespan	 extension	 across	multiple	 longevity	pathways	 and	that	 protein	 synthesis	 rates	 per	 se	 regulate	 lifespan	 as	 noted	 earlier,	 it	 was	intriguing	for	us	to	investigate	the	nucleolar	size	in	different	longevity	pathways	and	if	 there	 existed	 any	 connection	 between	 the	 size	 of	 the	 nucleolus	 and	 lifespan	 in	general.	 We	 started	 off	 by	 examining	 the	 nucleoli	 of	 eat-2(ad465)	 mutants.	 We	measured	the	nucleolar	size	in	the	superficial	hypodermal	cells	around	the	posterior	bulb	of	pharynx	in	age-synchronized	N2,	eat-2,	and	eat-2;ncl-1	worms.	Strikingly	we	observed	 that	 eat-2(ad465)	 possessed	 smaller	 nucleoli	 compared	 to	wildtype	 and	the	small	nucleolar	size	was	rescued	in	eat-2;ncl-1	suggesting	that	ncl-1	is	epistatic	to	eat-2	 for	both	nucleolar	 size	 and	 longevity	(Figure	8B).	 	Next	we	 examined	 the	nucleoli	 of	 the	worms	 subjected	 to	 BDR.	 And	 interestingly	we	 observed	 a	 similar	effect;	a	reduction	in	bacterial	concentration	led	to	a	reduction	in	nucleolar	size	with	a	 corresponding	 increase	 in	 lifespan	 (Figure	 8C).	 We	 could	 only	 use	 three	concentrations	 namely	 5.85×109	 CFU/ml	 (ad-libitum),	 1.95×109	 CFU/ml	 and	6.5×108	 CFU/ml	 for	 the	 nucleolar	 size	 analysis	 because	 at	 concentrations	 below	6.5×108	 CFU/ml	 the	 worms	 were	 getting	 developmentally	 arrested	 because	 of	reduced	food.	For	BDR	lifespan	analysis	this	problem	did	not	arise	because	day	one	adult	worms	were	subjected	to	the	different	food	concentrations.	This	result	points	towards	 a	 negative	 correlation	 between	 lifespan	 and	 nucleolar	 size	wherein	 food	reduction	mediated	lifespan	increase	is	accompanied	with	a	corresponding	drop	in	nucleolar	size.	We	further	wondered	if	this	effect	on	nucleolar	size	was	confined	to	DR	or	if	it	was	a	general	trait	of	long-lived	animals.	To	investigate	this	possibility,	we	examined	 nucleoli	 of	 other	 long-lived	 worms	 namely	 daf-2(e1370),	 isp-1(qm150),	
glp-1(e2141),	and	N2	upon	 let-363/TOR	RNAi.	Strikingly,	nucleoli	 in	all	 these	 long-
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lived	 worms	were	 reduced	 in	 size	 compared	 wildtype	 worms	 (Figure	 8D).	 Along	with	 these	 long-lived	worms	we	 also	 checked	 the	 nucleoli	 of	 the	 short	 lived	 daf-
2;daf-16	mutants	in	order	to	get	more	evidence	about	the	effect	on	nucleoli.	Longer	lived	 daf-2	 worms	 had	 smaller	 nucleoli	 compared	 to	 daf-2;daf-16	 which	 is	significantly	shorter	 lived	 than	daf-2,	further	supporting	 the	notion	 that	 long-lived	animals	 possess	 smaller	 nucleoli	 and	 vice	 versa	 (Figure	 8D).	 We	 also	 tested	 the	nucleolar	 size	 of	 the	 long-lived	 worms	 over-expressing	 ncl-1.	 We	 observed	 that	over-expression	of	ncl-1	reduced	the	size	of	nucleoli	compared	to	wildtype	worms	(Figure	4B,C).	We	also	investigated	nucleoli	in	other	tissues	to	get	more	convincing	evidence	 of	 this	 effect.	We	 examined	 the	 nucleolar	 size	 in	 pharyngeal	muscle	 and	germ	 cells	 in	 all	 these	 long-lived	 mutants.	 We	 observed	 a	 similar;	 nucleoli	 of	pharyngeal	muscle	and	germ	cells	were	also	reduced	 in	size	 in	 long-lived	mutants	compared	 to	wildtype	 (Figure	 8E,F).	Here	 again	we	 observed	 that	 the	 pharyngeal	muscle	and	germ	cell	nucleoli	of	the	long-lived	daf-2	were	significantly	smaller	than	the	 short	 lived	daf-2;daf-16	 further	 adding	 to	 the	 evidence	of	 nucleolar	 size	being	reduced	 in	 long-lived	 animals	 (Figure	 8E,F).	 These	 results	 also	 indicate	 that	nucleolar	size	is	affected	across	different	tissues	in	long-lived	mutants	and	leads	to	the	 assumption	 that	 may	 be	 the	 concerted	 effect	 of	 reduced	 nucleoli	 in	 different	tissues	causes	the	animals	to	attain	longevity,	which	needs	to	be	further	explored.			
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Figure 8. Nucleolar size inversely correlates with longevity. (A) ncl-1 mutants possess larger 
nucleoli compared to N2. Hypodermal nucleoli are depicted here. Scale bar represents 20 µm. 
(B) eat-2(ad465) animals have smaller nucleoli while ncl-1(e1942) and eat-2;ncl-1 animals 
possess larger nucleoli compared to N2. Scale bar represents 5 µm. (C) Nucleolar size is 
reduced upon bacterial food reduction with a corresponding increase in lifespan. (p<0.0001, log-
rank test). (D,E,F) eat-2(ad465), TOR RNAi, isp-1(qm150), glp-1(e2141) and daf-2(e1370) 
animals possess smaller nucleoli while daf-2;daf-16 have nucleoli similar to N2 in the hypodermis 
pharyngeal muscle and germ cells. * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001, ns: non-
significant, unpaired t-test. 
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																Isogenic	 wildtype	 worms	 show	 considerable	 variance	 in	 life	 expectancy,	with	 some	animals	 dying	 as	 early	 as	 day	10	 and	others	 as	 late	 as	 day	30,	 despite	culture	in	a	uniform	environment.	The	basis	of	this	variance	however	has	remained	elusive.	We	also	found	that	wildtype	animals	showed	variance	in	nucleolar	size,	and	therefore	asked	if	these	differences	associate	with	lifespan	in	wildtype	populations.	To	address	this	question,	we	imaged	the	nucleoli	of	age-matched	worms	on	the	first	day	 of	 adulthood,	 recovered	 them	 on	 single	 plates	 and	 monitored	 their	 lifespan	individually	 (Figure	 9A).	 A	mild	 anesthetic	was	 used	 for	 imaging	 live	worms	 and	then	they	were	recovered	on	OP50	bacteria.	From	the	images	of	 individual	worms	nucleolar	 size	was	measured	and	 strikingly,	 the	animals	with	 larger	nucleoli	 lived	shorter	 compared	 to	 the	 animals	with	 smaller	 nucleoli.	 This	 piece	 of	 data	 further	substantiates	the	idea	of	an	association	between	longer	lifespan	and	smaller	nucleoli	(Figure	 9B).	 Taken	 together,	 our	 data	 draws	 an	 inverse	 correlation	 between	nucleolar	 size	 and	 lifespan.	 This	 phenomenon	 can	 thus	 be	 used	 as	 a	 proxy	 for	lifespan	and	the	lifespan	of	an	animal	can	be	approximated	on	day	one	of	adulthood	based	on	the	size	of	its	nucleoli.			
	
	
Figure 9. Nucleolar size can approximate C. elegans’ life expectancy (A,B) Schematic 
diagram illustrating the experiment, which shows that longer-lived worms exhibit small nucleoli 
and vice versa (Pearson correlation coefficient R2 = 0.93).  
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3.5	Reduced	Nucleolar	Function	Associates	with	Longevity	
It	 was	 very	 striking	 to	 discover	 the	 negative	 correlation	 between	 lifespan	 and	nucleolar	 size.	 Therefore	 to	 have	mechanistic	 insights	 as	 to	 how	 smaller	 nucleoli	might	 be	 linked	 to	 aging,	we	 examined	 how	ncl-1	and	various	 long-lived	mutants	affected	 nucleolar	 function.	 It	 was	 previously	 reported	 that	 the	 expression	 of	nucleolar	marker	 fib-1	increases	drastically	upon	ncl-1	loss	(Lee	et	al.,	2012).	 fib-1	encodes	 the	 C.	 elegans	 ortholog	 of	 Fibrillarin	 which	 is	 an	 rRNA	 2'-O-methyltransferase	 enzyme.	 It	 is	 an	 essential	 component	 of	 the	U3	 small	 nucleolar	ribonucleoproteins	(snoRNPs)	complex	that	functions	in	rRNA	processing.	We	used	transgenic	worms	expressing	FIB-1	fused	to	GFP	for	our	analysis	(Lee	et.	al.,	2010).	The	GFP	signal	in	these	worms	is	punctate	and	each	punctum	represents	a	nucleolus	(Figure	10A).	We	crossed	these	worms	 into	ncl-1	mutant	background.	As	reported	earlier,	we	could	see	an	increase	in	FIB-1::GFP	levels	upon	ncl-1	loss	(Figure	10A,B).	And	conversely,	FIB-1	goes	down	in	ncl-1	over-expressing	worms	(Figure	10C).	This	indicates	that	NCL-1	acts	as	a	suppressor	of	FIB-1.	Next	we	asked	if	the	levels	of	FIB-1	are	altered	in	long-lived	mutants.	This	would	give	us	an	indication	of	the	activity	of	NCL-1	in	these	worms.	We	started	with	eat-2,	specifically	asking	if	DR	regulates	the	levels	of	FIB-1.	To	address	this	question,	we	crossed	the	transgenic	worms	carrying	FIB-1::GFP	into	eat-2	background	and	surprisingly	we	found	that	the	levels	of	FIB-1	were	highly	reduced	in	eat-2	(Figure	10A,B).	To	study	epistasis,	we	further	crossed	FIB-1::GFP	into	eat-2;ncl-1	double	mutant	background	and	looked	at	the	expression	of	 FIB-1.	 Strikingly	 in	 the	 double	 mutant	 eat-2;ncl-1	 the	 levels	 of	 FIB-1	 were	dramatically	high	again	like	in	ncl-1	single	mutant	suggesting	that	ncl-1	 is	epistatic	over	eat-2	in	terms	of	FIB-1	regulation	(Figure	10A,B).	We	could	also	confirm	these	results	 by	 western	 blotting	 using	 an	 antibody	 detecting	 the	 endogenous	 FIB-1	protein	ruling	out	any	effects	that	could	occur	due	to	dysregulation	of	the	FIB::GFP	transgene.	We	observed	 lower	 levels	of	FIB-1	 in	eat-2	and	higher	amount	FIB-1	 in	
ncl-1	compared	to	wildtype	(Figure	10C).																		Next	we	wanted	to	confirm	the	levels	of	FIB-1	in	other	long-lived	animals	as	well.	We	used	FIB-1::GFP	transgenic	strain	to	address	this	question.	We	crossed	FIB-
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1::GFP	strain	 in	daf-2(e1370),	 isp-1(qm150)	and	glp-1(e2141)	genetic	backgrounds.	And	 we	 observed	 a	 significant	 down-regulation	 of	 the	 GFP	 signal	 compared	 to	wildtype	 indicating	 that	 the	 levels	of	FIB-1	are	reduced	 in	 these	 long-lived	worms	(Figure	10D).	Additionally	TOR	knockdown	via	RNAi	 in	wildtype	worms	with	FIB-1::GFP	 also	 reduced	 the	 GFP	 signal	 (Figure	 10D).	 However	 the	 reduction	 of	 FIB-1::GFP	was	 totally	 abolished	with	 the	 loss	 of	ncl-1	 in	 all	 these	 long-lived	mutants	(Figure	 10D).	We	 also	 confirmed	 these	 findings	 by	western	 blotting	 to	 assess	 the	levels	 of	 endogenous	 FIB-1	 in	 daf-2,	 isp-1	 and	 glp-1	mutants	 and	 also	 in	 animals	subjected	to	TOR	RNAi.		Consistent	with	the	findings	observed	using	FIB-1::GFP,	we	saw	 that	 FIB-1	 was	 down	 regulated	 in	 all	 these	 long-lived	 animals	 compared	 to	wildtype	(Figure	13A,B).	However	loss	of	ncl-1	reversed	these	effects	and	increased	the	levels	of	FIB-1	in	these	long-lived	worms	(Figure	13A,B).		
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Figure 10. ncl-1 and longevity mutants regulate fibrillarin. (A,B) FIB-1::GFP is strongly down-
regulated in eat-2(ad465) animals but up-regulated in ncl-1 and eat-2;ncl-1 double mutants. (C) 
Western Blot showing reduced levels of FIB-1 in eat-2(ad465) and upon ncl-1 over-expression 
and increased levels in ncl-1 mutants. (D) FIB-1 levels are reduced in long-lived daf-2(e1370), 
isp-1(qm150), glp-1(e2141) and let-363/TOR RNAi animals and this effect is lost with the loss of 
ncl-1. Scale bar represents 20 µm. **** P<0.0001, unpaired t-test. 
 															Since	 the	 levels	 of	 FIB-1	 went	 down	 in	 all	 the	 longevity	mutants	 that	 we	tested	here,	 this	 in	 turn	 led	us	 to	 ask	 if	 reducing	 fib-1	 levels	per	 se	would	 lead	 to	longevity.	 fib-1	 is	an	essential	gene	and	 fib-1	mutants	are	not	viable.	Therefore	we	
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performed	RNAi	to	knockdown	fib-1.	However	we	observed	that	the	RNAi	treatment	initiated	 egg-on	 was	 making	 the	 worms	 sick	 and	 some	 of	 the	 worms	 were	 also	getting	developmentally	arrested.	Thus	we	initiated	the	RNAi	knockdown	of	fib-1	in	the	adulthood	and	interestingly	we	found	that	fib-1	knock	down	led	to	a	modest	but	significant	 lifespan	extension	of	wildtype	worms	(Figure	11A).	We	also	performed	
fib-1	RNAi	on	eat-2	worms	but	 there	was	no	additive	 longevity	 in	eat-2	upon	 fib-1	RNAi	(Figure	11A)	indicating	an	overlapping	mechanism.		
	
Figure 11. Reduction of fib-1 levels induces longevity. (A) N2 worms are long-lived when 
subjected to fib-1 RNAi but eat-2(ad465) is not further long-lived with fib-1 RNAi (P = 0.0004, log-
rank test). (B) fib-1 RNAi reduces the nucleolar size of N2 and ncl-1 mutants. (C) N2 worms but 
not ncl-1 mutants are long-lived upon fib-1 RNAi (P<0.0001, log-rank test). **** P<0.0001, 
unpaired t-test. 																We	next	asked	how	fib-1	genetically	interacts	with	ncl-1.	To	confirm	this	we	went	on	to	study	genetic	epistasis	between	ncl-1	and	fib-1.	We	knocked	down	fib-1	
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by	RNAi	 in	ncl-1	mutants	and	checked	 the	nucleolar	 size	of	ncl-1.	Interestingly	we	found	 that	 reduction	 of	 fib-1	 significantly	 reduced	 the	 big	 nucleolar	 size	 of	 ncl-1,	however	 not	 to	 wildtype	 levels	 (Figure	 11B).	 And	 the	 nucleolar	 size	 of	 wildtype	worms	was	 also	 reduced	with	 fib-1	RNAi	 compared	 to	 control	RNAi	 (Figure	11B).	These	results	indicate	that	fib-1	is	genetically	downstream	of	ncl-1.	However	to	our	surprise	 we	 did	 not	 observe	 longevity	 in	 ncl-1	mutants	 upon	 fib-1	 knock	 down	(Figure	11C).	We	 interpret	 these	 results	with	 the	 caveat	 that	we	 cannot	 carry	out	epistasis	 experiments	with	 fib-1	 null	mutants.	 Taken	 together,	 these	 data	 suggest	that	 fib-1	 is	 negatively	 regulated	 across	 different	 longevity	 pathways	 and	 that	reduction	of	fib-1	 is	sufficient	to	extend	lifespan.	Since	fib-1	is	negatively	regulated	by	 ncl-1,	 these	 data	 may	 suggest	 that	 ncl-1	 is	 activated	 across	 these	 longevity	pathways	and	its	activation	inhibits	fib-1	in	these	long-lived	worms.	These	findings	are	 in-line	with	our	data,	which	 indicates	ncl-1	 regulates	a	convergent	mechanism	focused	on	the	nucleolus,	and	is	required	for	longevity	in	all	the	long-lived	mutants	investigated	here.	Since	FIB-1	is	regulated	in	the	longevity	mutants	our	data	further	suggest	that	fib-1	works	in	the	same	convergent	pathway	downstream	of	ncl-1.																	A	major	function	of	nucleolus	is	ribosome	biogenesis.	We	therefore	asked	if	ribosome	 biogenesis	 is	 affected	 in	 ncl-1	 and	 long-lived	 mutants.	 We	 started	 by	investigating	the	levels	of	ribosomal	RNA	(rRNA).	We	extracted	RNA	from	the	same	number	of	worms	with	different	genotypes	(ncl-1,	long-lived	mutants	and	long-lived	mutants	in	ncl-1	background).	Interestingly	we	observed	that	the	mutation	of	ncl-1	increased	 rRNA	 levels	 in	 worms.	 And	 rRNA	 levels	 were	 reduced	 in	 long-lived	mutants	eat-2(ad465),	isp-1(qm150),	glp-1(e2141),	daf-2(e1370)	and	upon	TOR	RNAi	(Figure	 12A,B).	 Furthermore,	 rRNA	 levels	 were	 also	 reduced	 in	 worms	 over-expressing	ncl-1	(Figure	12C).	With	 the	 loss	ncl-1,	 the	 reduction	 in	 rRNA	 levels	 in	long-lived	worms	was	lost	and	double	mutants	displayed	rRNA	levels	almost	similar	to	wildtype	 (Figure	 12A,B).	 Interestingly,	 rRNA	 levels	were	 similar	 to	wildtype	 in	
daf-2;daf-16	which	lives	like	wildtype	and	not	as	long	as	daf-2	single	mutant	(Figure	12A,B).			
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Figure 12. ncl-1 and longevity mutants affect rRNA levels. (A,B) rRNA levels are increased in 
ncl-1 mutants and reduced in long-lived eat-2(ad465), isp-1(qm150), glp-1(e2141), daf-2(e1370) 
and TOR RNAi worms. Loss of ncl-1 rescues this effect and increases rRNA levels. daf-2(e1370) 
has significantly lower rRNA levels compared to daf-2;daf-16(mu86). (C) rRNA levels are reduced 
in worms over-expressing ncl-1. * P<0.05, unpaired t-test 
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															We	 further	 went	 on	 to	 investigate	 the	 levels	 of	 ribosomal	 proteins	 to	 get	more	insights	on	ribosomal	biogenesis	in	ncl-1	and	long-lived	mutants.	We	observed	the	same	trend	with	ribosomal	proteins	RPS6	and	RPS15.	Both	these	proteins	were	significantly	reduced	in	all	the	long-lived	mutants	examined	and	also	in	the	worms	over-expressing	 ncl-1.	 (Fig.	 13A,C,D,E).	 ncl-1	 loss	 partially	 reversed	 this	 effect	increasing	RPS6	and	RPS15	in	the	long-lived	animals	similar	to	the	effects	observed	on	rRNA	levels	(Fig.	13A,C,D).	Ribosomal	protein	levels	were	similar	to	wildtype	in	
daf-2;daf-16	and	significantly	higher	than	daf-2	single	mutant	(Fig.	13F).	These	data	suggest	 that	reduced	nucleolar	size	also	associates	with	reduced	nucleolar	activity	in	 terms	 of	 ribosome	 biogenesis.	 Our	 findings	 further	 suggest	 reduced	 ribosome	biogenesis	 associates	 with	 longevity	 and	 is	 exhibited	 by	 different	 long-lived	mutants.	 Loss	 of	ncl-1	 in	 these	 long-lived	mutants	 increases	 their	 rRNA	and	RPS6	and	RPS15	levels	similar	to	the	effects	observed	on	FIB-1.			
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Figure 13. ncl-1 and longevity mutants affect FIB-1 and ribosomal protein levels. (A,B,C,D) 
FIB-1 and ribosomal proteins RPS6 and RPS15 are down-regulated in long-lived eat-2(ad465), 
isp-1(qm150), glp-1(e2141), daf-2(e1370) and TOR RNAi worms. ncl-1 mutation in these long-
lived worms significantly abolishes this effect. (E) ncl-1 over-expression leads to a reduction in 
RPS6 and RPS 15. (F) RPS6 and RPS15 are lower in daf-2(e1370) and higher in daf-2;daf-
16(mu86). * P<0.05, ** P<0.01, *** P<0.001, unpaired t-test. 																Our	 results	 are	 also	 in	 line	with	 a	 previous	 study	 that	 reported	 that	 TOR	knockdown	in	C.	elegans	reduced	nucleolar	size	(Sheaffer	et	al.,	2008).	Based	on	this	we	wanted	to	investigate	if	the	inhibition	of	the	TOR	pathway	would	also	reduce	the	size	 of	 the	 large	 nucleoli	 of	 ncl-1	 mutants.	 We	 subjected	 ncl-1	 mutants	 to	 RNAi	against	 let-363/TOR.	And	 interestingly,	 reduction	 in	TOR	 levels	did	not	reduce	 the	size	 of	 the	 large	 nucleoli	 in	ncl-1	mutants	 (Figure	 14B).	 In	 line	with	 our	 previous	data	where	we	found	ncl-1	to	be	required	for	lifespan	extension	upon	TOR	inhibition	(Figure	7A,B),	our	findings	suggest	that	ncl-1	is	genetically	downstream	of	TOR.	We	extended	this	nucleolar	size	epistasis	 to	 the	rest	of	 the	 long-lived	mutants	as	well.	We	examined	the	nucleoli	of	ncl-1	upon	daf-2	RNAi,	eat-2;ncl-1,	 isp-1;ncl-1	and	glp-
1;ncl-1	and	we	observed	 that	 the	 reduced	nucleolar	 size	of	 the	 long-lived	mutants	was	rescued	by	ncl-1	mutation	(Figure	14A).			
	
Figure 14. Nucleolar Size epistasis between ncl-1 and long-lived mutants. (A) Small nucleoli 
of eat-2(ad465), isp-1(qm150) and glp-1(e2141) are enlarged with the loss of ncl-1 but not to the 
level of ncl-1 single mutants. TOR RNAi in ncl-1 mutants does not rescue the large nucleolar 
phenotype of ncl-1 mutants, however daf-2 RNAi induces a significant reduction of nucleoli of ncl-
1 mutants. ** P<0.01,  **** P<0.0001, ns: non-significant, unpaired t-test. 	
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3.6	ncl-1	is	Not	Regulated	in	Long-Lived	Worms	
Since	our	 findings	suggest	 that	ncl-1	plays	an	 important	role	 in	mediating	 lifespan	extension	 in	different	 long-lived	mutants,	we	wanted	 to	 test	 if	 the	 levels	of	NCL-1	are	regulated	in	these	mutants.	We	started	by	checking	the	relative	mRNA	levels	of	
ncl-1	 in	 eat-2	 and	 N2	worms	 by	 qPCR	 but	 we	 did	 not	 see	 any	 significant	 change	(Figure	15A).	Next	we	monitored	the	levels	of	NCL-1	in	eat-2	background	using	the	
ncl-1::gfp	transgenic	construct	 in	eat-2	and	compared	the	levels	of	NCL-1	using	the	same	transgenic	line	in	wildtype	background.	Surprisingly,	the	levels	did	not	differ	significantly	 (Figure	 15B).	We	 next	 subjected	 the	ncl-1	 transgenic	worms	 to	RNAi	against	 let-363/TOR	but	we	did	not	observe	significant	differences	 in	 the	 levels	of	NCL-1	 (Figure	 15B).	 We	 also	 followed	 the	 same	 strategy	 using	 daf-2	 RNAi.	 We	treated	 wildtype	 worms	 expressing	 transgenic	 ncl-1	 with	 daf-2	 RNAi	 and	surprisingly	 we	 did	 not	 see	 any	 changes	 yet	 again	 (Figure	 15B).	 Taken	 together,	these	 results	 suggest	 that	 ncl-1	 is	 not	 directly	 regulated	 under	 DR,	 TOR	 and	 IIS	pathway	knockdown.	We	therefore	speculate	that	the	activity	of	ncl-1	might	be	post-translationally	 regulated.	 Further	 studies	will	 be	needed	 to	 study	 its	 regulation	 in	detail.		
	
Figure 15. ncl-1 is not regulated in long-lived mutants. (A) qPCR results depicting similar 
mRNA levels of ncl-1 in N2 and eat-2(ad465). (B) ncl-1 transgenic line shows similar expression 
levels in eat-2(ad465) and upon daf-2 and TOR RNAi. Scale bar represents 20 µm. 
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3.7	Nucleolar	Size	in	Other	Long-Lived	Organisms			
Our	findings	about	reduced	nucleolar	size	in	longevity	mutants	in	C.	elegans	incited	us	to	investigate	if	this	phenomenon	also	existed	in	higher	organisms.	We	started	a	collaboration	 with	 Prof.	 Linda	 Partridge’s	 lab	 (MPI-AGE,	 Cologne),	 Chirag	 Jain	performed	 the	 fly	 experiments.	 To	 start	 with,	 we	 examined	 the	 nucleoli	 of	
Drosophila	subjected	to	DR.	Wildtype	flies	were	fed	two	different	concentrations	of	food;	 2X	 yeast	 concentration	 which	 served	 as	 the	 ad-libitum	 diet	 and	 0.5X	 yeast	concentration	which	served	as	the	DR	condition.	The	flies	were	reared	on	these	food	conditions	for	12	days	and	afterwards	the	intestine	and	fat	body	of	these	flies	were	dissected	out.	Immunofluorescence	using	an	antibody	staining	Fibrillarin	revealed	a	significant	 reduction	 in	 nucleolar	 size	 in	 both	 intestine	 and	 fat	 body	 of	 DR	 flies	compared	 to	 the	 ad-libitum	 fed	 flies	 (Figure	 16A,B).	 We	 further	 extended	 our	analysis	 to	 the	 long-lived	 Drosophila	 insulin-like	 peptides	 (DILPs)	 knockout	 flies.		
Drosophila	 possesses	 seven	 DILPs	 and	 their	 loss,	 which	 in	 turn	 inhibits	 the	 IIS	pathway,	 has	 been	 associated	 with	 increased	 lifespan	 (Gronke	 et	 al.,	 2010).	 We	stained	 the	 intestine	 and	 fat-body	 of	 age-matched	 long-lived	 dilp2-3,5	 and	 wDah	control	 flies	 with	 anti-Fibrillarin	 antibody.	 The	 results	 were	 consistent	 with	 our	findings	 in	 worms;	 dilp2-3,5	 flies	 had	 significantly	 smaller	 nucleoli	 compared	 to	wildtype	flies	(Figure	16A,B).	We	also	performed	antibody	staining	on	the	intestine	and	 fat-body	 of	 flies	 exposed	 to	 200µM	 Rapamycin.	 It	 is	 known	 that	 Rapamycin	treatment	 extends	 lifespan	 of	 Drosophila	 (Bjedov	 et	 al.,	 2010).	 Nucleolar	 size	 in	intestinal	 and	 fat-body	 cells	 was	 significantly	 smaller	 in	 the	 flies	 exposed	 to	Rapamycin	compared	to	EtOH	vehicle	control	flies	(Figure	16A,B).	These	results	are	in	 accord	 with	 the	 results	 that	 we	 obtained	 in	 C.	 elegans.	 Long-lived	 flies	 also	possess	smaller	nucleoli	across	multiple	tissues.		
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Figure 16. Long-lived Drosophila possess small nucleoli. (A) Drosophila intestinal nucleoli 
stained with anti-fibrillarin antibody. (B) Long-lived dietary restricted, Rapamycin treated and 
dilp2-3,5 mutant flies exhibit smaller nucleoli compared to controls in intestine and fat body. 
Nucleoli are stained in green and nuclei are DAPI stained in blue. **** P<0.0001, unpaired t-test. 
Scale bar represents 10 µm.   
 															After	 observing	 the	 striking	 conservation	 of	 the	 phenomenon	 of	 reduced	nucleoli	 in	long-lived	flies	we	further	wanted	to	investigate	the	levels	of	Fibrillarin	and	ribosomal	proteins	in	these	long-lived	flies.	Using	western	blotting	we	observed	that	Fibrillarin	and	RPS6	and	RPS15	were	down-regulated	in	long-lived	flies	similar	to	our	results	in	C.	elegans	(Figure	17).	Although	we	observed	a	significant	reduction	in	RPS6	and	RPS15	in	flies	that	were	long-lived	due	to	DR	and	reduced	IIS	signaling,	there	 were	 no	 significant	 alterations	 in	 the	 levels	 of	 RPS6	 and	 RPS15	 in	 flies	subjected	 to	Rapamycin	 treatment	unlike	our	 results	obtained	 in	C.	elegans	where	
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TOR	 down-regulation	 via	 RNAi	 decreased	 the	 levels	 of	 RPS6	 and	 RPS15	 (Figure	17A,C,D).	However	we	observed	that	Fibrillarin	levels	were	significantly	reduced	in	all	the	long-lived	flies	that	we	examined	here	compared	to	controls	(Figure	17A,B).	
 
 
Figure 17. Fibrillarin and ribosomal proteins are reduced in long-lived flies. (A,B) In flies 
subjected to DR and Rapamycin treatment and in dilp2-3,5 mutants Fibrillarin levels are 
significantly down compared to their respective controls. (A,C,D) RPS6 and RPS15 are 
significantly reduced in DR flies and dilp2-3,5 mutants but not in Rapamycin treated flies. * 
P<0.05, ** P<0.01, *** P<0.001, ns: non-significant, unpaired t-test.   																We	further	asked	if	the	effects	of	reduction	in	nucleolar	size	are	also	true	in	the	case	of	long-lived	mice.	We	collaborated	with	Dr.	Roman	Mueller’s	lab	(CECAD-Cologne)	where	Dr.	Martin	Spaeth	performed	DR	treatment	on	wildtype	mice	for	28	days.	They	were	exposed	to	75%	of	normal	chow	diet	as	against	wildtype	that	had	100%	food	availability.	After	28	days	of	DR,	the	mice	were	sacrificed	and	stained	on	liver	 and	kidney	 sections	with	 anti-Fibrillarin	 antibody.	We	observed	a	 significant	reduction	in	nucleolar	size	of	DR	mice	compared	to	ad-libitum	fed	mice	in	both	liver	
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and	kidney	(Figure	18	and	19).		
	
Figure 18. Nucleolar size is reduced in kidneys of long-lived mice. (A,B) Mice exposed to DR 
and IRS-1 KO mice possess smaller nucleoli in kidney tissue. Nucleoli are stained in magenta 
and nuclei are DAPI stained in blue. **** P<0.0001, unpaired t-test. Scale bars represent 10 µm.   	We	 further	 resorted	 to	 another	 long-lived	mouse	model,	 the	 long-lived	 IRS-1	 KO	mouse	(we	obtained	tissues	of	IRS-1	KO	mice	from	Joana	Goncalves,	Linda	Partridge	lab).	 IRS-1	encodes	the	Insulin	Receptor	Substrate-1	protein,	which	plays	a	critical	
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role	in	transmitting	signals	from	the	insulin	and	insulin-like	growth	factor-1	(IGF-1)	receptors	 to	 the	 intracellular	 pathways	 and	 a	 mutation	 of	 IRS-1	 reduces	 insulin	signaling	 and	 enhances	 lifespan	 in	 mice	 (Selman	 et	 al.,	 2008).	 Antibody	 staining	revealed	 that	 IRS-1	 knockout	 mice	 exhibited	 smaller	 nucleolar	 size	 in	 brain	 and	kidney	 compared	 to	 wildtype	 counterparts	 (Figure	 18	 and	 19).	 These	 results	suggest	 that	 even	 in	 mammals	 longevity	 is	 inversely	 associated	 with	 the	 size	 of	nucleoli	 in	 different	 tissues.	 This	 points	 towards	 an	 evolutionarily	 conserved	nucleolar	 function	 that	 is	 associated	with	 longevity	 in	 different	 organisms.	 It	 still	remains	to	be	understood	if	a	reduction	in	nucelolar	size	and	function	is	a	cause	or	consequence	of	aging.		
	
Figure 19. Nucleolar size is reduced in liver and brain tissues of long-lived mice. (A,B) Mice 
exposed to DR and IRS-1 KO mice possess smaller nucleoli in liver and brain tissue respectively. 
Nucleoli are stained in magenta and nuclei are DAPI stained in blue. **** P<0.0001, unpaired t-
test. Scale bars represent 10 µm (liver sections) and 5 µm (brain sections).   
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3.8	Nucleolar	Size	in	Humans	Undergoing	DR 
Having	 observed	 a	 striking	 reduction	 in	 the	 size	 of	 the	 nucleolus	 of	 long-lived	animals	 from	 lower	 model	 system	 to	 mammals,	 we	 were	 intrigued	 to	 ask	 if	 the	effects	might	be	conserved	in	humans	as	well.	We	started	a	successful	collaboration	with	Prof.	P.	Eline	Slagboom’s	lab	at	the	Leiden	Medical	Center.	Yotam	Raz	from	the	Slagboom	 lab	 stained	muscle	 biopsies	 of	 humans	who	had	 taken	up	 a	 healthy	 life	style	regime,	referred	to	as	the	Life	Style	Intervention,	which	included	a	reduction	of	caloric	intake	by	12.5%	and	an	increase	in	exercise	by	12.5%.	The	intervention	was	carried	 out	 for	 a	 period	 of	 13	 weeks.	 (Details	 of	 the	 intervention	 are	 given	 in	Chapter	 2).	 After	 the	 intervention,	 the	 subjects	 experienced	 a	 weight	 reduction,	lowered	 blood	 glucose	 levels	 and	 reduced	 body	mass	 index	 (BMI).	 There	was	 an	average	 7.7	 kg	 weight	 loss	 in	 men	 and	 6.0	 kg	 in	 women.	 Additional	 clinical	characteristics	of	this	group	of	men	and	women	are	detailed	in	Supplementary	Table	4.	 Muscle	 biopsies	 were	 taken	 from	 these	 individuals	 before	 and	 after	 the	intervention	 from	 the	 vastus	 lateralis	 muscle.	 Fibrillarin	 staining	 of	 these	 muscle	biopsies	 revealed	 that	 the	 nucleolar	 size	 of	 the	 individuals	 declined	 significantly	after	going	through	the	intervention	(Figure	20).	Samples	of	age	matched	five	men	and	five	women	were	analyzed	for	this	experiment.			
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Figure 20. Nucleolar size is reduced in muscle biopsies of humans undergoing DR. (A,B) 
Humans exposed to 12.5% reduced caloric intake and 12.5% increased exercise exhibit reduced 
nucleoli after the intervention. Nucleoli are stained in magenta and nuclei are DAPI stained in 
blue. * P<0.05, unpaired t-test. Scale bars represent 20 µm. 	
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3.9	Nucleolar	Size	in	Mammalian	Cells	
We	further	wanted	to	investigate	the	effect	of	nutrient	deprivation	on	nucleolar	size	in	primary	Mouse	Embryonic	Fibroblasts	(MEFs)	and	primary	human	keratinocytes.	We	 subjected	 these	 cells	 to	 starvation	 and	 then	 harvested	 them,	 fixed	 them	 and	performed	 antibody	 staining	 on	 these	 cells	 using	 anti-Fibrillarin	 antibody.	 We	observed	 that	 nucleoli	 of	 both	 primary	 MEFs	 and	 primary	 human	 keratinocytes	became	fragmented	upon	starvation	when	compared	with	non-starved	control	cells	(Figure	 21).	 This	 might	 indicate	 a	 stress	 response	 that	 the	 cells	 exhibit	 upon	starvation.	Since	starvation	is	a	very	harsh	treatment,	it	thus	is	not	quite	comparable	to	DR.	Moreover,	DR	is	generally	performed	on	organisms	for	their	entire	lifetime	or	for	substantially	longer	periods	of	time,	for	them	to	exhibit	longevity	and	improved	health	 span	 response.	 Nutrient	 deprivation	 for	 a	 few	 hours	 might	 again	 not	 be	equivalent	 to	 DR	 in	 terms	 of	 time	 period.	 And	 finally	 DR	 mounts	 a	 combined	systemic	response,	which	collectively	leads	to	improvement	in	health	and	extension	in	life.	 It	 is	very	difficult	to	mimic	this	response	on	an	individual	cell	 level	 in	vitro.	These	reasons	might	explain	why	we	did	not	observe	a	reduction	in	nucleoli	in	cells.																	Primary	cells,	and	not	any	of	the	widely	used	cancer	cell-lines	like	HeLa	cells,	were	 used	 for	 this	 experiment	 because	 of	 the	 fact	 that	 cancer	 cells	 are	 known	 to	possess	 a	 large	 nucleolus	 and	 consequently	 translational	 levels	 are	 highly	 up-regulated	in	those	cells.	We	wanted	to	mimic	a	physiological	response	at	the	cellular	level	and	wanted	to	investigate	if	we	could	observe	effects	of	starvation	leading	to	reduced	nucleolar	size	in	different	kinds	of	primary	cells.				
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Figure 21. Mammalian cells exhibit nucleolar fragmentation upon starvation. Primary MEFs 
(A) and primary human keratinocytes (B) undergo nucleolar fragmentation upon 3 hour and 8 
hour starvation respectively. Scale bars represent 10µm. 
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4.1	ncl-1	as	a	Regulator	of	Lifespan	Across	Multiple	Pathways	
Our	RNAi	based	genetic	screens	identified	ncl-1	as	a	novel	regulator	of	DR	mediated	longevity	 in	 C.	 elegans.	 	 We	 confirmed	 these	 findings	 further	 with	 ncl-1	mutants	where	we	found	that	ncl-1	mutation	in	long-lived	eat-2(ad465)	worms	reverses	their	longevity.	We	confirmed	these	findings	with	two	independent	alleles	of	ncl-1	both	of	which	 are	 point	 mutations	 rendering	 the	 protein	 non-functional.	 We	 however	observed	that	eat-2,ncl-1	double	mutants	 lived	even	shorter	 than	wildtype	worms.			This	effect	can	be	due	to	a	synthetic	phenotype	that	affects	the	double	mutants	and	not	the	single	mutants	alone.	There	are	multiple	ways	of	inducing	a	DR	response	in	
C.	 elegans.	 eat-2(ad465)	 is	 a	 genetic	 model	 of	 DR	 and	 additionally	 there	 are	 a	number	of	dietary	interventions	that	can	be	employed	to	induce	the	state	of	DR	in	worms.	These	methods	mostly	have	to	do	with	a	direct	reduction	of	food	that	is	fed	to	worms.	We	 performed	 a	method	 called	 BDR	 in	which	we	 diluted	 bacteria	 and	induced	 DR	 in	 liquid	 culture.	 ncl-1	 mutants	 did	 not	 respond	 to	 the	 longevity	inducing	 effects	 of	 BDR	while	 the	wildtype	worms	were	 significantly	 longer	 lived	when	subjected	to	BDR.	Between	the	two	alleles	of	ncl-1	mutants	also	we	observed	slight	 differences	 in	 terms	 of	 their	 response	 to	 BDR.	ncl-1(e1942)	exhibited	 slight	longevity	 initially	 leading	 to	 a	 low	 peak	 for	 lifespan	 extension	 against	 bacterial	dilution.	 However	 with	 further	 reduction	 in	 bacteria	 there	 was	 no	 longevity	observed	 and	 the	 curves	 for	 wildtype	 and	 ncl-1(e1942)	 mutant	 separated	significantly.	ncl-1(e1865)	on	the	other	hand	exhibited	a	very	blunted	response	for	all	the	bacterial	dilutions.	These	results	point	towards	the	crucial	role	played	by	ncl-
1	in	mediating	longevity	under	DR	conditions.																		It	is	not	only	under	DR	where	ncl-1	plays	a	key	role	in	inducing	longevity	but	we	 also	 found	 that	ncl-1	 is	 required	 for	 long	 life	 of	 other	 long-lived	mutants.	 It	 is	well	known	that	a	down-regulation	of	the	TOR	pathway	has	life	extending	benefits	across	multiple	species	(McCormick	et	al.,	2011).	Investigating	the	TOR	pathway	in	the	 context	 of	 ncl-1	 function	 was	 intriguing	 for	 us	 because	 the	 TOR	 pathway	 is	closely	 associated	 with	 DR.	 Our	 results	 clearly	 show	 that	 ncl-1	 is	 required	 for	lifespan	extension	mediated	by	the	inhibition	of	the	TOR	pathway.	ncl-1	mutants	do	
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not	exhibit	longevity	upon	TOR	inhibition	unlike	wildtype	animals.		This	places	ncl-1	genetically	downstream	of	the	TOR	pathway.	In	addition	to	DR	and	TOR	inhibition	modest	inhibition	of	the	IIS	pathway,	mitochondrial	activity	and	germline	loss	lead	to	lifespan	extension	in	different	organisms.	We	investigated	if	ncl-1	plays	a	role	in	modulating	 longevity	 in	 these	 established	models	 of	 lifespan	 increase.	Our	 results	show	that	ncl-1	is	a	critical	factor	required	in	these	longevity	pathways	as	well.	ncl-1	mutation	 in	 daf-2(e1370)	 and	 isp-1(qm150)	 partially	 but	 significantly	 reduces	lifespan	 of	 these	 long-lived	mutants	 indicating	 that	 a	 part	 of	 the	mechanism	 that	leads	 to	 lifespan	 extension	 of	 these	 worms	 relies	 on	 the	 function	 of	 ncl-1.	Furthermore	 longevity	 of	glp-1(e2141)	was	 totally	 abolished	 in	 glp-1;ncl-1	double	mutants	 suggesting	 that	 ncl-1	 is	 required	 for	 lifespan	 extension	 in	 glp-1(e2141)	animals.	 These	 results	 indicate	 that	 ncl-1	 is	 an	 important	 factor	 in	 modulating	longevity	 across	multiple	 longevity	pathways.	A	 large	number	of	 genes	have	been	implicated	in	regulating	longevity	in	different	pathways	but	how	all	these	pathways	cross-talk	with	each	other	and	if	there	are	downstream	mechanisms	that	are	shared	by	different	longevity	pathways	still	remains	elusive.	In	this	study	our	discovery	of	
ncl-1	as	being	a	universal	regulator	of	 lifespan	extension	across	multiple	 longevity	pathways	points	 towards	 the	 fact	 that	 the	 cellular	mechanisms	 regulated	by	ncl-1	are	significantly	shared	by	different	pathways	that	extend	lifespan.													
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4.2	Nucleolar	Size	as	a	Potential	Predictor	of	Life	Expectancy	in	C.	
elegans	
ncl-1	regulates	 nucleolar	 size	 in	worms.	 Since	we	 identified	 the	 role	 of	ncl-1	as	 a	convergent	 factor	 for	 lifespan	 regulation	 across	 multiple	 pathways	 we	 were	intrigued	to	confirm	if	the	mechanism	by	which	ncl-1	works,	acts	as	a	downstream	convergent	 mechanism	 for	 lifespan	 regulation	 in	 these	 longevity	 pathways.	 For	understanding	 this	 we	 went	 ahead	 to	 establish	 if	 the	 downstream	 convergent	mechanism	 by	 which	 ncl-1	 functions	 converges	 somehow	 on	 nucleolar	 function.			The	nucleolus	 is	 the	 cellular	 site	of	 ribosome	biogenesis.	 It	 is	 the	most	prominent	subnuclear	 structure	 where	 ribosomal	 RNA	 (rRNA)	 and	 ribosomal	 subunits	 are	synthesized.	These	cellular	processes	are	energetically	very	demanding	and	thus	are	coordinated	in	a	very	strict	manner.	Within	the	nucleolus,	ribosomal	DNA	(rDNA)	is	transcribed	 by	 RNA	 polymerase	 I	 (Pol	 I).	 The	 precursor	 rRNA	 (pre-rRNA)	 thus	generated	is	 further	processed	and	modified	to	produce	28S,	18S,	and	5.8S	rRNAs.	The	mature	rRNAs	are	then	assembled	with	ribosomal	proteins	and	shuttled	to	the	cytoplasm	 for	protein	synthesis	 (Boulon	et	al.,	2010;	van	Sluis	and	McStay,	2014).	The	size	of	the	nucleolus	varies	between	cells	and	in	turn	points	towards	the	rate	of	ribosome	 biogenesis.	 Actively	 proliferating	 cells	 possess	 large	 nucleoli	 because	 of	higher	demands	of	 ribosome	biogenesis	and	protein	synthesis	whereas	 the	size	of	the	nucleolus	decreases	upon	cell	cycle	arrest	where	the	cells	are	in	quiescence.																	In	 order	 to	 investigate	 the	 nucleolar	 function	 in	 long-lived	 mutants	 we	started	by	analyzing	the	size	of	nucleoli	in	these	mutants.	We	made	use	DIC	optics	to	capture	high	magnification	images	of	different	tissues	where	we	could	visualize	and	measure	nucleoli	 directly.	 Strikingly	we	observed	 that	 all	 the	 examined	 long-lived	mutants	 in	our	study	namely	eat-2(ad465),	daf-2(e1370),	 let-363/TOR	knockdown,	
glp-1(e2141)	 and	 isp-1(qm150)	 possessed	 smaller	 nucleoli	 in	 multiple	 tissues	including	 hypodermis	 and	 pharyngeal	 muscle.	 This	 was	 indicative	 of	 reduced	nucleolar	function.	And	interestingly	when	crossed	in	ncl-1	mutant	background	the	small	nucleolar	size	was	enlarged	again.	Notably,	these	long-lived	mutants	also	lose	their	longevity	with	the	loss	of	ncl-1	(discussed	in	section	4.1).	These	observations	
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were	 very	 exciting	 and	pointed	 towards	 a	 negative	 correlation	 between	nucleolar	size	and	 lifespan.	 In	other	words,	worms	representing	distinct	 longevity	pathways	possessed	 smaller	 nucleoli	 and	 were	 significantly	 longer-lived	 but	 when	 their	nucleolar	size	was	perturbed	genetically	they	lost	their	longevity.		We	also	observed	the	 same	 effects	 with	 worms	 subjected	 to	 DR	 using	 BDR	 regimen.	 Lifespan	 of	animals	 increased	 upon	 bacterial	 food	 reduction	 but	 this	 increase	 in	 lifespan	was	accompanied	with	a	 corresponding	drop	 in	 their	nucleolar	 size.	 	And	we	obtained	another	 piece	 of	 evidence	 in	 favor	 of	 this	 notion	 of	 reduction	 in	 nucleolar	 size	 in	long-lived	worms.	daf-2(e1370)	worms	are	long-lived	and	when	daf-2	worms	harbor		a	mutation	of	daf-16	(FOXO	homolog),	they	lose	their	longevity.	When	we	analyzed	the	 nucleoli	 of	 daf-2(e1370)	 and	 daf-2;daf-16(mu86)	 worms	 we	 found	 that	 the	nucleoli	of	daf-2(e1370)	worms	were	much	smaller	than	daf-2;daf-16(mu86)	which	exhibited	 nucleoli	 similar	 to	wildtype.	 This	 effect	was	 seen	 to	 be	 true	 in	multiple	tissues.	These	results	again	suggest	 that	nucleolar	size	and	 longevity	are	 inversely	linked	 to	 one	 another.	 These	data	 also	point	 towards	 the	 fact	 that	 this	 concept	 of	inverse	correlation	between	nucleolar	size	and	lifespan	also	holds	true	in	the	case	of	environmental	 interventions	 that	 reduce	 nucleolar	 size	 like	 food	 reduction	 and	 is	not	only	limited	to	genetic	interventions.																These	 intriguing	 findings	 between	 nucleolar	 size	 and	 lifespan	 made	 us	wonder	if	nucleoli	could	be	predictive	for	life	expectancy.	Isogenic	wildtype	worms	grown	under	similar	conditions	show	considerable	variation	in	lifespan	with	some	worms	dying	as	early	as	day	10	and	some	others	living	all	the	way	upto	day	30.	And	in	 isogenic	 wildtype	 worms	 interestingly	 there	 exists	 a	 significant	 variation	 in	nucleolar	 size	 also.	 Therefore	 we	 reasoned	 if	 this	 disparity	 in	 lifespan	 could	 be	attributed	to	differences	in	nucleolar	size.	We	explored	this	by	imaging	the	nucleoli	of	age-matched	worms	and	following	each	worm	through	its	lifespan.	Strikingly	we	observed	that	the	animals	with	smaller	nucleoli	 lived	considerably	longer	than	the	ones	with	 large	nucleoli.	This	strong	correlation	can	be	used	 in	approximating	 the	life	expectancy	of	C.	elegans.				
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4.3	Reduced	Nucleolar	Fibrillarin	Expression	and	Longevity	
Since	we	 observed	 small	 nucleoli	 associate	with	 longevity	 and	 that	 nucleolar	 size	could	 essentially	 have	 the	 potential	 of	 predicting	 the	 lifespan	 of	 C.	 elegans,	 we	wondered	 if	 nucleolar	 function	was	 affected	 in	 long-lived	worms.	We	 looked	 at	 a	nucleolar	marker	 fib-1/Fibrillarin,	which	 is	 a	 nucleolar	 protein	with	 an	 important	role	 in	pre-rRNA	processing	during	 ribosomal	biogenesis.	 It	 is	 known	 that	 fib-1	 is	up-regulated	in	ncl-1	mutants	(Lee	et.	al.,	2012).	It	was	also	shown	by	a	recent	study	from	the	same	lab	that	ncl-1	directly	regulates	fib-1.	They	reported	that	ncl-1	binds	to	 the	 3’	 UTR	 of	 fib-1	 and	 thereby	 down-regulates	 the	 expression	 of	 fib-1.	Consequently,	ncl-1	loss	abolishes	this	check	on	 fib-1	levels	and	thus	 fib-1	is	highly	up-regulated	in	ncl-1	mutants	(Yi	et	al.,	2015).	Since	fib-1	is	directly	regulated	by	ncl-
1	 and	ncl-1	 is	 required	 for	 longevity	 in	multiple	 lifespan	 extending	 pathways,	we	wondered	if	fib-1	is	regulated	in	long-lived	mutants.	Using	the	transgenic	FIB-1::GFP	strain,	 we	 observed	 a	 significant	 down-regulation	 of	 FIB-1	 in	 eat-2(ad465),	 daf-
2(e1370),	glp-1(e2141),	 isp-1(qm150)	and	 in	animals	with	TOR	knock-down.	These	results	 are	 in	 accord	with	 our	 findings	 that	ncl-1	 is	required	 in	 these	mutants	 for	their	long	life.	These	results	indirectly	hint	towards	a	higher	activity	of	ncl-1	in	these	mutants,	 which	 in	 turn	 down-regulates	 fib-1.	 We	 observed	 a	 similar	 down-regulation	 of	 FIB-1	 in	 long-lived	 ncl-1	 over-expressing	 worms.	 Interestingly,	 this	effect	 of	 reduction	 in	FIB-1	 levels	was	 lost	when	we	knocked	down	ncl-1	 in	 these	long-lived	mutants,	 adding	more	 evidence	 that	 the	 activity	 of	ncl-1	 is	 required	 in	these	 mutants	 for	 down-regulation	 of	 fib-1.	 The	 effects	 on	 fib-1	 regulation	 are	convincing	 because	 we	 saw	 similar	 effects	 using	 western	 blotting	 against	 the	endogenous	protein.	Furthermore	the	effects	on	fib-1	are	similar	to	the	effects	seen	on	nucleolar	 size;	 in	 long-lived	mutants	 nucleolar	 size	 is	 smaller	 and	 loss	 of	ncl-1	enlarges	 it	 again.	 These	 findings	 suggest	 a	 mechanistic	 role	 that	 ncl-1	 plays	 in	regulating	lifespan	by	reducing	the	expression	of	fib-1	and	maintaining	the	smaller	size	 of	 nucleoli	 which	 is	 lost	 in	 ncl-1	 mutants	 and	 both	 fib-1	 expression	 and	nucleolar	 size	 increase	 and	 that	may	 be	 the	 reason	 behind	 loss	 of	 longevity.	 The	detailed	 mechanistic	 role	 needs	 to	 be	 further	 explored	 as	 to	 how	 this	 ncl-1	 fib-1	
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cascade	regulates	nucleolar	size	and	 in	 turn	how	nucleolar	size	plays	 into	 lifespan	regulation.																	Since	 FIB-1	 was	 seen	 to	 be	 down	 regulated	 in	 all	 the	 long-lived	 worms	examined,	we	wondered	if	fib-1	could	play	a	role	in	regulating	lifespan.	Indeed,	we	observed	 that	 fib-1	 knock-down	 via	 RNAi	 was	 sufficient	 to	 induce	 a	 modest	 but	significant	 lifespan	extension	 in	wildtype	worms.	And	 fib-1	RNAi	 also	 reduced	 the	nucleolar	 size	of	wildtype	worms,	going	 in	conjunction	with	our	previous	 findings	that	long-lived	worms	possess	smaller	nucleoli.		In	order	to	study	epistasis	between	
ncl-1	and	 fib-1,	we	examined	 the	nucleoli	of	ncl-1	mutants	and	observed	 that	 fib-1	RNAi	reduced	the	large	sized	nucleoli	of	ncl-1	mutants	however	not	back	to	wildtype	levels.	These	results	suggest	that	fib-1	functions	downstream	of	ncl-1.	However,	we	did	 not	 see	 an	 increased	 lifespan	 of	 ncl-1	 mutants	 when	 subjected	 to	 fib-1	 RNAi	which	was	surprising	because	the	nucleolar	size	experiment	suggested	fib-1	works	downstream	 of	 ncl-1.	Since	 fib-1	 is	 an	 essential	 gene	 we	 cannot	 draw	 convincing	conclusions	 from	 these	 results	 because	 of	 our	 failure	 to	 use	 fib-1	 loss	 of	 function	mutants,	which	are	 inviable.	RNAi	against	 fib-1	through	development	also	 leads	 to	larval	 arrest	 of	worms.	 Therefore,	 the	RNAi	 treatment	was	 initiated	 from	 the	 day	one	of	adulthood.																	Furthermore,	FIB-1	acted	as	a	handy	indirect	tool	to	be	used	as	a	read-out	to	gauge	the	activity	of	ncl-1.	Our	qPCR	expression	analysis	and	transgenic	expression	of	 ncl-1::gfp	 did	 not	 show	 any	 regulation	 of	 ncl-1	 in	 long-lived	 worms	 yet	 we	observed	 that	 it	was	 required	 for	 the	 longevity	of	 these	mutants.	 So	we	 speculate	that	there	might	be	some	post-translational	modification	occurring	on	NCL-1,	which	might	be	regulating	its	activity.	We	will	try	to	understand	this	in	detail	using	mass	spectrometric	approaches	to	identify	post-translational	modifications	on	NCL-1	and	how	they	further	modulate	the	expression	of	the	protein.				
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4.4	Reduced	Ribosome	Biogenesis	and	Longevity	
The	next	step	was	to	investigate	ribosome	biogenesis	in	long-lived	worms	and	ncl-1	mutants	because	ribosome	biogenesis	 is	a	key	process	happening	in	the	nucleolus.	We	examined	ribosome	biogenesis	 indirectly	by	 looking	at	 the	 levels	of	 rRNA	and	ribosomal	 proteins.	We	 observed	 the	 same	 trend	 in	 rRNA	 and	 ribosomal	 protein	levels	as	in	FIB-1.	Long-lived	mutants	eat-2(ad465),	daf-2(e1370),	glp-1(e2141),	isp-
1(qm150)	and	 animals	with	 TOR	 knock-down	 exhibited	 lower	 levels	 of	 rRNA	 and	ribosomal	proteins	RPS6	 and	RPS15	 indicative	 of	 reduced	 ribosome	biogenesis	 in	these	worms.	 It	 is	 plausible	 to	 think	 that	 ribosome	biogenesis	 is	 reduced	 in	 long-lived	 worms	 because	 it	 is	 a	 highly-energy	 consuming	 process	 and	 a	 reduction	 in	ribosome	 biogenesis	 would	 spare	 energy	 reserves	 to	 operate	 other	 physiological	processes.	It	is	already	known	that	a	reduction	in	protein	synthesis	and	knockdown	of	 a	 handful	 of	 ribosomal	 proteins	 extends	 lifespan	 in	 C.	 elegans	 (Hansen	 et.	 al.,	2007;	 Syntichaki	 et.	 al.,	 2007).	We	wondered	 if	we	 could	 rescue	 this	 reduction	 of	rRNA	and	ribosomal	protein	levels	seen	in	long-lived	worms	by	mutating	ncl-1	gene	in	 these	worms.	 And	 indeed	 that	 is	 exactly	what	we	 observed.	 Long-lived	worms	have	 a	 reduction	 in	 rRNA	 and	 ribosomal	 protein	 levels	 which	 is	 partially	 but	significantly	rescued	with	 the	 loss	of	ncl-1	again	 following	 the	same	 trend	 that	we	observed	in	FIB-1	expression.	Additionally,	long-lived	ncl-1	over-expressing	worms	exhibit	 reduced	 levels	 of	 rRNA	 and	 ribosomal	 proteins,	 again	 similar	 to	 our	observations	of	reduced	FIB-1	levels	in	these	worms.	And	finally	we	also	observed	that	 rRNA	and	 ribosomal	proteins	were	 significantly	higher	 in	daf-2;daf-16(mu86)	mutants	 compared	 to	 daf-2(e1370)	 alone,	 again	 hinting	 towards	 ribosome	biogenesis	 being	 perturbed	 in	 daf-2	 mutants	 upon	 the	 introduction	 of	 daf-16	mutation	which	might	be	the	cause	of	their	reduced	lifespan.																Overall	 our	 results	 suggest	 that	 long-lived	 mutants	 have	 a	 reduction	 in	nucleolar	 size,	 FIB-1,	 rRNA	 and	 ribosomal	 protein	 levels.	 This	 is	 indicative	 of	 a	reduced	ribosomal	function	being	associated	with	longevity	(Figure	22).	And	in	turn	if	 we	 down-regulate	 fib-1	we	 can	 induce	 longevity,	 which	 indicates	 that	 reduced	nucleolar	 function	 may	 be	 the	 causal	 factor	 for	 longevity.	 We	 need	 to	 further	
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investigate	the	mechanistic	details	to	get	a	clear	understanding	of	how	reduction	of	ribosome	biogenesis	brings	about	an	increase	in	lifespan.						
	
	
	
	
	
	
	
	
	
	
	
Figure 22. NCL-1 functions downstream of longevity pathways to regulate nucleolar size 
and longevity. NCL-1 down-regulates FIB-1 and mediates lifespan extension across different 
pathways. Long-lived mutants possess small nucleoli and reduced ribosome biogenesis and 
these effects are mediated by NCL-1. 	
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4.5	Nucleolus	and	Longevity	in	Higher	Organisms	
Given	 our	 interesting	 results	 in	 C.	 elegans,	 we	 wanted	 to	 explore	 if	 longevity	pathways	relay	their	effects	on	the	nucleolus	in	other	organisms	as	well.	We	looked	at	the	nucleoli	of	long-lived	Drosophila	melanogaster.	We	subjected	Drosophila	to	DR	and	Rapamycin	treatment	both	of	which	extend	lifespan	(Bass	et	al.,	2007;	Kapahi	et	al.,	2004).	We	observed	that	these	long-lived	flies	possessed	smaller	nucleoli	 in	fat	body	 and	 intestine	 compared	 to	 their	 respective	 controls.	 We	 further	 tested	 a	genetic	model	of	longevity	in	flies;	dilp2-3,5	mutant	flies	which	harbor	a	deletion	of	insulin-like-peptide	 (Gronke	 et.	 al.,	 2010).	 These	 flies	 have	 a	 modest	 down-regulation	of	 the	 IIS	pathway,	which	 in	 turn	renders	 them	long-lived.	We	detected	smaller	nucleoli	in	dilp2-3,5	mutants	compared	to	wDah	control	flies	in	fat	body	and	intestine.	 These	 results	 are	 very	 exciting	 for	 the	 reason	 that	 we	 could	 observe	similar	nucleolar	changes	in	long-lived	Drosophila	like	we	noticed	in	worms.	Further	going	to	the	molecular	level,	we	spotted	reduced	levels	of	Fibrillarin	and	ribosomal	proteins	RPS6	and	RPS15	 in	 long-lived	DR	and	dilp2-3,5	flies	 compared	 to	 control	flies.	 A	 distinct	 exception	 was	 Rapamycin	 treatment	 where	 we	 did	 not	 observe	significant	changes	in	RPS6	and	RPS15.	However	Rapapmycin	treatment	did	reduce	Fibrillarin	 levels	 like	 in	 DR	 and	 in	 dilp2-3,5	mutants.	 These	 results	 are	 again	 in	conjunction	 with	 our	 findings	 in	 worms	 where	 we	 observed	 longevity	 to	 be	associated	with	reduced	ribosome	biogenesis.																	Next	we	wondered	if	we	could	detect	effects	on	nucleolar	size	in	long-lived	mammals.	 We	 resorted	 to	 investigating	 these	 effects	 in	 long-lived	 mice.	 We	examined	 the	 nucleoli	 of	 long-lived	 DR	 mice.	 We	 observed	 that	 these	 mice	 had	reduced	 nucleoli	 in	 the	 liver	 and	 the	 kidney.	 We	 also	 tested	 it	 in	 the	 long-lived	genetic	model;	the	IRS-1	knockout	mice	(Selman	et.	al.,	2008),	which	lack	insulin	like	receptor	 (IRS)	 1.	 IRS1	 is	 a	 major	 intracellular	 effector	 of	 the	 IIS	 receptors	 and	knockout	of	IRS1	extends	lifespan	of	mice.	We	noticed	that	IRS1	knockout	mice	also	had	smaller	nucleoli	in	the	kidney	and	the	brain.																	Furthermore,	 we	 investigated	 muscle	 biopsies	 from	 humans	 voluntarily	undergoing	 reduced	 caloric	 intake	 and	 increased	 exercise	 for	13	weeks.	This	pro-
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health	 intervention	 also	 reduced	 the	 size	 of	 the	 nucleoli	 in	 the	 muscles	 of	 these	individuals	significantly.																					Therefore	our	 results	 from	Drosophila,	mice	and	humans	are	 in	agreement	with	 our	 data	 from	 C.	 elegans.	 Small	 nucleoli	 seem	 to	 be	 a	 cellular	 hallmark	 of	longevity	 and	 reduced	 ribosome	 biogenesis	 and	 reduced	 Fibrillarin	 levels	 are	 the	signatures	that	associate	with	longevity	at	least	in	C.	elegans	and	Drosophila.																							
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5.1	Investigating	the	Mechanism	of	Nucleolar	Function	in	Aging		
Our	findings	clearly	show	that	nucleolar	size	and	nucleolar	function	are	affected	in	long-lived	mutants.	Ribosome	biogenesis	which	is	a	major	function	of	the	nucleolus	seems	 to	 be	 down-regulated	 in	 different	 long-lived	 worms	 and	 mutations	 that	abrogate	 longevity	of	 these	worms,	perturb	 this	effect	on	ribosome	biogenesis.	On	the	 contrary	 we	 observe	 that	 ncl-1	 over-expression	 reduces	 rRNA	 and	 protein	synthesis	rates.	But	it	is	unclear	if	and	how	these	processes	contribute	to	longevity.	To	address	this	issue,	we	will	examine	interactions	of	ncl-1	mutation	together	with	various	 mutations/RNAi	 knockdowns	 that	 decrease	 protein	 synthesis	 and	 rRNA	production.	 Specifically,	 we	 will	 examine	 the	 cap	 binding	 subunit	 translation	initiation	 factor	4f	 ife-2,	 the	eIF-4G	homolog	 ifg-1	 and	various	 ribosomal	 subunits,	whose	modest	knockdown	promotes	longevity.	We	will	also	examine	rrn3,	a	subunit	of	RNA	Polymerase	I	involved	in	rRNA	synthesis.	If	these	genes	work	downstream	of	NCL-1,	then	their	knockdown	should	reverse	the	phenotypes	of	ncl-1	null	mutants.	Alternately	 if	 they	work	upstream,	ncl-1	 loss	would	 reverse	 their	 phenotypes.	We	will	 monitor	 nucleolar	 size,	 fibrillarin	 production,	 protein	 synthesis	 rates,	 rRNA	levels,	 and	 longevity	 in	 various	 single	 and	 double	 mutants	 to	 get	 detailed	mechanistic	insights.		
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5.2	Investigating	Nucleolar	Regulation	of	Proteostasis	
We	 hypothesize	 that	 NCL-1	 not	 only	 affects	 protein	 synthesis,	 but	 also	 protein	quality	control.	Accordingly,	our	preliminary	data	suggest	that	autophagy	is	down-regulated	in	ncl-1	mutants.	To	unravel	potential	roles	in	protein	quality	control,	we	would	like	to	examine	how	ncl-1	mutation	and	fib-1	knockdown	impact	autophagy,	by	monitoring	autophagic	puncta	containing	LGG-1/ATG8	and	SQST-1/p62.	Further	we	will	measure	proteasome	activity	by	biochemical	methods	as	well	as	measuring	the	 stability	 of	 in	 vivo	 model	 substrates	 using	 a	 transgenic	 strain	 containing	 a	proteasomal	 substrate	 fused	 to	GFP.	We	also	want	 to	 test	whether	ncl-1	 and	 fib-1	affect	 induction	of	 stress	markers	 for	 the	endoplasmic	 reticulum	unfolded	protein	response	 (UPR)	 (hsp-4),	mitochondrial	UPR	 (hsp-6,	hsp-60),	 and	 the	 cytosolic	 heat	shock	 response	 (hsp-70),	 or	 influence	 the	 stability	 of	 endoplasmic	 reticulum	associated	degradation	(ERAD)	substrates.																		Other	 aspects	 of	 protein	 quality	 control	 tightly	 associated	 with	 ribosomal	function	 include	 compartmental	 sorting	 and	 translational	 fidelity	 (Gamerdinger	 et	al.,	 2015;	 Sherman	 and	 Qian,	 2013).	 We	 will	 test	 whether	 ncl-1	 missorts	mitochondrial	 proteins	 into	 the	 ER	 with	 existent	 split	 GFP	 reporters,	 or	compromises	the	fidelity	of	protein	synthesis	by	monitoring	translational	error	read	through	 rates	 on	 luciferase	 reporters.	 Moreover	 the	 mTOR	 signaling	 pathway	 is	known	to	affect	protein	synthesis	and	protein	quality	control.		We	will	test	the	idea	that	 NCL-1	 works	 within	 the	 TOR	 pathway	 by	 checking	 TOR	 outputs,	 including	phospho-S6K	 levels,	 phospho-ULK1/UNC-51	 and	 HLH-30/TFEB	 nuclear	localization.																	Disrupted	 proteostasis	 can	 also	 increase	 susceptibility	 to	 proteotoxic	disease.	 	We	will	 also	 examine	 how	ncl-1	mutants	 respond	 to	 challenge	 by	 Aβ42,	polyglutamine	 repeats,	 and	 α-synuclein,	 which	 model	 Alzheimer’s,	 Huntington’s,	and	 Parkinson’s	 disease,	 respectively,	 in	C.	elegans.	 In	 addition	we	will	 determine	the	influence	of	these	proteotoxic	species	on	nucleolar	size.	These	experiments	may	allow	us	to	link	nucleolar	function	and	age-related	disease.	
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5.3	Investigating	the	Mechanism	Underlying	NCL-1	Action	
The	 biochemical	mechanisms	 underlying	 NCL-1	 action	 are	 currently	 unclear.	 It	 is	not	 known	 how	 this	 cytosolic	 protein	 regulates	 nucleolar	 functions	 and	 what	 its	molecular	 targets	 are.	 Recent	 evidence	 points	 towards	 a	 role	 as	 an	 RNA	 binding	protein,	 associated	with	 the	3’	UTR	of	 germline	 expressed	genes	 (Yi	 et.	 al.,	 2015).	RING	domains	are	also	implicated	in	ubiquitin-mediated	proteolysis.		To	clarify	NCL-1	mechanism	we	will	immunoprecipitate	NCL-1,	and	identify	associated	proteins	by	mass	 spectrometry.	 Associated	 proteins	 will	 be	 validated	 by	 pairwise	immunoprecipitation,	 interaction	domains	 characterized,	 and	 complexes	 analyzed.	Interestingly,	 yeast	 two	 hybrid	 data	 from	 C.	 elegans	 and	 Drosophila	 indicate	 a	conserved	interaction	of	NCL-1/BRAT	with	the	argonaute	homologs,	NRDE-3/AGO1	(string-db.org),	respectively,	suggesting	a	potential	link	to	the	RNAi	machinery.	We	will	 test	 NRDE-3	 as	 a	 candidate	 protein	 interactor.	 In	 addition,	 we	 will	 perform	pulldown	 experiments,	 and	 sequence	 associated	 RNAs	 to	 see	 if	 NCL-1	 has	 RNA	targets.	 	Associated	proteins	or	RNAs	will	be	 functionally	analyzed	by	mutation	or	RNAi	 knockdown,	 for	 effects	 on	 protein	 synthesis,	 protein	 quality	 control,	 RNAi	silencing,	nucleolar	function,	and	longevity.		
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5.4	Identifying	Novel	Genes	Regulating	Nucleolar	Function	and	
Longevity		Our	 findings	 clearly	 show	 that	 FIB-1	 is	 down	 regulated	 and	 lifespan	 extension	 is	promoted	in	different	longevity	models	in	a	ncl-1	dependent	manner.	However	it	is	not	understood	how	FIB-1	is	suppressed	in	these	longevity	pathways.	We	aim	to	get	a	 clear	understanding	of	 the	mechanism	by	performing	genetic	 screens	using	FIB-1::GFP	 translational	 reporter.	 The	 transgenic	 strain	 will	 be	 subjected	 to	 EMS	mutagenesis,	 which	 introduces	 random	 mutations	 in	 the	 genome.	 And	 we	 will	screen	 for	 the	 worms	with	 reduced	 FIB-1::GFP	 levels.	Whole	 genome	 sequencing	will	 be	 performed	 on	 these	 worms	 to	 identify	 the	 causal	 gene	 mutations.	 These	genes	 will	 be	 further	 characterized	 by	 assessing	 their	 role	 in	 aging,	 nucleolar	size/function	 and	 ribosome	 biogenesis/protein	 synthesis.	 This	 method	 will	 be	helpful	 in	 identifying	novel	 lifespan	 regulating	 genes	 that	have	 a	 role	 in	nucleolar	function.	Additionally	this	strategy	will	also	be	employed	to	identify	new	factors	that	regulate	ncl-1/fib-1	axis.			
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5.5	Probing	Other	Nucleolar	Functions	in	Aging	
Besides	 regulating	 ribosome	biogenesis	nucleolus	 is	 also	 involved	 in	other	 critical	processes	including	assembly	of	signal	recognition	particle	(SRP)	and	regulation	and	induction	of	nucleolar	stress	under	cellular	stress	conditions	(Boulon	et	al.,	2010).	We	will	investigate	both	these	roles	of	the	nucleolus	in	the	context	of	aging	and	the	involvement	of	ncl-1	in	these	functions.	It	is	well	known	that	upon	nucleolar	stress,	which	can	be	caused	by	DNA	damage,	cytotoxic	drugs	or	transcriptional	 inhibition	etc,	 p53	 is	 induced	which	 serves	 as	 the	marker	 of	 nucleolar	 stress	 (Boulon	 et	 al.,	2010).	There	are	several	reports	that	have	associated	increased	activity	of	p53	with	aging	(Donehower,	2005).	Concordantly	in	C.	elegans	it	has	been	reported	that	loss	of	p53	homolog	cep-1	promotes	longevity	(Arum	and	Johnson,	2007)	dependent	on	autophagy	(Tavernarakis	et	al.,	2008).	We	will	 investigate	if	ncl-1	affects	the	levels	of	cep-1	and	if	cep-1	is	regulated	in	long-lived	worms.	We	will	also	confirm	if	ncl-1	is	required	 for	 longevity	 induced	 by	 cep-1	 loss.	 These	 experiments	will	 be	 useful	 in	confirming	 if	 nucleolar	 stress	 is	 induced	upon	ncl-1	 loss.	We	will	 also	 check	 if	 the	SRP	 function	 is	 altered	 in	 ncl-1	mutants.	We	will	 use	 antibodies	 against	 different	subunits	 of	 the	 SRP	 to	 check	 by	western	 blotting	 if	 the	 levels	 differ	 in	 long-lived	animals	and	ncl-1	mutants.	These	experiments	will	reveal	if	ncl-1	is	required	for	the	SRP	pathway.					
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SUPPLEMENTARY	MATERIALS	
	
	
Supplementary	Table	1:	qPCR	Primers	
 
Gene		 Primer	 										Sequence	
	
  
								ncl-1													ncl-1	Forward									CCAGCAGCAAATGACTTTTTGA	
																																ncl-1	Reverse												TTGTGCTCGTCCGATTGGT					
Supplementary	Table	2:	Lifespan	Analyses		
	
Strain/Treatment	 Median	Lifespan	
Median	
Difference	
from	Control	
(%)	 	Worms*	 P	value	 Reference	Control.	
N2                        26                                            91/120  
eat-2(ad465)                   28                       +7.69                68/120            <0.0001              vs N2 
ncl-1(e1942)                   24                        -7.69                75/120                 ns                   vs N2 
ncl-1(e1865)                   24                        -7.69                98/120               0.03                vs N2 
eat-2;ncl-1(e1942)                          21      -25                   40/120           <0.0001 vs eat-2                                                   
eat-2;ncl-1(e1865)        16              -42.85              72/120           <0.0001 vs eat-2 
 
N2                        25                                           100/120  
eat-2(ad465)                   30                       +20                    48/120             0.002                vs N2 
ncl-1(e1942)                   25                          0                     83/120                ns                  vs N2 
ncl-1(e1865)                   25                          0                     91/120                ns                   vs N2 
eat-2;ncl-1(e1942)                         25   -16.66                 43/120            <0.0001 vs eat-2                                                   
eat-2;ncl-1(e1865)        17           -43.33                  79/120            <0.0001 vs eat-2 
 
N2                        24                                             89/120  
eat-2(ad465)                   27                       +12.5                 64/120               0.002              vs N2 
ncl-1(e1942)                   24                          0                     82/120                 ns                  vs N2 
ncl-1(e1865)                   24                          0                     79/120                 ns                  vs N2 
eat-2;ncl-1(e1942)                          24    -12.5                  58/120             <0.0001  vs eat-2                                                   
eat-2;ncl-1(e1865)        17            -37.07                 94/120             <0.0001 vs eat-2 
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BDR 
N2 (5.85×109CFU/ml)  23                                                 76/90   
N2 (1.95×109CFU/ml)                   36                       +56.52                83/90              <0.0001              vs 
5.85×109 
N2 (6.5×108CFU/ml)                     50                       +38.88                82/90              <0.0001              vs 
1.95×109 
N2 (2.1×108CFU/ml)                     43                       -14                      89/90              <0.0001              vs 
6.5×108 
N2 (7.2×107CFU/ml)                     32                       -25.50                 86/90              <0.0001              vs 
2.1×108 
N2 (2.4×107CFU/ml)                     23                       -28.12                 84/90              <0.0001              vs 
7.2×107 
N2 (8×106CFU/ml)                        18                       -21.73                 81/90                0.0003              vs 
2.4×107 
 
ncl-1(e1942)                                   23                          0                      58/90                   ns                  vs N2 
5.85×109 
(5.85×109CFU/ml)  
ncl-1(e1942)                                   23                       -36.11                 76/90              <0.0001             vs N2 
1.95×109 
(1.95×109CFU/ml) 
ncl-1(e1942)                                   32                       -36                      85/90              <0.0001             vs N2 
6.5×108    
(6.5×108CFU/ml) 
ncl-1(e1942)                                   27                       -37.20                 88/90              <0.0001             vs N2 
2.1×108 
(2.1×108CFU/ml)  
ncl-1(e1942)                                   23                       -28.12                 83/90              <0.0001             vs N2 
7.2×107 
(7.2×107CFU/ml)  
ncl-1(e1942)                                   18                       -21.73                 84/90                0.0092             vs N2 
2.4×107 
(2.4×107CFU/ml) 
ncl-1(e1942)                                   13                       -27.77                 86/90                   ns                  vs N2 
8×106 
(8×106CFU/ml) 
ncl-1(e1865)                                   23                          0                      77/90                   ns                  vs N2 
5.85×109 
(5.85×109CFU/ml) 
ncl-1(e1865)                                   23                       -36.11                 85/90              <0.0001             vs N2 
1.95×109  
(1.95×109CFU/ml) 
ncl-1(e1865)                                   27                       -46                      78/90              <0.0001             vs N2 
6.5×108 
(6.5×108CFU/ml) 
ncl-1(e1865)                                   23                       -46.51                 79/90              <0.0001             vs N2 
2.1×108 
(2.1×108CFU/ml) 
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ncl-1(e1865)                                   23                       -28.12                 86/90              <0.0001             vs N2 
7.2×107 
(7.2×107CFU/ml) 
ncl-1(e1865)                                   18                       -21.73                 75/90                0.0253             vs N2 
2.4×107 
(2.4×107CFU/ml) 
ncl-1(e1865)                                   18                          0                      87/90                   ns                  vs N2 
8×106 
(8×106CFU/ml) 
 
N2 GFPi                                         21                                                 94/120 
N2 let-363/TORi                            28                       +33.33              82/120              <0.0001            vs N2 
GFPi 
ncl-1(e1942) GFPi                         26                                                 79/120 
         ncl-1(e1942)                                   23                       -17.85               82/120                0.0046        vs N2 let-
363/TORi 
let-363/TORi  
ncl-1(e1865) GFPi                         23                                                 92/120  
ncl-1(e1865)                                  26                        -7.14                 83/120               <0.0001       vs N2 let-
363/TORi 
let-363/TORi 
 
N2 GFPi                                         24                                                90/120 
N2 let-363/TORi                            29                       +20.83              65/120               <0.0001            vs N2 
GFPi 
ncl-1(e1942) GFPi                         22                                                45/120 
ncl-1(e1942)                                  27                        -6.89                79/120                <0.0001       vs N2 let-
363/TORi 
let-363/TORi  
ncl-1(e1865) GFPi                         22                                                65/120  
ncl-1(e1865)                                  24                        -17.24              92/120                <0.0001       vs N2 let-
363/TORi 
let-363/TORi 
 
N2 GFPi                                         19                                                81/120 
N2 let-363/TORi                            27                       +42.10              60/120                <0.0001           vs N2 
GFPi 
ncl-1(e1942) GFPi                         17                                                54/120 
ncl-1(e1942)                                  15                        -44.44              49/120                 <0.0001      vs N2 let-
363/TORi 
let-363/TORi  
ncl-1(e1865) GFPi                         19                                                90/120  
ncl-1(e1865)                                  23                        -14.81              78/120                <0.0001       vs N2 let-
363/TORi 
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let-363/TORi 
 
N2 GFPi                                         25                                                99/120 
N2 daf-2i                                        55                       +120                 83/120                 <0.0001           vs N2 
GFPi  
ncl-1(e1942) GFPi                         21                                                84/120 
ncl-1(e1942) daf-2i                        34                       -38.18               77/120                 <0.0001           vs N2 
daf-2i 
ncl-1(e1865) GFPi                         21                                               104/120 
ncl-1(e1865) daf-2i                        45                       -18.18              42/120                  <0.0001            vs N2 
daf-2i 
 
N2 GFPi                                         20                                                 87/120 
N2 daf-2i                                        58                       +190                  86/120               <0.0001             vs N2 
GFPi 
ncl-1(e1942) GFPi                         20                                                 64/120 
ncl-1(e1942) daf-2i                        51                       -12.06                58/120               <0.0001             vs N2 
daf-2i 
ncl-1(e1865) GFPi                         20                                                 94/120 
ncl-1(e1865) daf-2i                        47                       -18.96                79/120               <0.0001             vs N2 
daf-2i 
 
N2 GFPi                                        24                                                  62/120 
N2 daf-2i                                       59                        +145                  69/120               <0.0001             vs N2 
GFPi 
ncl-1(e1942) GFPi                        24                                                  31/120 
ncl-1(e1942) daf-2i                       48                        -18.64                47/120               <0.0001             vs N2 
daf-2i 
ncl-1(e1865) GFPi                        24                                                  74/120 
ncl-1(e1865) daf-2i                       48                        -18.64                73/120               <0.0001             vs N2 
daf-2i 
 
N2                                                  22                                                 66/120 
ncl-1(e1942)                                  20                                                 64/120 
glp-1(e2141)                                  33                        +50                 102/120               <0.0001              vs N2  
glp-1;ncl-1                                     22                        -33.33               92/120               <0.0001              vs glp-
1 
 
N2                                                  24                                                 83/120 
ncl-1(e1942)                                  24                                                 57/120 
glp-1(e2141)                                  40                        +66.66            102/120               <0.0001              vs N2  
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glp-1;ncl-1                                     24                        -40                    92/120               <0.0001              vs glp-
1 
 
glp-1(e2141)                                  37                                                 76/120               <0.0001  
glp-1;ncl-1                                     25                        -32.43             103/120               <0.0001              vs glp-
1 
 
N2                                                   23                                                93/120 
ncl-1(e1942)                                   23                                                89/120 
isp-1(qm150)                                  29                       +26.08              39/120                <0.0001              vs N2  
isp-1;ncl-1                                      25                       -13.79             103/120                   0.002               vs isp-
1 
 
N2                                                   23                                                93/120 
ncl-1(e1942)                                   23                                                89/120 
isp-1(qm150)                                  34                       +47.82              38/120                <0.0001              vs N2  
isp-1;ncl-1                                      26                       -23.52               69/120                  0.0016              vs isp-
1 
 
isp-1(qm150)                                  34                                                29/120                <0.0001  
isp-1;ncl-1                                      22                       -35.29               70/120                <0.0001              vs 
isp-1 
 
N2                                                   24                                                86/120 
N2+ncl-1::gfp                                29                       +20.83              78/120                <0.0001              vs N2 
(dhEx1007)                    
N2+ncl-1::gfp                                27                       +12.50              63/120                <0.0001              vs N2 
(dhEx1008)  
 
N2                                                   16                                                78/120 
N2+ncl-1::gfp                                22                       +37.50              57/120                <0.0001              vs N2 
(dhEx1007) 
 
N2                                                   17                                                63/120 
N2+ncl-1::gfp                                23                       +35.29              48/120                <0.0001              vs N2 
(dhEx1007)  
 
N2                                                   26                                                91/120 
eat-2(ad465)                                   28                       +7.69                68/120                <0.0001              vs N2 
ncl-1(e1942)                                   24                                                75/120       
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eat-2;ncl-1                                      21                        -25                   40/120                <0.0001              vs 
eat-2 
eat-2;ncl-1+                                   27                       +3.57                78/120                      ns                  vs 
eat-2 
ncl-1::gfp(dhEx1007)  
eat-2+ncl-1::gfp                           30                        +7.14                62/120                      ns                  vs eat-
2 
(dhEx1007) 
 
N2                                                   20                                                87/120 
eat-2(ad465)                                   26                       +30                   66/120                <0.0001              vs N2 
ncl-1(e1865)                                   20                                                94/120       
eat-2;ncl-1                                      23                       -11.53               77/120                <0.0001              vs 
eat-2 
eat-2;ncl-1+                                   26                            0                   56/120                      ns                  vs 
eat-2 
ncl-1::gfp(dhEx1007) 
 
N2 GFPi                                          24                                               90/120 
N2 fib-1i                                          27                      +12.50              56/120               <0.0001               vs N2 
GFPi  
 
N2 GFPi                                          19                                               81/120 
N2 fib-1i                                          23                      +21.10              47/120                 0.0004               vs N2 
GFPi  
 
N2 GFPi                                          19                                               81/120 
N2 fib-1i                                          29                      +52.63              87/120                <0.0001              vs N2 
GFPi 
 
N2 GFPi                                          24                                               89/120   
N2 fib-1i                                          29                      +20.83              87/120                <0.0001              vs N2 
GFPi 
  
 
N2 GFPi                                          24                                               90/120                       
N2 fib-1i                                          26                      +8.33                75/120                 0.0004                vs N2 
GFPi 
  	*	no.	of	dead	worms/total	no.	of	worms	analyzed	p-values	for	statistical	analyses	were	calculated	using	Mantel-Cox	Log	Rank	test.	
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Worms	that	escaped	the	dishes,	had	internal	hatching	or	had	bursting	of	vulva	were	censored	from	the	experiment.	
	
Supplementary	Table	3:	Nucleolar	Size	Analyses	
	
	
	
Strain/Condition	
Average	nucleolar	
area	(µm2)	
Standard	Deviation	 %	Change	relative	to	
N2	or	N2	Control	
RNAi	
	
Nucleoli	in	hypodermis		N2																																			5.390																											±	2.480									
eat-2(ad465)																						2.821																											±	0.919																										-47.65	N2	let-363/TORi															2.835																											±	1.141																										-47.40		
isp-1(qm150)																					2.845																											±	1.053																											-47.22	
glp-1(e2141)																						3.354																											±	1.447																											-37.76	
daf-2(e1370)																						2.321																											±	1.032																											-56.92	
daf-2;daf-16(mu86)									4.583																											±	1.965																											-14.98		N2	Control	RNAi														4.492																											±	1.150		N2	fib-1i																														2.131																											±	0.779																											-52.56		
	
Nucleoli	in	pharyngeal	muscle		 N2																																			2.017																											±	0.562	
eat-2(ad465)																						1.581																											±	0.481																												-21.60	N2	let-363/TORi															1.719																											±	0.455																												-14.79		
isp-1(qm150)																					1.222																											±	0.350																												-39.42	
glp-1(e2141)																						1.669																											±	0.466																												-17.25	
daf-2(e1370)																						1.555																											±	0.426																												-22.91	
daf-2;daf-16(mu86)									2.240																											±	0.668																												+11.05		
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Nucleoli	in	germ	cells		 N2																																	10.769																										±	2.657	
eat-2(ad465)																							6.549																										±	2.050																											-39.18	N2	let-363/TORi																	9.227																										±	1.451																											-14.32		
isp-1(qm150)																							7.264																										±	2.119																											-32.54	
daf-2(e1370)																								8.047																										±	1.471																											-25.27	
daf-2;daf-16(mu86)											10.633																								±	1.779																											-1.269		
BDR	
	
Strain	and	Condition	
Average	nucleolar	
area	(µm2)	
Standard	Deviation	 %	Change	relative	to	
N2	(5.85x109)			N2	(5.85x109)																				4.218																										±	1.725								N2	(1.96	x109)																			2.757																										±	0.988																												-	34.61	N2	(6.50	x108)																			1.531																										±	0.365																												-	63.70	
	
	
	
Supplementary	 Table	 4:	 Characteristics	 of	 human	 volunteers	 following	
lifestyle	intervention		
 
Growing	Old	Together	
participants	(N=10)	Age,	years	 62.4	(4.1)	Females,	N	(%)	 5	(50)	Lipid	lowering	medication,	N	(%)	 3	(30)	Antihypertensive	medication,	N	(%)	 3	(30)	
Intervention	parameters	 		Baseline	weight,	kg	 81.0	(12.8)		After	intervention	weight,	kg	 74.2	(12.1)		Baseline	glucose,	mmol/L		 5.1	(0.4)		After	intervention	glucose,	mmol/L	 4.9	(0.5)		Baseline	SBP,	mmHg	 146.5	(14.9)		After	intervention	SBP,	mmHg	 136.4	(9.4)		Baseline	BMI,	kg/m2	 28.4	(2.7)		After	intervention	BMI,	kg/m2	 26.0	(2.4)		Means	(standard	deviations)	are	provided	unless	otherwise	stated.		
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